Modulation of DNA repair : studies on the xenobiotic activation of poly(adenosine diphosphate ribosylation) in humans by Stierum, R.H.
  
 
Modulation of DNA repair : studies on the xenobiotic
activation of poly(adenosine diphosphate ribosylation)
in humans
Citation for published version (APA):
Stierum, R. H. (1996). Modulation of DNA repair : studies on the xenobiotic activation of poly(adenosine
diphosphate ribosylation) in humans. Maastricht: Rijksuniversiteit Limburg.
Document status and date:
Published: 01/01/1996
Document Version:
Publisher's PDF, also known as Version of record
Please check the document version of this publication:
• A submitted manuscript is the version of the article upon submission and before peer-review. There can
be important differences between the submitted version and the official published version of record.
People interested in the research are advised to contact the author for the final version of the publication,
or visit the DOI to the publisher's website.
• The final author version and the galley proof are versions of the publication after peer review.
• The final published version features the final layout of the paper including the volume, issue and page
numbers.
Link to publication
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these
rights.
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
• You may not further distribute the material or use it for any profit-making activity or commercial gain
• You may freely distribute the URL identifying the publication in the public portal.
If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license above,
please follow below link for the End User Agreement:
www.umlib.nl/taverne-license
Take down policy
If you believe that this document breaches copyright please contact us at:
repository@maastrichtuniversity.nl
providing details and we will investigate your claim.
Download date: 04 Dec. 2019
Hct verschijnen van dit proerschnit werd mede
mogeliJR gemaakt door de rinanciele steun van de
Stichting Dr. Ir. J.H.J. van de Laar
en de Johan Vermeij Stichting
MODULATION OF DNA REPAIR
Studies on the xenobiotic activation of
poly(adenosine diphosphate ribosylation)
in humans
MODULATION OF DNA REPAIR
Studies on the xenobiotic activation of
poly(adenosine diphosphate ribosylation)
in humans
PROEFSCHRIFT
ter verkrijging van de graad van doctor
aan de Rijksuniversiteit Limburg te Maastricht,
op gezag van de Rector Magnificus, Prof. mr. MJ. Cohen,
ingevolge het besluit van het College van Dekanen,
in het openbaar te verdedigen op
vrijdag 9 februari 1996 om 16.00 uur
door
Robertus Henricus Stienim
geboren te Geldrop op 25 maart 1968
Promotor:
Prof. dr. J.C.S. Kleinjans
Co-promotor:
Dr. ir. GJ. Hageman
Beoordelingseommissie:
Prof. dr. J.P.M. Geraedts, voorzitter
Dr. W.A. Buurman
Prof. dr. J.H.J. Hoeijmakers (Erasmus Universiteit Rotterdam)
Prof. dr. ir. P.H.M. Lohman (Rijksuniversiteit Leiden)
Prof. dr. F.C.S. Ramaekers
C1P-DATA KON1NKLIJKE BIBLIOTHEEK, DEN HAAG
Slierum, Ro/wtus, Heiiricws
Modulation o /DNA repair Studies OM ifot xmobiot/c activation o
di7>bos/>bdlf rifcosylationj I'H foumaiis / SfiVrum, Rofcertus, Hfnricus. -
/SBN 90-5681-003-0
Sufejcct fcertdiVufS: DNA fcfrstef / f oly (aaVnosmr Ji/os/adt rifcosy/mn^) /^oictiscbf
nicotinrzuur / u'lttf Moe^cellfii / frrnzo faj/)yrfot loxia'teit
Drufe.- L/«f^rrt/)fcic, Rijfesum'pfrsiteit Li'mtur^, Mrtrtstricfet
.Hey I hope it's true what my wife said to me She says,
hahy, it's the Beginning of a Great Adventure...
(Lou Reed, New York, 1989)
Contents
Abbreviations 8
Chapter 1 Introduction 11
1.1 Chemical carcinogenesis. A historical overview 11
1.2 The multi-stage model of chemical carcinogenesis 11
1.3 DNA damage 13
1.4 DNA repair 14
1.4.1 DNA alkyltransferases • 15
1.4.2 Base excision repair 15
1.4.3 Nucleotide excision repair 16
1.4.4 Factors influencing DNA repair in humans 19
1.5 Poly(ADP-ribosylation) and niacin metabolism 20
1.5.1 Poly(ADP-ribosylation). The enzymatic process 20
1.5.2 Poly(ADP-ribosylation). Induction by DNA strand break-
inducing agents 22
1.5.3 Poly(ADP-ribosylation). Proposed functions with regard
to cellular responses to DNA damage 23
1.5.4 Poly(ADP-ribosylation). Relation to carcinogenesis 25
1.5.5 Niacin metabolism 26
1.5.6 Niacin metabolism. Importance with regard to modulation
of poly(ADP-ribosylation), DNA repair and cancer risk 27
1.6 The adaptive response 28
1.6.1 The adaptive response. A phenomenon reflecting the
ex two induction of DNA repair mechanisms 28
1.6.2 Possible involvement of poly(ADP-ribose) polymerase in
the adaptive response to ionizing radiation 32
1.7 DNA damage and p53 accumulation 32
1.7.1 A role for wild-type p53 tumour suppressor protein in
modulating the persistence of DNA damage 32
1.7.2 Poly(ADP-ribose) polymerase. Possible involvement in
DNA damage inducible pathways of p53 accumulation ? 35
1.8 Benzo[a]pyrene and its reactive diolepoxides 36
1.8.1 Benzo[a]pyrene and its reactive diolepoxides. Model
compounds to study DNA damage, DNA repair,
mutagenicity and carcinogenicity 36
1.8.2 Interactions of (±)-<jnh'-benzo[a]pyrene diolepoxide
with DNA 36
1.8.3 Repair of (±)-a/ih-benzo[a]pyrene diolepoxide-
induced DNA damage 38
1.9 Aims and outline of this thesis 40
Chapter 2
Chapter 3
Chapter 4
Chapter 5
Chapter 6
Chapter 7
Measurement by 32p postlabeling of (±)-<JMfi-
benzo[a]pyrene-diolepoxide-N2-deoxyguanosine adduct
persistence in unstimulated human peripheral blood
lymphocytes
Increased poly(ADP-ribose) polymerase activity during
repair of (±)-a«h-benzo[a]pyrene diolepoxide-induced
DNA damage in human peripheral blood lymphocytes
59
Age-related negative associations between parameters of
cytogenetic damage and ex w'uo (±)-awf/-benzo[a]pyrene
diolepoxide-induced unscheduled DNA synthesis in
smoking humans
69
Effect of nicotinic acid supplementation on niacin status in
relation to cytogenetic damage and ex i>ii>o (±)-flnh-
benzo[a]pyrene diolepoxide-induced DNA repair in
smoking humans 89
(±)-an/i-benzo[a]pyrene diolepoxide-induced adaptive
response in human peripheral blood lymphocytes is not
associated with enhanced induction of
poly(ADP-ribosylation)
Inhibition of poly(ADP-ribose) polymerase increases
(±)-flnfi-benzo[a]pyrene diolepoxide-induced
micronuclei formation and p53 accumulation in
isolated human peripheral blood lymphocytes
Chapter 8 General discussion
Summary
Samenvatting
Dankwoord
Curriculum vitae
111
121
137
153
165
169
173
175
List of publications 175
Abbreviations
3-AB
actD
ADP
(±)-o«f/-BPDE
AP
AR
AT
ATP -
B[a]P
BEAS
BER
BLM
BrdU
BSA
C
CA
cdk
CS
CT
cytB
dG
DHB-Biorex
DMS
DMSO
ENU
EO
eRado
FCS
G
HPRT
HT
HTO
IR
U
M
MMC
MMS
MN
3-aminobenzamide
actinomycin D
adenosine diphosphate
(±)-<Jnfi-benzo[a]pyrene diolepoxide: (±)-7P,8a-dihydroxy-
9a,10a-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene
apurinic/apyrimidinic
adaptive response
ataxia-telangiectasia
adenosine triphosphate
benzo[a]pyrene
SV40-immortalized BEAS-2B human bronchial epithelial
cells
base excision repair
bleomyciri
bromodeoxyuridine
bovine serum albumine
challenge
chromosomal aberrations
cyclin-dependent kinase(s)
Cockayne's syndrome
[l4C]thymidine
cytochalasin B
deoxyguanosine
dihydroxyboryl Bio-Rex
dimethylsulfate
dimethylsulfoxide
N-ethyl-N-nitrosourea
ethylene oxide
ethenoribosyladenosine
foetal calf serum
guanine
hypoxanthine guanine phosphoribosyltransferase
hyperthermia
tritiated water
ionizing radiation
labeling index
mutations
mitomycin C
methylmethanesulfonate
micronuclei
MNU
MNNG
MTT
N-AAAF
N-AAF
NAD+
NE
NER
NQO
PADPR
PADPRT
PAH
PBLs
PBS
PHA
PT
SCE
SDS
TG""
TT
TTD
UDS
UV
VF
XP
N-methyl-N-nitrosourea
N-methyl-N'-nitro-N-nitrosoguanidine
3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium
bromide
N-acetoxy-N-acetylaminofluorene
N-acetylaminofluorene
nicotinamide adenine dinucleotide
niacin equivalent: the dietary amount of niacin precursors
equivalent to 1 mg of nicotinic acid (60 mg tryptophan ~ 1
mg nicotinic acid ~ 1 NE)
nucleotide excision repair
4-nitroquinoline-l-oxide
poly(adenosine diphosphate ribosylation)
poly(adenosine diphosphate ribose) polymerase:
NAD+ ADP-ribosyltransferase (EC 2.4.2.30)
polycyclic aromatic hydrocarbon(s)
human peripheral blood lymphocytes
phosphate buffered saline
phytohemagglutinin
pre-treatment
sister chromatid exchange
sodium dodecyl sulphate
6-thioguanine resistent
[3H]thymidine
trichothiodystrophy
unscheduled DNA synthesis
ultraviolet light
variant frequency
xeroderma pigmentosum

Introduction
1.1 Chemical carcinogenesis. A historical overview
Cancer. The word originates from the Grecian civilization, referring to the
invasive character of carcinomas into surrounding tissues with the arms and
pincers of a lobster or a crab (Greece: Karkinos, Latin: Cancer).
About two thousand years later, it became apparent that exposure to chemicals
could be a causal factor in the development of cancer. In 1761, Hill suggested the
existence of a relation between use of tobacco snuff and nasal cancer. A few years
later, in 1775, the London surgeon Pott tried to relate his observation of high
incidence of scrotum cancer in young chimney sweeps to soot exposure. In 1895,
Rehn reported associations between chronic exposure to aromatic amines and
urinary bladder cancer in humans working in the dye industry. In the beginning
of the 20th century, the first studies on experimental chemical carcinogenesis
were performed. In 1915, two Japanese pathologists, Yamagawa and Ichikawa,
showed that topical application of coal tar to the ears of rabbits resulted in the
induction of skin carcinomas. Some years later, Kennaway and Hieger (in 1930)
and Cook (in 1933) identified dibenz[a,h]anthracene and benzo[a]pyrene (B[a]P) as
carcinogenic polycyclic aromatic hydrocarbons (PAH) present in coal tar
(reviewed in 1). Since 1940, a large number of other carcinogenic chemical
substances has been identified. Some examples are vinyl chloride and ethyl
carbamate, aflatoxin Bl, bis(chloromethylether), N-acetylaminofluorene (N-
AAF), dimethylnitrosoamine, aflatoxins and various PAH. Today, it is believed
that besides genetic factors, infectious organisms and ionizing radiation (IR),
various environmental factors, such as tobacco smoke, alcohol consumption,
dietary factors, sexual habits, reproductive factors, and occupational exposure to
chemicals all attribute to the causation of cancer in humans (2). Although some
of these factors cannot be classified as true chemical carcinogens themselves, it is
quite certain that chemicals are involved in the ways these factors may cause
cancer.
1.2 The multi-stage model of chemical carcinogenesis
In the period between 1940 and 1950, in parallel with the discovery of numerous
carcinogens, an important finding was that the process of (chemical)
carcinogenesis consisted of more than one stage (reviewed in 1). Further, Miller
and Miller (3) proposed that the majority of chemical carcinogens are directly, or
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after metabolization to electrophylic intermediates, capable of reacting with
cellular macromolecules such as DNA. Their hypothesis was a major
breakthrough in the understanding of chemical carcinogenesis. Since the
beginning of the eighties, the complex process of cancer development has
essentially been divided into three stages: initiation, promotion and progression.
During initiation, a process which is irreversible, normal cells are converted to
neoplastic cells. The first step in this process is the interaction of electrophylic
compounds with DNA. A critical following step is DNA replication, in which
misincorporation of a nucleotide takes place opposite to the damaged base. This
results in a DNA molecule with an altered nucleotide sequence in the newly
synthesized daughter strand. After subsequent mitosis, cell division and DNA
replication - using the altered daughter strand in one of the (first-generation)
daughter cells as replication template - a second cell division will ultimately
result in formation of one (second-generation) daughter cell with a DNA
molecule, in which both strands contain an altered sequence. The latter process is
called DNA mutation-fixation. In this way, a single base-pair within the coding
region (exon) of a gene may be substituted by a different one, which is called
point-mutation. In addition, DNA polymerases may fail to incorporate any, or
incorporate additional nucleotides opposite to a damaged nucleotide in the
template strand. Consequently, one ore more nucleotides will be gained or lost
from the resulting daughter strand leading to so called frame-shift mutations in
coding regions. Besides gene mutations, other alterations such as deletions, gene
amplifications or rearrangements may result from interaction of carcinogens
with macromolecules and contribute to initiation or subsequent steps in
carcinogenesis.
Promotion can be characterized as the (reversible) clonal outgrow of initiated
cells into neoplasms. Loss of several factors that regulate normal cell
proliferation is believed to be responsible for this process. An examples is loss of
intercellular communication. Continued exposure to agents (promotors) that
stimulate cellular proliferation, is believed to be responsible for tumour
promotion.
Progression is the final stage of carcinogenesis, during which benign or
malignant neoplasms can be characteristically seen. Additional genetic
alterations accumulate, such as karyotypic changes. These changes are directly
related to the increased growth rate, invasiveness, metastatic capability and
biochemical changes in the neoplastic cell. The process of progression is
presumed to be irreversible (reviewed in 1).
In particular, alterations in growth-regulatory proto-oncogenes and tumour
suppressor genes are believed to be responsible for tumorigenesis. Proto-
oncogenes, initially identified as genes of acutely transforming (retro)viruses, are
genes that are involved in regulation of normal cell proliferation. Their gene
products are components of cellular signalling pathways of growth stimulatory
12
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signals, such as hormones, hormone receptors, cytoplasmic signalling proteins
and nuclear factors. Alterations in proto-oncogenes, such as point mutations,
chromosome translocations, gene amplification or aberrant 5-methylcytosine
methylation may lead to aberrant gene products or alternatively, to enhanced
gene expression. Ultimately, these changes may result in acceleration of cell
division. In addition, loss of normal tumour suppressor genes is believed to
attribute to carcinogenesis. Tumour suppressor genes code for proteins that
inhibit cell proliferation by arresting progression through the cell cycle, blocking
differentiation or inducing senescence or cell death (4,5). Although the nature
and order of appearance during tumorigenesis is not fully understood, it is
believed that cumulative alterations in both oncogenes and tumour suppressor
genes are crucial for tumorigenesis (6).
1.3 DNA damage
As mentioned, Miller and Miller (3) proposed that the majority of carcinogens
are themselves electrophylic intermediates (direct carcinogens) or first need to be
converted to reactive metabolites (pro-carcinogens or pre-carcinogens). At
present, indeed numerous carcinogens are known which either directly or
indirectly interact with DNA. Without the intention of giving an exhausting
complete enumeration, examples illustrating the wide spectrum of interactions
of various carcinogens with DNA are given below.
Sulfate esters, like dimethylsulfate (DMS) and methylmethanesulfonate
(MMS) and nitrosoamides and nitrosoureas, like N-methyl-N-nitrosourea
(MNU) and N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), may transfer
methyl- or higher alkylgroups towards oxygen and nitrogen atoms of
nucleotides. Examples of these small adducts are O^-alkylguanine; N7-
alkylguanine; 3-alkyladenine; G"*-alkylthymine and phosphotriesters. Reaction of
DNA with N-hydroxylated metabolites from aromatic amines like N-AAF, 1-
naphtylamine, 2-naphtylamine, 4-aminobiphenyl and benzidine, may primarily
yield large adducts on C8 and N^ of deoxyguanosine (dG), but also on G* of dG
and N7 of deoxyadenosine. Diolepoxide intermediates of PAH like B[a]P,
dibenzo[a,h]pyrene, 7,12-dimethylbenzo[a]anthracene, benzo[a]anthracene and
chrysene form large covalent adducts with DNA (7,8). An example is the adduct
between the 2-aminogroup of guanine and the CIO position of B[a]P (9,10).
Interaction of reactive metabolites from fungal and plant toxins like aflatoxins
and safrole, may yield large unstable adducts on N7 of guanine and N^ of
guanine and N^ of adenine respectively (11). Small exocyclic (etheno-bridged)
DNA adducts may be formed on adenine, cytosine and guanine bases, as a
consequence of interactions between DNA and vinyl compounds like vinyl
chloride monomer, halogenated aldehydes like chloro- and bromo-acetaldehyde
and non-radical lipid peroxidation products like frons-4-hydroxy-2-nonenal (12).
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In addition to chemicals, physical agents may also induce via chemical
intermediates DNA damage. Ultraviolet light (UV) causes formation of
cyclobutane pyrimidine dimers, pyrimidine-pyridone 6-4 photoproducts and
pyrimidine hydrates (13,14). Ionizing radiation, like y-rays, X-rays, P-particles and
radon (a-particles) may cause, via hydroxyl radical intermediates, formation of
oxidized bases like 8-oxoguanine, 5-hydroxycytosine and thymine glycol;
damaged bases like pyrimidine imidazole ring open products; damaged
deoxyribose moieties and DNA single and double strand breaks (15-17). Finally,
active oxygen species, formed by exposure to mineral dusts like asbestos or coal
mine dust, may generate a variety of modified bases (18).
1.4 DNA repair
From an evolutionary point of view, changes in the genetic code are necessary to
attribute to the diversity and survival of species. At the individual level
however, it is absolutely required to retain the integrity of DNA prior to DNA
replication, DNA transcription and cell division. In order to maintain this
genetic integrity, prokaryotic and eukaryotic cells possess DNA repair systems. As
a matter of course, it can be imagined that without any repair, every carcinogen-
DNA interaction potentially may lead to a genetic alteration and thus ultimately
to cell-death, the onset of carcinogenesis or other aberrant phenomena like birth
defects. The clearest example illustrating that defective DNA repair is associated
with carcinogenesis, is the high incidence of skin cancer seen in patients with
xeroderma pigmentosum (XP). Individuals affected by this disease have a
marked inability to perform nucleotide excision repair (NER) of cyclobutane
pyrimidine dimers and pyrimidine-pyridone 6-4 photoproducts induced by UV
(19,20). In addition, in mammalian cells treated ex y/fo with DNA damaging
carcinogens, negative associations have been found between the extent of DNA
repair and the extent of mutagenesis (21-24).
At present, several mechanisms of pre-replicational DNA repair are known in
mammalians, like DNA alkyltransferases, base excision repair (BER) and
nucleotide excision repair (NER). Besides pre-replicational repair, other repair
mechanisms, such as mismatch repair ensures the restoration of mis-
incorporated nucleotides, after normal DNA replication. This particular repair
mechanism, known for years in £. co/i, has been recently characterized in
humans (25-29). Detailed discussion of post-replicational repair mechanisms are
beyond the scope of this Thesis. However, it has to be mentioned that defects in
the human mismatch repair gene /iMSH2 were recently associated with
hereditary nonpolyposis colorectal cancer (26,28), thus highly emphasizing the
importance of accurate DNA repair in prevention of human carcinogenesis.
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1.4.1 DNA alkyltransferases
DNA alkyltransferases are proteins capable of repair of alkylated DNA bases. The
main characteristic of these group of proteins is the direct transfer, without base
or nucleotide removal, of alkylgroups from damaged bases towards
sulfhydrylgroup-containing cysteine residues within the protein. After this
transfer, the binding site of the protein is not regenerated. Instead, repair via this
pathway is dependent on rfe noz>o synthesis of additional alkyltransferase. In £.
co/i, two DNA alkyltransferases have been identified: the inducible Ada protein
and the constitutive Ogt (O^-alkylguanine DNA alkyltransferase) protein. Other
prokaryotic alkyltransferases have been identified as well. These alkyltransferases
are capable of removing alkylgroups from O^-methylguanine, C*-
methylthymine and methyl phosphotriesters (30-32). In mammalians (human
and rat), only the O^-alkylguanine DNA alkyltransferase has been characterized
in detail (33-35). Besides removal of methyl groups from the Opposition of
guanine, the mammalian alkyltransferase can also remove ethyl, M-propyl, 2-
chloroethyl, n-butyl, isopropyl, isobutyl and 2-hydroxyethyl groups (32). In
contrast to prokaryotic alkyltransferases, the mammalian O^-alkylguanine DNA
alkyltransferase lacks methyl phosphotriester methyltransferase activity. Further,
it is unlikely that repair of alkylated exocyclic oxygen atoms on thymine proceeds
via the O^-alkylguanine DNA alkyltransferase (32,36).
1.4.2 Base excision repair
During BER, the combined action of several enzymes is required to replace a
damaged base by its undamaged counterpart. Two classes of enzymes are
involved in BER of modified DNA bases: DNA glycosylases and
apurinic/apyrimidinic (AP) endonucleases. Some enzymes called DNA-
glycosylase-AP endonucleases possess the combined action of both enzymes.
DNA glycosylases are enzymes with a narrow substrate specificity, which
recognize a damaged or unusual base. They catalyze hydrolysis of the N-
glycosilic bond between the modified base and the deoxyribose group. Several
prokaryotic DNA glycosylases have been identified. Examples are the uracil-DNA
N-glycosylase, recognizing uracil originating from deaminated cytosine and 3-
methyladenine-DNA N-glycosylases, recognizing besides 3-methyladenine also
3-methylguanine, 7-methylguanine, O^-methylguanine and O^-methylcytosine.
Further, the formamidopyrimidine-DNA N-glycosylase recognizes the
imidazole-ring open products of guanine and adenine. These products may arise
from unstable adducts formed after hydroxyl radical attack on guanine and
adenine (4,6-diamino-5-formamidopyrimidine and 2,6-diamino-4-hydroxy-5-
formamidopyrimide) or alkylation at N7 of guanine (2,6-diamino-4-oxy-5-
(methylformamido)pyrimidine) (15,30). Hypoxanthine-DNA N-glycosylase
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recognizes hypoxanthine, that results either from physiological deamination of
adenine or interaction of DNA with chemical agents like nitrous acid. Finally,
hydroxymethyluracil-DNA N-glycosylase recognizes hydroxymethyluracil,
produced by hydroxyl radical attack on the methylgroup of thymine (15,37).
Similar DNA glycosylase activities have been identified in mammalians,
including humans (15,30,37) although the enzymes themselves have not been all
purified and characterized in detail yet.
Besides enzymatic removal of the damaged base by a DNA glycosylase,
apurinic or apyrimidinic sites may also arise from spontaneous cleavage of the
N-glycosylic bond between the deoxyribose group and the damaged base. This
bond may become unstable upon alkylation (30) or hydroxyl radical attack (15).
The non-enzymatically or enzymatically generated AP sites are substrates for
AP endonucleases. These enzymes, which can be categorized into four classes,
incise either on 3' or 5' side of the abasic sugar residue, leaving on both sites 3'-
OH and 5'-P or 3'-P and 5'-OH termini, respectively (30). Prokaryotic AP-
endonucleases of all four classes have been identified (30,37). Further, human
Mg2+-dependent AP endonucleases have been purified from Hela cells,
fibroblasts and placenta (30,37). The nick in the phosphodiester linkage (or the
one-nucleotide gap resulting from |}-elimination of the 5'-incised nucleotide or
from enzymatic removal by an exonuclease) is recognized by a DNA polymerase
which fills the gap with a new nucleotide. Finally, a DNA ligase restores the
phosphodiester bond between the newly incorporated nucleotide and the
nucleotide, already present. Recently, Dianov and Lindahl (38) reconstituted a
BER excision repair pathway in i>ifro using the purified E. co// proteins Uracil-
DNA glycosylase, AP endonuclease IV, a protein called RecJ capable of removing
the abasic deoxyribose-phosphate residue, DNA polymerase I and DNA ligase.
Interestingly, in absence of RecJ, a minor pathway of BER was also found to
occur, during which DNA polymerase I cuts out (due to its 5' nuclease activity)
and replaces a short (abasic) deoxyribosephosphate residue-containing
oligonucleotide with new nucleotides, followed by action of DNA ligase (38).
1.4.3 Nucleotide excision repair
In contrast to BER which act on minor DNA adducts, NER mechanisms mainly
act on larger DNA adducts. Examples are UV-induced cyclobutane pyrimidine
dimers and pyrimidine-pyridone 6-4 photoproducts. Further, DNA containing
large adducts from chemicals like cisplatin, mitomycin C, B[a]P, psoralen, N-
AAF and 4-nitroquinoline are substrate for NER mechanisms (37,39-41). Given
the heterogeneous substrate range for NER mechanisms, recognition of damage
can not simply rely on a binary recognition mechanism in which enzyme-
substrate binding is accomplished through complementary surfaces. Instead, the
activity of NER mechanisms results from sequential and partly overlapping
16
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activities of several DNA-binding polypeptides, requiring the energy released
from hydrolysis of adenosine triphosphate (ATP).
The most extensively studied and best understood mechanism of NER is the
Uvr(A)BC exinuclease system from £. co//. In this prokaryote, NER involves the
concerted action of several polypeptides. First, in presence of ATP, a complex of
two UvrA proteins is formed. Subsequently, this dimer complexes with an UvrB
protein, recognizes the damaged nucleotides and binds near to the lesion with
DNA. Then, the UvrA2B complex locally unwinds the DNA, due to its 5'—>3'
helicase activity, and scans for major helix distortions. When a particular large
lesion is encountered, the UvrA2 homodimer dissociates from the heterotrimer.
UvrB tightly binds to and locally denaturates the DNA, in an ATP-dependent
manner. Then, the UvrC protein complexes with UvrB. Upon binding with
UvrC, UvrB catalyzes the hydrolysis of the 5th phosphodiester bond on the 3'-
side of the lesion. This incision step causes a conformational change in the
UvrBC complex, which allows the UvrC protein to catalyze hydrolysis of the 8th
phosphodiester bond in 5'-direction from the lesion. UvrC dissociates from the
complex and subsequent combined action of UvrD, with DNA unwinding
properties, and DNA polymerase I results in removal of a 12-13 oligomer
containing the damaged nucleotide(s) and refilling the excision gap with new
nucleotides opposite to the undamaged template. Finally, a DNA ligase restores
the final open phosphodiester bond. (20,30,37,42,43). Additional factors may be
involved in the £. co//' Uvr(A)BC exinuclease system. For example, the m/rf-
gene product dissociates RNA polymerase molecules, stalled at DNA lesions and
facilitates UvrA binding, thus being a transcription-repair coupling factor (44,45).
In contrast to the £. co// Uvr(A)BC exinuclease system, the human NER
mechanism is much more complex and less well understood. In humans, three
clinical syndromes are known, which are related to deficiencies in NER. Besides
XP, patients with Cockayne's syndrome (CS) or Trichothiodystrophy (TTD) also
have repair defects and are also sensitive to UV (46). In the past years, most genes
and gene products involved in these human syndromes have been
characterized. Defects in at least seven genes (XPA up to and including XPG, that
are called complementation groups) have been found to be responsible for XP.
Fusion of cells from each of these NER-deficient complementation groups with
cells from another NER-deficient complementation group was found to result in
cell hydrids with normal UV-inducible repair capacity. At least two
complementation groups and thus genes (CSA and CSB) are involved in CS,
while defects in the 7TDA gene or (surprisingly) XPB and XPD genes contribute
to TTD. In parallel to these findings, NER genes have been characterized in two
yeast species, S. cerei^s/ae (RAD genes) and S. pomfre (rad genes). Further,
certain human genes (called ERCC genes, for Excision Repair C_ross
Complementing) have been isolated that were found to correct UV-induced
repair in repair-deficient rodents. A remarkable structural and functional
homology appears to exist between these eukaryotic gene products. For example,
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Figure 1.1. Proposed mechanism of human nucleotide excision repair (according to ref. 20,46-48).
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the human XPD gene product turned out to be similar to ERCC2 (rodent), RAD3
(S. cerep/siae) and radl5 (S. pombe). Thus NER genes seem to be highly
conserved during evolution. Based on these findings, the human NER
mechanism is now becoming elucidated and recently a model has been proposed
(Figure 1.1). (20,46-48).
It is believed that at least 17 polypeptides are involved in human NER. The
first step which takes place is damage recognition by the XPA protein complexed
to XPF-ERCC1 proteins or to the XPE protein. This complex of proteins is
stabilized by the HSSB (RP-A) replication protein and binds to DNA near the
lesion site. Secondly, local unwinding of DNA takes place by a complex of
proteins consisting of XPB, XPG (which have both a helicase activity) and the
transcription factor TFIIH. This complex is recruited by the XPA protein towards
the DNA-bound XPA/XPF-ERCC1(XPE)/HSSB protein complex. XPG and XPC
proteins are also tightly associated with TFIIH, or alternatively are directed to the
complex. The next step involves dual incision of the damaged template 5
phosphodiester bonds in 3'-direction by the XPG protein, and 24 phosphodiester
bonds in 5'-direction by the XPF (+ ERCC1, ERCC4, ERCC11) proteins. In this
manner, a damaged oligomer of approximately 27 to 29 nucleotides is released. In
a similar way as for the Uvr(A)BC exinuclease system, a DNA polymerase (E or 8)
fills in the excision gap (in 5'->3' direction) and a DNA ligase restores the final
open phosphodiester bond. In addition, other factors (proliferating cell nuclear
antigen (PCNA) and perhaps the RFC replication protein) may be needed to
facilitate release of the damaged oligomer and DNA bound repair proteins
(49,50). Recently, this mammalian nucleotide excision repair system was
reconstituted i« y/fro with purified protein components of factors mentioned
(252) and with an additional new factor called IF7.
1.4.4 Factors influencing DNA repair in humans
In humans, DNA repair mechanisms are certainly controlled by specific genetic
factors, as is evidently illustrated by the genetically-based DNA repair deficiencies
discussed. Moreover, other endogenous and exogenous factors may influence
human DNA repair as well. Most of this evidence comes from large scale
population-based studies in which DNA repair synthesis is measured as
unscheduled (non-replicative) DNA synthesis (UDS), induced ex two in
peripheral blood lymphocytes (PBLs) by DNA damaging agents. For example,
DNA repair has been negatively (51-54), positively (52) or not at all associated
with age (55-57). Further, in chronic alcoholics, ex uiuo MNU-induced repair
synthesis was found to be reduced in comparison to controls (58). In contrast,
Madden et al. (55) observed no association between alcohol consumption and
UV-induced repair synthesis. In the latter study, considerably reduced repair
synthesis was observed in heroin addicts, which, remarkably, was reversed to
normal control levels upon methadone treatment (55). In addition, DNA repair
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has been negatively (55) or positively (59,60) related or has been shown not to be
related at all to smoking of tobacco (56,61). Further, cells obtained from patients
with Altzheimer's disease showed decreased repair of alkylation damage (62).
Occupational exposure to chemicals may also modulate DNA repair activities.
PBLs obtained from individuals exposed to propylene oxide and ethylene oxide
(EO) (63) or individuals working in the rubber industry (56) showed decreased
repair synthesis, in comparison to controls. Celotti et al. (64) did not observe any
effect of occupational exposure to anti-neoplastic drugs on ex two-induced
DNA repair.
Thus, varying results have been reported regarding the effects of these factors
on repair. Part of this variation could be attributed to inherent limitations in the
methods applied in these studies to measure UDS. First, different agents have
been used to induce UDS, resulting in the estimation of the capacity of different
repair mechanisms. Further, in some of these studies, agents used to induce UDS
require metabolization before interaction with DNA is possible. Therefore,
interindividual differences in metabolization of carcinogens to electrophylic
intermediates and consequently initial formation of DNA damage may actually
determine the extent of observed repair. Moreover, in most of these studies,
hydroxyurea is used as agent to block semiconservative DNA replication, which
may also influence DNA repair itself. Also, differences in both cellular uptake of
radiolabeled nucleotide precursors, used to visualize repair synthesis, and
duration of exposure to carcinogen or nucleotide precursor, may explain part of
the discrepancies observed between these studies.
Little is known regarding the effects of nutrition on DNA repair. As will be
elucidated in detail below, the activity of the nicotinamide adenine dinucleotide
(NAD+)-dependent DNA-repair-related enzyme poly(ADP-ribose) polymerase
(NAD + ADP-ribosyltransferase, EC 2.4.2.30; PADPRT), may be subject to
modulation by alterations in dietary niacin intake (65).
1.5 Poly(ADP-ribosylation) and niacin metabolism
1.5.1 Poly(ADP-ribosylation). The enzymatic process
In 1963, Chambon, Weill and Mandel (66) observed that nicotinamide
mononucleotide stimulated the incorporation of ATP into acid-insoluble
fractions of chicken liver nuclei and the product of their reaction was identified
as poly(ADP-ribose). Their report was in fact the first indication for activity of the
enzyme poly(ADP-ribose) polymerase (NAD+ ADP-ribosyltransferase, EC
2.4.2.30).
Poly(ADP-ribosylation) (PADPR) is a post-transcriptional process, capable of
modifying several nuclear proteins, at least ;« i>i7ro. Examples are linker and
core histones (67-73), Ligase I (74) and ligase II (75), DNA polymerase a and DNA
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polymerase p (74), topoisomerase I (76,77) an topoisomerase II (78), acetylated
histones (79), HMG proteins (80) nuclear matrix proteins (81,82), and
interestingly, the PADPRT itself (83-85). The active PADPRT gene is located on
chromosome 1, and additional regions with sequence homology have been
identified on chromosomes 13 and 14 (86,87). The enzyme contains three
functional domains: a 46 kDa aminoterminal DNA-binding domain containing
two zinc-binding fingers; a central 22 kDa domain, containing automodification
sites and a carboxyterminal fragment of 54 kDa containing the NAD+-binding
site.
In response to DNA single or double strand breaks, the enzyme associates with
DNA and catalyzes rapid transfer of the adenosine diphoshate ribose (ADP-
ribose) moieties of intracellular nicotinamide adenine dinucleotide (NAD+) by
hydrolysis of the N-glycosylic bond between nicotinamide and the ribose group-
towards linear and branched (88) protein-bound poly(ADP-ribose) polymers
(Figure 1.2). The poly(ADP-ribose) polymer has a half-life as short as 1 minute
due to the activity of poly(ADPrribose) glycohydrolase (89). This enzyme degrades
the polymer into ADP-ribose monomers. The last protein-bound ADP-ribose
monomer is removed by the enzyme ADP-ribosyl protein lyase (90). Besides its
potential roles in DNA repair and carcinogenesis, PADPR has been suggested to
be involved in proliferation and differentiation (reviewed in 91). However,
while this Thesis was in preparation, Wang et al. (276) showed that mice carrying
homozygous germ-line mutations within the PADPRT gene are healthy and
develop normally. These data suggest that PADPRT or PADPR are not required
for proliferation and differentation during normal development in two.
1.5.2 Poly(ADP-ribosylation). Induction by DNA strand break-inducing agents
There are several indications that PADPR plays a crucial role in cellular
responses to DNA damage. Numerous studies indicate that treatment of
mammalian cells with various DNA damaging agents causes rapid formation of
poly(ADP-ribose) polymers and reduces intracellular NAD+ levels. Examples are
MNNG-treated rat hepatocytes (92), human keratinocytes (70), C3H10T1/2 cells
(93,94) and PBLs (95); MNU-treated mouse leukemia cells (96); y-ray-treated
mouse leukemia cells (96); UV-treated rat hepatocytes (92), human fibroblasts (97)
and PBLs (95); active oxygen species-treated human keratinocytes (70),
C3H10Tl/2-cells (98); hydrogen peroxide-treated PBLs (99,100), murine
macrophages (101), porcine endothelial cells and human fibroblasts (102);
cumene hydroperoxide-treated PBLs (103); calicheamicin yl-treated human HL60
cells (104), tumor promotor-treated human lymphocytes (105); cisplatin-treated
rat ovarian tumor cells and monkey cells (106) and hyperthermia-treated
C3H10T1/2 cells (107,108). Thus, a common feature of agents that may cause
either directly or indirectly, via enzymatic incision at a DNA lesion by other
repair enzymes, DNA strand breakage is the induction of PADPR. In addition,
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the absolute necessity for DNA strand breaks to activate PADPRT is confirmed by
observations that DNAse I treatment of permeabilized mammalian cells resulted
in poly(ADP-ribose) polymer formation (92,107). Also, only DNA containing
single or double strand breaks activates PADPRT m wfro (109).
1.5.3 Poly(ADP-ribosylation). Proposed functions with regard to cellular
responses to DNA damage
At least four mechanisms have been proposed with regard to the role of PADPR
in cellular recovery from DNA damage (Figure 1.3).
One of the first models was proposed by Creissen and Shall (110), who
suggested that PADPR stimulates the activity of ligase II in rodent cells in
response to alkylation damage, and thus may facilitate the final step in BER. In
line, intracellular NAD+-depletion and PADPRT inhibition caused enhanced
strand break accumulation in DMS-treated mouse leukemia cells (111) and
decreased X-ray or y-ray-induced single strand break resealing (112). However,
later reports do not support the idea that stimulation of ligase activity is the
main function of PADPR during DNA repair (74,113). Besides ligase, PADPR may
influence the activity of other enzymes (114).
Secondly, PADPR of histones may influence chromatin structure, thereby
increasing the accessibility of damaged DNA for other repair enzymes. Althaus et
al. (71,115) and Boulikas (91) suggested that PADPR may serve to shuttle histones
off and onto DNA. In this model, PADPRT interacts with DNA-nucleosome
complexes. In presence of NAD+, DNA-bound PADPRT automodifies itself with
numerous branched (ADP-ribose) polymers and dissociates from DNA. Since
histones have a higher affinity for poly(ADP-ribose) polymers in comparison to
DNA (116), PADPRT-bound polymers would attract core and linker histones
from the DNA, leaving the DNA more accessible to other repair enzymes.
Subsequent degradation of the polymer by the poly(ADP-ribose) glycohydrolase
decreases the number of polymer-binding sites for histones, allowing
reassociation of histones with DNA. In addition to the unfolding of individual
nucleosomes, formation of poly(ADP-ribose) polymers on histone HI and
degradation by poly(ADP-glycohydrolase) may serve the temporarily
deconsensation and subsequent recondensation, respectively, of higher order
chromatin structures (histone Hl-nucleosome interactions) (117-119).
According to the most recent and probably most attractive mechanism
proposed, the DNA binding domain of the PADPRT may temporarily shield
DNA breaks until other repair enzymes are present at the damaged site. Upon
automodification by the catalytic domain, the enzyme dissociates from the DNA,
allowing access of the damaged site to other repair enzymes. Such a temporal
DNA-break protection mechanism would prevent recombination or,
alternatively spurious DNA replication by transiently blocking the progress of
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Figure 1.3. Proposed roles of poly(adenosine diphosphate ribosylation) in DNA repair.
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DNA polymerases along replication forks, near damaged sites. This would
ultimately result in a cell cycle delay, thereby increasing time for adequate DNA
repair before DNA replication takes place. In addition, the DNA break-associated
PADPRT or synthesis of poly(ADP-ribose) polymers may represent an early
general cellular warning signal that DNA has been damaged. Interestingly, this
DNA break protection mechanism is proposed to be only associated with BER,
but not with NER (13,14,85,120,121).
Finally, PADPR may represent itself a cellular suicide mechanism (114) or
contribute to programmed cell death (apoptosis). This would reduce the
possibility that heavily damaged cells undergo DNA replication and division. In
response to DNA strand breaks, reduced levels of intracellular NAD+ may
interfere with glycolysis and ATP formation and thereby contribute to loss of cell
viability. Several studies report associations between DNA strand break
formation, induction of PADPR and NAD+ depletion, ATP depletion, release of
lactate dehydrogenase and cell lysis, when mammalian cells are exposed to
oxidants or alkylating agents (101,102,122,123). In addition, it has been recently
proposed that PADPR is required for stress-induced apoptosis in human cells
(124).
1.5.4 Poly(ADP-ribosylation). Relation to carcinogenesis
When cultured mammalian normal or transformed cells are treated with DNA
damaging agents in combination with PADPRT inhibitors, both potentiation and
reduction of the mutagenic or transforming effect, in comparison to the effects
caused by carcinogen exposure alone, have been observed. Similarly, PADPRT
inhibitors both potentiated and reduced the carcinogenicity of DNA damaging
compounds in rodents in yi'uo (reviewed in 91). It is likely that part of these
variations may be explained by studied cell type or animal organ, proliferation
and differentiation state of the cells, stage of the cell cycle, genetic loci studied and
type and concentration of DNA damaging agents and PADPRT inhibitors used
(89). However, a mechanistic explanation for these discrepancies may be the
following. First, inhibition of PADPR may prevent cellular suicide to occur in
normal cells and thereby cause elevated accumulation of DNA damage and
increased mutation frequencies in these cells. Alternatively, inhibition of
PADPR and repair of lesions induced by DNA damaging agents in highly
proliferating transformed cells may cause preferential killing over normal cells.
In a few studies in humans, attempts have been made to relate the extent of
basal or carcinogen-induced lymphocytic PADPRT activities, measured in PBLs
or surgically removed cancer specimens, with (the stage of) various cancers. Both
increased (73,105) and decreased (99,103) basal or induced PADPRT activity has
been reported, in patients with several cancers. Moreover, a homozygous germ-
line deletion in a sequence located on chromosome 13, with homology to the
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PADPRT gene, was frequently found in DNA obtained from various human
tumors, suggesting that loss of this particular sequence may predispose
individuals to malignancy (125). However, this deletion was not associated with
alterations in parameters related to poly(ADP-ribosylation). Applying the in
y/i)o model of Teebor and Becker (126) for N - A A F - i n d u c e d
hepatocarcinogenesis in rats, Cesarone et al. (127) initially observed a decrease in
amount of hepatic PADPRT and enzyme activity, while, with increased risk for
hepatocarcinogenesis, both amount and activity of the enzyme returned to levels
before treatment. Using the same model, Kiehlbauch et al. (128) found, with
increased cancer risk, both decreased hepatic poly(ADP-ribose) polymer levels m
yiDO and increased basal PADPRT activity measured in isolated hepatocytes.
Thus, despite the proposed role of PADPR in modulation of DNA repair, a
potential negative relation between PADPR and carcinogenesis has not been
demonstrated, at present.
1.5.5 Niacin metabolism
Nicotinamide adenine dinucleotide, the pyridine nucleotide required for
PADPR, can be synthesized from three precursors. Among these are nicotinic
acid and nicotinamide, both of which have been referred to as niacin (reviewed
in 129). Niacin actually is the general description for pyridine 3-carboxylic acid
and derivatives with the qualitative biological activity of nicotinic acid (130). In
humans and other mammalians, nicotinic acid is readily absorbed in the
stomach and small intestine (131) and may be enzymatically converted to
nicotinic acid mononucleotide by the nicotinic acid phosphoribosyltransferase.
This intermediate subsequently acquires an adenylic acid group from ATP in a
reaction catalyzed by the nicotinic acid mononucleotide adenylyltransferase to
form nicotinic acid adenine dinucleotide. Then, NAD synthase transfers an
amide group from glutamine to nicotinic acid adenine dinucleotide, thereby
completing NAD+ synthesis (Preiss-Handler Pathway). Nicotinamide, the other
niacin NAD+-precursor, can be metabolized by the nicotinamide
phosphoribosyltransferase to nicotinamide mononucleotide, which is converted
to NAD+ by the nicotinamide mononucleotide adenyltransferase (Dietrich
Pathway) (131-136). Under physiological conditions in DJUO , the direct
conversion of nicotinamide into nicotinic acid by a nicotinamidase, found in
homogenates of various mammalian tissues, is unlikely (130,131). Tryptophan is
the third precursor for NAD+, which can be converted via the kynurenine
pathway to quinolinic acid. In turn, quinolinic acid can be converted to nicotinic
acid mononucleotide, which can be further metabolized to NAD+ via the Preiss-
Handler Pathway. In fact, in humans, 60 mg of tryptophan can provide 1 mg of
niacin equivalents (129). In humans, nicotinamide can be methylated by
nicotinamide methyltransferase towards Nl-methylnicotinamide, which is
excreted in urine or alternatively further metabolized by the Nl-
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methylnicotinamide oxidases to secondary excretion products Nl-methyl-4-
pyridone-3-carboxamide and Nl-methyl-2-pyridone-5-carboxamide (137-139).
Other human urinary excretion products of nicotinamide and nicotinic acid
include nicotinamide N^-oxide, nicotinuric acid, nicotinamide and nicotinic acid
(131). A detailed scheme of niacin metabolism is presented in Chapter 4, Figure
4.5.
1.5.6 Niacin metabolism. Importance with regard to modulation of poly(ADP-
ribosylation), DNA repair and cancer risk
As discussed in previous paragraphs, PADPR is believed to be required for
efficient DNA repair or alternatively, for preferential killing of cells in which the
number of premutagenic lesions is undesirable high. Moreover, since at least
some studies have shown negative associations between PADPR and cancer risk
in humans and rodents (99,103,125,128), it can be hypothesized that an increase in
intracellular levels of precursors of NAD+ may contribute to improved DNA
repair and ultimately to decreased cancer risk. Treatment of isolated human and
rodent cells with millimolar concentrations of nicotinamide indeed enhances
the activity of DNA repair, triggered by simultaneous treatment with UV,
alkylating agents, EO or y-rays (95,140-146). However, since nicotinamide, next to
being a precursor for NAD+, also directly inhibits PADPRT (94,95,147),
interpretation of these results, solely with regard to the former function of
nicotinamide, is complicated.
A limited number of studies have reported effects of ex v/yo and /'«
nicotinic acid supplementation on DNA repair in mammalian cells ex
treated with carcinogens. Berger and Sikorski (140) observed no potentiation of
DNA repair synthesis, induced by alkylating agents, when PBLs were
simultaneously treated with nicotinic acid. In contrast, Weitberg and Corvese
(148) observed a reduction in number of single strand breaks, induced in
lymphocytes and human leukemia cells by agents that interfere with adenosine
metabolism, when cells were pre-exposed to nicotinic acid. Further,
supplementation of two humans with nicotinic acid during several weeks
resulted in enhanced peripheral blood lymphocytic NAD+-levels and in reduced
number of single strand breaks, induced by oxygen radicals in PBLs ex u;i>o
(149).
In a few studies, the effects of in u/i>o niacin depletion in rats, by giving diets
with no or reduced tryptophan and nicotinic acid contents, on NAD+-levels,
PADPR and DNA damage and repair have been investigated. Zhang et al. (150)
reported reduced blood, liver and muscle NAD+-levels in niacin-deficient rats,
together with an increased number of ex y/uo oxygen radical-induced
lymphocytic and hepatocytic DNA single strand breaks. They further observed
both increased and decreased ex uii>o oxygen radical-induced PADPRT activity,
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at different stages of niacin deficiency. Rawling et al. (151) reported reduced
NAD+-levels in several organs of niacin deficient rats and decreased basal hepatic
poly(ADP-ribose) polymer levels.
It is known that niacin depletion during several weeks, achieved by
tryptophan and nicotinic acid deficient diets, in male humans results in reduced
erythrocytic NAD+-levels (152) and decreased levels of plasma and urinary Nl-
methylnicotinamide (153). These levels turned to basal levels, as determined
before depletion, when niacin was repleted. At present however, no studies with
an integrated approach have been reported in humans /« u/uo, with regard to
the effects of altered niacin intake on niacin status, PADPRT activity, DNA repair
activity and persistence of DNA damage.
1.6 The adaptive response
1.6.1 The adaptive response. A phenomenon reflecting the ex i>n>o induction
of DNA repair mechanisms
In 1977, Samson and Cairns showed that pre-treatment of E. co/i with low levels
of MNNG resulted in protection against cytotoxic and mutagenic effects, induced
by high levels of MNNG (154). They proposed that pre-treatment resulted in
induction of a DNA repair system, requiring de /IOTO protein synthesis. The
process was termed the adaptive response (AR). Later, it was shown that the AR
involved the induction of several gene products. An example is the nrffl gene
product mentioned before, capable of removing O^-methylguanine.
In 1984, Olivieri et al. (155) observed a comparable phenomenon in isolated
PBLs. They demonstrated that the number of chromosome aberrations was
reduced when human lymphocytes were pre-treated with low levels of
radioactive thymidine followed later by a challenge of X-rays, in comparison to
the number of chromosome aberrations induced by X-ray exposure alone. They
proposed that the AR to IR involved the induction of a chromosomal repair
mechanism. Several investigators have confirmed the existence of an inducible
AR to IR in PBLs. In addition, AR-like phenomena have been observed for
damage induced by other agents. In the past ten years, the AR to IR and other
compounds has been characterized in more detail. Table 1.1 summarizes current
available literature data on the AR in PBLs. The main conclusions that can be
drawn from these studies are the following: The AR to IR is not induced when
cells are pre-treated during GO, instead, pre-treatment during Gl is necessary to
elicit the AR. Thus, the induction of the AR requires cell proliferation. Synthesis
of proteins is necessary for expression of the AR, while the phenomenon is not
related to diffusible inter-cellular factors. Once induced, the AR persists for at
least three cells cycles, suggesting that induced repair proteins can be transferred
to daughter cells. Further, a minimum period of time is required between pre-
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Table 1.1. Literature data on the adaptive response in human peripheral blood lymphocytes.
pre-treatment
dose agent
challenge
dose agent
endpoint observation
with regard to
effect of
pre-treatment
on endpoint
comments reference
0.01-0.1 nCi/ml TT
5-5Ong/ml, MNNG
repeated
0.5nG-1.0nCi/ml TT
lcGy
0.5-50 cGy
0.01-0.1 uCi/ml
X-rays
X-rays
TT
0.3; 0.4; 1.5 Gy
2-4 Mg/ml
1.5-3.0 uM
75-150 uM
1.5 Gy
1.5 Gy
1.5 Gy
1.5 Gy
X-rays
MNNG
MMC
ENU
X-rays
X-rays
X-rays
X-rays
CA
SCE
CA
CA
CA
CA
reduction
reduction
no effect
no effect
reduction
reduction
reduction
reduction
AR not related to cell-stage
sensitivity or delay in cell-cycle
AR dependent on PT dose;
interindividual differences;
no cross-reactivity
3-aminobenzamide inhibits AR;
AR not related to diffusible factors;
AR not an artefact of cell-cycle
related differential sensitivity
AR absent in GO PBLs, but
persistent for at least 3 cell-cycles
in proliferating PBLs;
AR dependent on time-
interval between PT and C
no AR when PT > 20 cGy;
3-aminobenzamide inhibits AR
culturing cells in absence of
nicotinamide prevents AR
in whole blood cultures and
isolated PBLs
1 cGyor
0.1 uCi/ml
lcGy
0.1 uCi/ml
0.01 uCi/ml
lcGy
X-rays or
TT
X-rays
TT
TT
X-rays
1 uCi/ml
2.5 ug/ml
0.36 mM
1.5 uM
1.5 Gy
1.5 Gy
0.75 Gy
0.75 Gy
TT
BLM
MMC
MMS
X-rays
X-rays
X-rays
X-rays
CA
CA
CA
CA
CA
CA
CA
CA
reduction
reduction
reduction
elevation
no effect
no effect
reduction or
synergism
radiation induced AR is
different from AR induced
by alkylating agents
persistent absence of AR
in PBLs from 2 donors
4/18 donors showed no AR
in some cases synergism;
persistent absence of AR in
2 donors
(155)
(254)
(167)
(255)
(168)
(170)
(256)
(257)
(258)
g.
s-
Table 1.1. continunf
pre-treatment
dose agent
challenge
dose agent
endpoint observation
with regard to
effect of
pre-treatment
on endpoint
reference
0.01 uCi/ml
0.01 uCi/ml
0.1 uCi/ml
5 uCi/ml
5cCy
1-5 cGy
1 cGy; 0.5 Gy, at
various dose-rates
0.01-0.1 ng/ml
0.01-0.1 ug/ml
0.01-0.1 ng/ml
0.01-0.1 ug/ml
lcGy
25-250 (iM
25-250 uM repeatedly
1 cCyor
2x1 cGy
lcGy
2cGy
2cGy
2cGy
10-75 mGy
41°C-43°C
TT
CT
32p
HTO
X-rays
X-rays
X-rays
BLM
BLM
BLM
BLM
X-rays
H P 2
H2O2
X-rays
X-rays
X-rays
X-rays
X-rays
X-rays
HT
0.5 Gy
0.5 Gy
0.5 Gy
0.5 Gy
1.5 Gy
1.5 Gy
1.5 Gy
1.5 ug/ml
1.5 Gy
1.5 Mg/ml
1.5 Gy
150 cGy
1.5 Gy
1.5Gy
ICy
300 cGy
3Gy
15-16 cGy
1.5 Gy
0.75-1.5 Gy
0.75-1.5 Gy
X-rays
X-rays
X-rays
X-rays
X-rays
X-rays
X-rays
BLM
X-rays
BLM
X-rays
X-rays
X-rays
X-rays
X-rays
X-rays
X-rays
radon
X-rays
X-rays
X-rays
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
M
CA
CA
CA
CA
CA
reduction
reduction
reduction
reduction
reduction
no effect
reduction
reduction
reduction
reduction
reduction
reduction
reduction
no effect
reduction
reduction
reduction
reduction
no effect
reduction
reduction
interindividual differences
in AR
absence of AR in PBLs from
3 donors
AR dependent on both dose
and dose-rate of PT
3-aminobenzamide inhibits AR
cycloheximide inhibits AR
repeated PT did not enhance
AR, observed after single PT
AR absent in GO PBLs;
AR dependent on time-
interval between PT and C;
interindividual differences
HT potentiates radiation-
induced AR; cycloheximide
inhibits AR; AR not related to
diffusible factors
(259)
(260)
(261)
(262)
(169)
(263)
(264)
(265)
(266)
(267)
(268)
(269)
(270)
Table 1.1. conimun?
pre-treatment
dose
1 cGy-2 cGy
lOcGy
25-250 MM
5cGy
2cGy
5-20 ng
agent
X-rays
X-rays
H2O2
X-rays
X-nys
MMC
challenge
dose
0.5-1.5 Gy
1.5 Gy
1.5-3 Gy
100 cGy
15-16 cCy
200;400ng/ml
agent
X-rays
X-rays
X-rays
X-rays
radon
MMC
endpoint
CA
CA
MN
CA
cell survival
CA
SCE
observation
with regard to
effect of
pre-treatment
on endpoint
no effect
or synergism
reduction
reduction
reduction
increase
reduction
reduction
comments
absence of AR in PBLs from
2 donors, throughout the
cell-cycle.
PBLs from 3 donors
AR persistent in cells in
differential cell-stage;
interindividual differences
increase in cell survival
not only explainable by
decrease in singly
aberrant cells —> AR acts on
lethal damage in non-
aberrant cells.
reference
(271)
(272)
(273)
(274)
(17)
(275)
abbreviations: AR: adaptive response; BLM: bleomycin; C: challenge; CA: chromosomal aberrations; CT: ["C]thymidine; ENU: N-ethyl-N-nitrosourea; HT: hyperthermia; HTO:
tritiated water; M: mutations; MMC: mitomycin C; MMS: methylmethanesulphonate; MN: micronuclei; MNNC: N-methyl-N-nitro-nitrosoguanidine; PBLs: human peripheral
blood lymphocytes; PT: pre-treatment; SCE: sister chromatid exchanges; TT: pHlthymidine.
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exposure and challenge, to allow expression of the AR. Moreover, the extent of
adaptation is influenced by the concentration of the agent or radiation-dose and
dose-rate applied during pre-exposure. Not surprisingly, pre-treatment with
radiomimetic agents that cause single strand scission can also induce an AR to
IR. In addition, pre-treatment with hydrogen peroxide induces an AR to IR
indicating that the induced repair mechanism(s) likely act(s) on IR-induced
oxydative damage. Moreover, interindividual differences exist in the extent of
AR to IR. In PBLs obtained from some individuals no adaptation has been
observed at all. These data suggest that some individuals may be genetically
predisposed for the AR to IR. Further, the AR to IR is not only observed with
regard to chromosome aberrations, but also related to prevention of
mutagenesis, micronuclei formation and non-lethal damage, undetectable by
chromosome aberrations-analysis. Therefore, the AR may involve the induction
of different repair mechanisms. Furthermore, pre-exposure to low levels of
alkylating and cross-linking agents can induce an AR to chromosomal damage
induced by the same agent. However, the AR induced by low IR pre-exposure
does not act on damage, induced by these agents. Thus, pre-exposure to alkylating
agents or to IR does not likely induce the same repair mechanism(s) (for
references see Table 1.1).
Besides in human PBLs, the AR to IR and alkylating agents has been
demonstrated in other human and mammalian cells (156-164). Further, in
rodents, the AR to IR and alkylating agents has been induced m i>;w (165,166).
At present, it is unknown whether similar adaptive mechanisms with regard to
DNA repair may occur in human populations in i>/uo chronically exposed to
low doses of environmental carcinogens, like PAH.
1.6.2 Possible involvement of poly(ADP-ribose) polymerase in the adaptive
response to ionizing radiation
Little is known with regard to the nature of repair mechanism(s) that may be
induced by pre-exposure to low doses of IR. When PADPRT inhibitors like 3-
aminobenzamide were added to pre-exposed PBLs after challenge with X-rays,
the AR to IR was no longer observable (167-169). Further, when PBLs were grown
in absence of nicotinamide, one of the precursors for NAD+ in PBLs (132), the AR
to IR was found to be absent (170). Therefore, there is indirect evidence that the
AR may involve the induction of PADPRT, thus a chromosomal repair
mechanism.
1.7 DNA damage and p53 accumulation
1.7.1 A role for wild-type p53 tumour suppressor protein in modulating the
persistence of DNA damage
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In 1979, Lane and Crawford identified the p53 protein as part of a complex with
Large T antigen in SV-40 transformed cells (171). Later, several lines of evidence
have led to the assumption that /?53 is a tumour suppressor gene. First, about
60% of all human cancers have mutations within the p53 gene. In most cases,
these genetic alterations consist of missense mutations, with loss of
heterozygosity -which is a hallmark of tumour suppressor genes- thus resulting
in loss of normal functional p53 protein (5). Further, individuals with Li-
Fraumeni syndrome (172), having inborn defects in one of the p53 alleles, are
pre-disposed to cancer. It is evident that genetic alterations in the other allele can
readily result in loss of heterozygosity and thus in loss of functional p53. Also,
mice with absent or mutant p53 develop tumours with greater frequency than
normal mice (173).
The first demonstration that p53 was actually involved in the cellular
response to DNA damage was published by Maltzman and Czyzyk in 1984. They
observed that treatment of non-transformed mouse cells with UV resulted in an
increase in p53 levels (174), which was confirmed by others (175,176). Other DNA
damaging agents can cause p53 accumulation in mammalian cells as well.
Examples are y-rays (177-179), bleomycin and actinomycin D (180), NQO (174),
MMS (181), mitomycin C, cisplatin and nucleotide analogues (182,183). The
accumulation of p53 after DNA damage is not related to increased mRNA
expression, but instead to a combination of increased protein stability and
ongoing translation (177,182).
Two functions have been proposed for p53 accumulation after DNA damage
(184): induction of apoptosis and induction of pathway(s) that arrests cells in Gl
phase of the cell cycle. Indeed, it has been demonstrated that p53 is required for
induction of apoptosis after treatment of mammalian cells with IR or DNA
damaging agents (185-187). Thus, by starting up a program of physiological cell
death, damaged cells, which could be initiated upon DNA replication and
subsequent cell division, are preferentially removed. When cells are exposed to a
variety of DNA damaging agents, arrest often occurs in both the Gl and G2-phase
of the cell cycle. This would provide additional time for efficient DNA repair
prior to initiation of replicative DNA synthesis or onset of mitosis, thus
ultimately decreasing the chance on malignant cells. Several lines of evidence
indicate that p53 mediate(s) (a) Gl cell cycle checkpoint pathway(s). When wild-
type p53 is reintroduced into transformed cells with absent functional p53,
growth arrest is achieved with apparant accumulation of cells in Gl phase.
Further, mammalian cells with no or mutant p53 fail to undergo Gl arrest after
Y-irradiation (177,188), while transfection of wild-type p53 genes into these cells
restores the Gl arrest (188). Moreover, introduction of mutant p53 genes in
normal cells has been found to prevent this Gl arrest (188). In addition, cells
expressing human papilomavirus E6 oncogene product which is known to
interfere with normal p53 function, continue cell cycle progression after
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actinomycin D or UV treatment (189-191).
The mechanisms of p53-mediated Gl arrest and apoptosis after DNA damage
are not known in full detail. Wild-type p53 protein is a sequence-specific DNA
binding protein capable of binding to and regulating transcription of other genes,
containing p53 responsive elements (192-195). In response to DNA damage, p53
binds to p53 responsive elements (196) and can induce transcription of at least
three down-stream effector genes: Gadd45 (179,197,198), Mdm2 (199-202) and
WAF2/C/P2 (178,203).
The Gadd45 gene (for G_rowth a_rrest and D.NA d_amage inducible), was
induced in a strictly p53-dependent manner after treatment of cells with IR
(179,197), while treatment by UV and MMS resulted in p53-independent Gndd45
induction (190,198). This illustrates the complexity of these pathways and
suggests the existence of at least two different mechanisms of Gadrf45 induction
and Gl arrest, depending on type of DNA damage induced. In addition, gene
products, absent in the disease Ataxia-Telangiectasia (AT) (so called AT products),
were presumed to be necessary for IR-induced p53 accumulation, Gfldrf45
mRNA expression and Gl arrest (181,197). Very recently, Savitsky et al. (253)
have identified a gene called i4TM, which is mutated in AT. Part of this gene
was found to encoded for a product with similarity to phosphatidylinositol-3'-
kinases. These enzymes are known to be involved in mitogenic signal
transduction and, important in this respect, in cell cycle control. Induction of p53
accumulation also depends on AT products, when cells are exposed to MMS and
bleomycin, but not when exposed to UV (181). The strict requirement for
Gadd45 gene product in either radiation induced cell cycle arrest or cell death
has not been directly demonstrated yet.
The p2lWAFl/CIPl protein was simultaneously discovered as a 21 kDa protein
product, originating from a sequence transcriptionally activated by p53 (WAF1:
jy_ild-type p53 activated fragment 1), and as a potent inhibitor of cyclin-
dependent kinases (cdk) (CIPl: cdk-interacting protein) (203,204). Cdk are believed
to be required for Gl to S-phase transition, probably in association with the
retinoblastoma gene product (205). Thus, the following model has been proposed
(206): Upon DNA damage, in particular DNA strand breaks, AT-gene products
mediate p53 accumulation, which in turn results in upregulation of
transcription of W/\F1/C/P2. Finally, the 21 kDa protein associates with cdk-
cyclin complexes, thereby inhibiting the onset of replicative synthesis. Recent
observations support the role of this pathway in both cell cycle inhibition and
induction of apoptosis (178,181).
The mrfm2 gene is proposed to act as a negative feedback regulator of p53
activity (207-209). mrfm2 may limit the strength of p53 induced Gl arrest after
IR, by possibly inhibiting p53-mediated transcription of g<idd45 (201).
In contrast to effects of p53 protein on downstream effector genes and cell cycle
progression, less is known with regard to mechanism(s) acting between initial
(recognition of) DNA damage and increase in p53 accumulation. As mentioned
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gene product(s), absent in AT, are believed to be required prior to p53
accumulation after IR. Nelson and Kastan (180) showed that, under conditions of
inhibited replicational DNA synthesis, UV treatment of NER-deficient XPA
lymphoblasts did not induce p53 accumulation, in comparison to normal
lymphoblasts. Treatment of these repair-deficient cells with X-rays resulted in
p53 accumulation to a similar extent as found in normal cells. These data suggest
that functional NER, and thus enzymatic strand scission, is required for
induction of p53 accumulation by agents that cause DNA base damage. In
contrast, Yamaizumi and Sugano (176) reported induction of p53 accumulation
in XPA fibroblasts at even lower doses of UV in comparison to repair proficient
fibroblasts. Interestingly, they also showed that induction of p53 was achieved at
lower UV doses in cells from patients with CS, that are defective in gene- and
strand-specific DNA repair (211). Therefore, they concluded that p53
accumulation was due to accumulation of UV-induced DNA base damage on
actively transcribed genes, with concomitant impaired RNA synthesis. Whatever
the roles of (preferential) NER or RNA synthesis in triggering pathway(s) for p53
accumulation upon DNA damage may be, there are indications that DNA strand
breaks could be sufficient to and probably necessary for induction of p53
accumulation upon DNA damage (179,180,183).
1.7.2 Poly(ADP-ribose) polymerase. Possible involvement in DNA damage
inducible pathways of p53 accumulation ?
Since PADPRT also requires the presence of DNA strand breaks for its activation
(92,107,109), it can be hypothesized that poly(ADP-ribose) polymers may be
involved in DNA-damage inducible pathway(s) of p53 accumulation and cell
cycle arrest. As mentioned before, poly(ADP-ribose) polymers are formed within
minutes after treatment with DNA damaging agents, while detectable p53
accumulation takes place after one to several hours (176,182). This might
implicate that poly(ADP-ribose) polymer formation precedes p53 accumulation.
It is tempting to speculate that PADPR-induced chromatin decondensation may
result in facilitated access of other factors involved in DNA-damage-induced
cascade(s) leading to p53 accumulation. Alternatively, temporarily shielding by
PADPRT of DNA strand breaks (120) may constitute itself an early emergency
signal that turns on other factors, involved in p53 accumulation. Fritsche et al.
(182) proposed that a drug-induced conformational change may be required for
p53 stabilization. Perhaps poly(ADP-ribose) polymers may directly interact with
wild-type p53 protein and thereby contribute to its metabolic stabilization.
At present, it is unknown whether p53 accumulation is involved in
protective pathways with regard to the onset of carcinogenesis in humans
exposed m iwo to environmental carcinogens. One may hypothesize that,
besides enhancement of efficiency of DNA repair mechanisms themselves,
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improved PADPR in humans may also contribute to pathways of DNA damage-
inducible p53-mediated cell cycle arrest in carcinogen-exposed target tissues.
1.8 Benzo[a]pyrene and its reactive diolepoxides
1.8.1 Benzo[a]pyrene and its reactive diolepoxides. Model compounds to study
DNA damage, DNA repair, mutagenicity and carcinogenicity
Polycyclic aromatic hydrocarbons (PAH) represent a group of chemicals
consisting of compounds with two or more condensed benzene rings. PAH are
widely distributed into the environment and may originate from coal tar, petrol-
and diesel engines, domestic heating systems, power plants, tobacco smoke and
charcoal-grilled food. Even generally used anti-dandruff shampoos, based on coal
tar extracts, have been shown to contain considerable amounts of PAH (211).
Associations have been reported between occupational PAH exposure and
human carcinogenesis (212-214). Nowadays, 11 PAH have been classified as full
carcinogens in experimental animals (215). Among a total of approximately 500
PAH, the most abundant and frequently studied is benzo[a]pyrene (B[a]P). Total
environmental emission of this carcinogenic PAH is estimated to be about 1200
tons per year (USA) (216).
B[a]P requires metabolic activation to electrophylic intermediates that can react
with DNA, before it can exert its carcinogenic action. In 1974, Sims et al. proposed
that after conversion of benzo[a]pyrene to the 7,8 dihydrodiol, subsequent
conversion to a 9,10 diol-epoxide yields the ultimate carcinogen form of B[a]P.
Later, it was shown that B[a]P is first metabolized by cytochrome p450-dependent
monooxygenases to a mixture of stereoisomers consisting of (+)-7,8-epoxide and
(-)-7,8 epoxide. These can be converted by epoxide hydrolases into two 7,8
dihydrodiols, which each can be further oxidized by cytochrome p450-dependent
mono-oxygenases towards two 7,8-dihydrodiol-epoxides. The resulting
diolepoxides thus comprise two diastereomers, in which the epoxide-oxygen is
on the opposite (n«f/) or same (syn) site of the benzylic ring as the
hydroxylgroup in the 7-position. In addition, from each diastereomers, two
enantiomers exist. Several studies indicate that the (+)-enantiomer of the nwfi-
benzo[a]pyrene diolepoxide has the highest mutagenic and carcinogenic
properties (218-222).
1.8.2 Interactions of (±)-<iHfi-benzo[a]pyrene diolepoxide with DNA
Most studies with regard to interaction of benzo[a]pyrene diolepoxides with DNA
have been performed with (±)-<oif/-benzo[a]pyrene diolepoxide ((±)-fl«fi'-BPDE
(±)-7p,8a-dihydroxy-9a,10a-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene), thus com-
prising the most reactive (+)-anfi'-enantiomer. The main interaction of
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(+)-nn/i-benzo[a|pyrene
N -deoxyguanosine O -deoxyguanosine
ax.
OH
N7-deoxyguanosine N7-deoxyguanosine
imidazole ring-open product
Figure 1.4. a«f/-benzo[a]pyrene diolepoxide ((+)-enantiomer) and flM/i-benzo[a]pyrene
diolepoxide deoxyguanosine adducts.
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(±)-flnf/-BPDE with DNA in fiyo and in pifro takes place between the benzylic
CIO atom of the diolepoxide and the exocyclic nitrogen atom (N^) on dG, mainly
via frans-addition of the (+)-enantiomer (Figure 1.4) (epoxide ring-opening at
the same site as the hydroxylgroup in the 7-position) (10,223-226). Formation of
cis-(±)-anfi-BPDE-N2-dG adducts (epoxide-ring opening at the opposite side as
the hydroxylgroup on the 7-position) has also been reported (227,228). The N^-dG
adduct itself is considered to be chemically stable, but it has been postulated that
slow rearrangement of the adduct could result in formation of AP sites and
subsequent DNA strand-breakage, after AP-endonuclease attack. (229-231),
However, Sage and Haseltine (226) argued against this mechanism.
Several other interactions of (±)-anfi'-BPDE with dG have been shown to
occur in uifro. Osborne et al. (232) showed formation of O^-substituted dG, N7-
dG and the N7-dG imidazole ring-open product (Figure 1.4). They further
showed that interaction between DNA and the (-)-flnfi-isomer yielded
predominantly O^- and N7-dG.
There is also evidence for formation of (±)-an(i-BPDE adducts with
deoxyadenosine and deoxycytidine, but not with deoxythymidine (10,224,225,233).
Jeffrey et al. (223) reported both the cis and frans addition of the exocyclic N^
group of adenine to the benzylic CIO position of the diol-epoxide. Recently, these
cis and trans-adducts have been characterized in more detail (228).
Several studies indicate that (±)-anfi-BPDE induces in wfro and in uiuo
formation of strand breaks under alkaline conditions (226,230,231,234-236). These
lesions may represent AP sites, originating from unstable adducts, probably N7-
dG. (226,230,234,235). An early proposal was that (±)-an/i-BPDE-DNA interaction
results in formation of unstable phosphotriesters, causing DNA strand scission
(237). However, later findings argue against phosphotriester formation, in favour
of AP sites, as intermediates in (±)-anh-BPDE-induced DNA strand break
formation (229,234).
1.8.3 Repair of (±)-anfi-benzo[a]pyrene diolepoxide-induced DNA damage
The use of carcinogens in studying DNA repair activities in human cells ex
two, that first need to be metabolized before interaction with DNA can take
place, has disadvantages. In this case, the extent of damage at a particular time
point after treatment will be the resultant of continued interaction of reactive
intermediates with DNA and repair processes, making conclusions regarding the
latter process complicated. Initial carcinogen-DNA interaction may be related to
metabolism, detoxification of reactive intermediates and kinetic processes,
resulting for example in delayed release of parent compound or metabolites from
other intracellular compartments. In case of B[a]P, one can exclude at least the
first process by use of the reactive diolepoxides in DNA repair studies ((±)-anfi-
BPDE).
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Several studies indicate that mammalian and human cells are capable of
repair of (±)-a/ifi-BPDE-induced DNA damage. In 1978, repair of (±)-anf/-BPDE-
induced DNA damage was reported for the first time by Day et al. (238) in human
fibroblasts and by Cerutti et al. (239) in human alveolar tumor cells. Further,
removal of (±)-a«f/-BPDE adducts was shown in human lung cells (240). Yang et
al. (21,39) reported error-free removal of the main N^-dG adduct in human
fibroblasts, while removal was absent in XP fibroblasts (21,22,39). Thus, repair of
certain (±)-flnH-BPDE-induced DNA adducts may proceed through NER
mechanisms. Another finding, giving indirect evidence for possible excision of
(±)-anfi-BPDE induced DNA adducts, was that i« uifro (±)-anf/-BPDE-modified
plasmid DNA could be cleaved by the purified £. co/i Uvr(A)BC exinuclease
system (40). Thus, it was shown that, at least ;n y/'fro, (±)-a;ih'-BPDE induced
DNA damage was substrate for a prokaryotic NER mechanism. Using this
Uvr(A)BC exinuclease system, Van Houten et al. (241), showed that DNA
extracted from ex u/uo (±)-a«f/-BPDE-treated normal fibroblasts had, with
increasing time after treatment, fewer number of endonuclease sensitive sites, in
comparison to DNA obtained from XP fibroblasts. Furthermore, (±)-anh'-BPDE
has been found to induce UDS in human fibroblasts (242), PBLs (236,243) and
cultured mouse epidermal keratinocytes (244). This indicates that in mammalian
cells, (±)-a«H-BPDE treatment results in activation of processes that result in
DNA repair synthesis. Chen et al. (245) reported preferential removal of (±)-
anh-BPDE-DNA adducts from the active /iprf gene of human fibroblasts,
mainly from the actively transcribed strand. These findings suggests that (±)-
fl/!h-BPDE-induced DNA adducts are substrate for human transcription-coupled
NER mechanisms (Figure 1.1). Further, these findings also explain why, in the
absence of repair, mutations induced by (±)-anfi'-BPDE have been found to be
related to pre-mutagenic lesions present in both strands of the /iprf gene, while
in presence of repair, mutations were only confined to pre-mutagenic lesions in
the non-transcribed strand (246,247). This emphasizes again the important role of
functional (preferential, strand-specific) DNA repair mechanisms in prevention
of mutagenesis.
Repair of unstable N7-guanine adducts has not been directly demonstrated yet
in mammalian cells ex iroo. Moran and Ebisuzaki (231) observed formation of
alkali-labile sites in HeLa cells, after (±)-anh-BPDE-treatment. However, these
sites were no substrate for a purified AP-endonuclease ex u/uo. Thus, far from
being conclusive, these data might indicate the absence of repair of AP-sites,
arisen from (±)-mzh-BPDE-induced unstable N7-guanine adducts.
There are no indications for the existence of proteins that can remove in a
direct manner large (±)-an//-BPDE-DNA adducts, comparable to O-alkylguanine
DNA alkyltransferase action on smaller alkyl adducts.
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1.9 Aims and outline of this Thesis
Electrophylic intermediates from various chemical or physical carcinogens may
damage DNA and other intracellular macromolecules in numerous ways.
Moreover, upon DNA replication or cell division, DNA damage may lead to
several irreversible genetic alterations. The onset of carcinogenesis is believed to
be directly related to these genetic alterations. Especially, structural alterations in
proto-oncogenes or tumour suppressor genes are presumed to result in loss of
normal cell growth control.
To maintain genetic integrity, biological organisms including humans, have
developed DNA repair mechanisms. The importance of adequate DNA repair
mechanisms is illustrated by the fact that absence of a particular form of DNA
repair has been shown to predispose human individuals to cancer. In order to
gain insight into mechanisms of human carcinogenesis, it is of fundamental
importance to understand DNA repair processes. Moreover, it is tempting to
hypothesize that upregulation-of DNA repair activities may result in decreased
DNA damage remaining after exposure to carcinogens, and thereby contribute to
a reduced risk for the onset of cancer. Approaches that can modulate DNA repair
activities in humans are therefore worthwhile to investigate.
The purposes of the studies described in this Thesis therefore were to
investigate the impact of modulating factors involved in human DNA repair. In
particular, the role of PADPR in DNA repair was explored. PADPR, catalyzed by
the enzyme PADPRT, is rapidly triggered by DNA damaging agents that cause
direct or indirect DNA strand break formation. The enzyme transfers the ADP-
ribose groups of NAD+ into linear and branched poly(ADP-ribose) polymers.
Several roles for PADPR during DNA repair have been proposed: direct
modification of other repair enzymes; increased access for other repair enzymes
to damaged sites by transient chromatin decondensation; temporarily DNA
strand break protection until other DNA repair enzymes are present at damaged
sites. Moreover, it can be hypothesized that PADPR may be involved in DNA
damage-inducible pathways of cell cycle arrest. These pathways would allow
damaged cells to perform repair for a longer period of time, prior to onset of
DNA replication or cell division.
As indicated, NAD+ is absolutely required as substrate for PADPR. In humans,
intake of niacin may influence intracellular NAD+-levels and therefore
modulate the efficiency of DNA repair in target organs. It is therefore tempting to
speculate that supplementation of carcinogen-exposed individuals with niacin
may ultimately result in reduced cancer risk. Further, at present, there is indirect
evidence that induction of PADPRT is involved in AR, the phenomenon that
ex D/PO pre-exposed PBLs become less susceptible to deleterious genotoxic effects
induced by exposure to higher levels of genotoxic agents. Similar PADPRT-
dependent adaptive mechanisms may occur in humans chronically exposed to
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low levels of environmental genotoxic carcinogens. Furthermore, in response to
DNA damage, activation of PADPRT and accumulation of p53 - the tumour
suppressor protein supposed to contribute to prevention of carcinogenesis by
inducing mechanisms which select against heavily damaged cells in favour of
efficiently repaired cells - both presumably require the presence of DNA strand
breaks. As outlined before, it may be hypothesized that formation of poly(ADP-
ribose) polymers is required for carcinogen-induced p53 accumulation and that
these phenomena constitute an anti-carcinogenic mechanism in carcinogen-
exposed humans. An overview of these hypotheses is given in Figure 1.5.
PBLs are useful tools to study human DNA repair and DNA damage. They can
perform DNA repair after ex y/uo exposure to a variety of DNA damaging
agents (52,55-59,61,236,243,248), which allows to study qualitative and
quantitative aspects of DNA repair mechanisms which act »M ui'yo. Further,
PBLs can be used to determine /« t'/yo DNA damage which can cause
chromosomal damage or mutagenesis, after stimulation to proliferation ex I'/uo
(249,250). Given the fact that increased lymphocytic chromosomal damage (251)
and decreased lymphocytic DNA repair capacity (54) have been associated with
increased risk for cancer, phenomena observed in PBLs may represent processes
that are involved in development of cancer in carcinogen-exposed target organs.
Studying these phenomena in PBLs may therefore be relevant to gain insight in
the roles of DNA damage and DNA repair in human carcinogenesis. Further,
since PBLs can be easily obtained, it is possible to estimate ex u/'uo the effects of
administration of modulating factors to (carcinogen-exposed) populations on
DNA repair n; y/uo.
As indicated, treatment of human cells with (±)-fl>if/-BPDE, benzo[a]pyrene
metabolites comprising the most carcinogenic and mutagenic (+)-enantiomer,
has been shown to result in formation of several DNA adducts and DNA strand
breaks and to induce DNA repair processes. Therefore, in combination with
PBLs, these reactive diolepoxides may be used as model compounds to study
DNA damage and DNA repair in humans ex i»/uo.
In the following Chapters, studies are described which attempt to modulate
the extent of PADPR in humans and, in relation to this, to modulate the activity
of DNA repair mechanisms and the extent of DNA damage, measured ex u/uo
in PBLs either directly or after induction by (±)-<?/ifi-BPDE. It is hypothesized that
modulation of PADPRT activity in human PBLs, either by JM U/UO nicotinic acid
supplementation, by low ex uiuo pre-exposure to (±)-<wf»-BPDE, or by ex y/i>o
treatment with PADPRT inhibitors, will result in alteration of ((±)-anti-BPDE-
induced) DNA repair activities and p53 tumour suppressor protein
accumulation, and, in relation to this, in alteration in the extent of ((±)-anfi-
BPDE-induced) DNA damage.
In Chapter 2, a newly developed assay to determine the persistence of (±)-
««f/-BPDE-N2-dG adducts in isolated (±)-anh-BPDE-treated PBLs is described.
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Figure 1.5. Overview of hypotheses regarding modulating factors on poly(ADP-ribosylation) and DNA repair. Phenomena shown within lightly
shaded areas f K/VJ) are subject to study in this thesis. Numbers represent chapters in which the particular hypothesis is addressed.
Introt/uctiOR
The aim of the study, described in Chapter 3, was to investigate whether PADPR
is triggered during repair of (±)-anh-BPDE-induced DNA damage in PBLs. In
Chapter 4, an attempt is described to modulate PADPR-dependent DNA repair
m ui'uo in humans. The purpose of this study was to improve endogenous
niacin status by supplementing human smoking volunteers with nicotinic acid.
Moreover, the effects of nicotinic acid supplementation on DNA repair and
PADPR in PBLs, induced by (±)-anfi-BPDE treatment ex two were examined.
Also, the effects of in two nicotinic acid supplementation on lesions causing
chromosomal damage and mutagenesis ex two were determined. Chapter 5
describes age-related correlations found in these volunteers, prior to nicotinic
acid supplementation, between ex y/yo (±)-a«h'-BPDE-induced repair synthesis
and parameters of cytogenetic damage in PBLs. In Chapter 6, the effects of low
(±)-anf/-BPDE pre-exposure on (±)-nnfi-BPDE-induced DNA damage and repair
synthesis were examined. The purpose of this study was to investigate whether
pre-exposure to low levels of PAH, like (±)-anfi-BPDE, can result in the
induction of adaptive repair mechanism(s), comparable as those, known to occur
for IR and alkylating agents. Further, the potential roles of NER mechanisms and
PADPR in this process were determined. In Chapter 7, attention is paid to DNA
damage-inducible accumulation of tumor suppressor protein p53. Experiments
were performed to determine whether (±)-anfi-BPDE induces p53 accumulation
in isolated PBLs. Furthermore, by using an inhibitor of PADPRT, the role of
PADPR as potential interjacent event between carcinogen-induced DNA strand
break formation and p53 accumulation, was determined.
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Abstract
In order to study the relative importance for human individuals of endogenous
and environmental factors on the relation between DNA damage and DNA
excision repair, a method was developed for measuring quantitatively the
persistence of N^-deoxyguanosine adducts formed in non-stimulated isolated
human peripheral blood lymphocytes after in uifro incubation with 0.2 uM (±)-
awfi-BPDE, applying 32p.postlabeling. Total binding of radiolabeled (±)-n«/i-
BPDE to DNA and its removal has been studied previously in human peripheral
blood lymphocytes, but the method presented here enables the direct
investigation of repair of the main (±)-anfi-BPDE-DNA adduct, which is
implicated in benzo[a]pyrene-induced mutagenesis. Using this method, it was
found that in lymphocytes, obtained from five individuals, most (±)-anfi-BPDE-
N^-dG adducts are removed within the first 24 hours after treatment, while
interindividual differences appear to exist in both adduct formation and rate and
extent of removal.
Introduction
Several factors may influence an individuals' capacity to perform DNA repair.
Apart from genetic variability, as reflected by inborn disorders causing DNA
repair defects (1), occupational exposure to chemicals (2,3), as well as nutritional
and smoking behaviour (4) may be of influence.
Benzo[a]pyrene, one of the carcinogenic PAH, is metabolized to reactive
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quinones (5) and to certain dihydrodiol epoxides (6), from which the (+
benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide ((+)-anfi-BPDE) possesses the most
potent genotoxic activity, /n u/fro (7) and in u/uo (8) (±)-fl«f;-BPDE primarily
forms a covalent binding between the exocyclic 2-amino position on guanine and
the CIO position of B[a]P. Formation of N7-guanine adducts as well as adenine
and cytosine adducts may also occur. It is known that BPDE-guanine adduct
formation may induce mutational events (9,10), and it has been suggested that
mainly the stable N^-dG adduct is responsible for BPDE-induced mutagenesis
(11-13).
Mutagenesis induced by (±)-anf/-BPDE has been inversely related to repair of
BPDE-dG adducts (8,10). Further, it has been suggested that repair of BPDE-dG
adducts may be mediated via an UvrABC-like excision repair mechanism (14),
and recently, Celotti et al. (15) showed that (+)-o«fi-BPDE treatment induces
repair synthesis and rejoining of DNA strand breaks in human peripheral blood
lymphocytes, indicating that (±)-anf/-BPDE DNA adducts induce excision repair
related processes in human cells in pifro. The same study also showed the wide
range of inter-individual variability in repair of alkali-labile sites and
unscheduled DNA synthesis induced by direct-acting mutagens.
To study the relative importance of endogenous and environmental factors
on the relation between individual differences in DNA excision repair and DNA
damage, quantitative assessment of excision repair is required. Therefore, a
protocol was developed for measuring the persistence of the N^-deoxyguanosine
DNA adducts, formed in non-stimulated isolated human peripheral
lymphocytes after ;n uitro incubation with (±)-7f3,8a-dihydroxy-9a,10a-epoxy-
7,8,9,10-tetrahydrobenzo[a]pyrene ((±)-a«f/-BPDE), using the nuclease PI
enhanced 32p postlabeling method of Reddy and Randerath (16). Although
binding of radiolabeled (±)-an/i-BPDE to DNA in human peripheral blood
lymphocytes and its subsequent removal has been reported previously (4,17), the
use of the method presented here, enables the study of repair kinetics of the
main (±)-anH-BPDE-DNA adduct, involved in benzo[a]pyrene-induced
mutagenesis, namely (±)-anf/-BPDE-N2-dG.
Materials and methods
100 ml of venous heparinized blood was collected from 5 healthy, non-smoking
volunteers. Lymphocytes were immediately isolated using Lymphoprep
(Nycomed), and washed with PBS. Pellets were dissolved in RPMI 1640 culture
medium (Gibco) and 10-15 x 10^  lymphocytes were transferred to culture tubes.
Medium was adjusted to a volume of exactly 5 ml. (±)-a«h-BPDE was obtained
from Midwest Research Institute USA, dissolved in anhydrous DMSO and stored
frozen prior to use. (±)-fl«fi-BPDE was quickly added to the cultures to a final
concentration of 0.2 uM. From each donor, two cultures were set up to serve as
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DMSO solvent control (final concentration 0.1%), for determination of putative
endogenous (±)-<7>if;-BPDE-N2-dG adduct levels. Suspensions were mixed by
swirling and were subsequently incubated for 15 minutes at 37 °C. Within 1
minute after incubation, cells were centrifuged for 10 minutes at 400 g and
washed once with PBS. For determination of adduct levels, DNA from cells was
digested with proteinase K, extracted once with phenol : chloroform : isoamyl
alcohol 25 : 24 : 1 (v/v/v), once with chloroform : isoamyl alcohol 24 : 1 (v/v)
and subsequently precipitated by the addition of 1/30 volume of 3 M sodium
acetate pH 5.2 and an equal volume of ice-cold isopropanol. DNA was washed
with cold 70% ethanol and dissolved in 2 mM Tris-HCl pH 7.4. DNA
concentrations of sheared homogeneous, non-viscous samples were measured
spectrophotometrically, using a Beckman DU-64 spectrophotometer, according to
Warburg and Christian (18). Variation in DNA concentration, as determined
from duplicate dilutions from one DNA sample was always less than 3%.
For determination of adduct levels at various time points after (±)-anri-BPDE
incubation, exposed cells were suspended in RPMI 1640 medium supplemented
with 100 ug/ml streptomycin, 100 U/ml penicillin, 5 mM L-glutamine, 50 U/ml
heparin and 10% foetal calf serum (FCS) (all from Gibco). At the respective time
points (4, 7 or 16, 24, 48 or 52, 72 hours) after treatment with (±)-nHfi-BPDE, DNA
was isolated as described above. Cytotoxicity was determined at these time points,
using the trypan blue exclusion technique.
The level of (±)-anfz'-BPDE-N2-deoxyguanosine adducts was determined
according to procedures developed by Reddy and Randerath (1986).
Approximately 5 ug DNA was digested for 3 hours at 37 °C with 200 mU
micrococcal nuclease and 2.8 mU spleen phosphodiesterase in a total volume of
5 ul containing 20 mM sodium succinate and 10 mM CaCl2 with pH 6.0.
Subsequently, samples were digested with 6.25 ug nuclease PI (± 6.25 U 3'-
phosphomonoesterase activity) in a total volume of 10 ul, containing 0.03 mM
ZnCl2 and 37.5 mM sodiumacetate pH 5.0, for 40 minutes at 37 °C. and then 2.5
ul of 0.5 M Tris Base was added. The DNA digest, containing the
deoxyribonucleoside 3'-monophosphates was incubated with 50 uCi [y-32p]ATP
(synthesized in our laboratory, using carrier free 32p, spec. act. > 3000 Ci/mmol)
and 5 units of T4 polynucleotide kinase to yield [5'-32p]-deoxyribonucleosides
3',5'-biphosphates. Termination of the reaction was performed by incubating the
mixture during 30 minutes at 37 °C with 15 mU potato apyrase. All enzymes
were from Boehringer Mannheim. 32p_iabeled adducts were purified and
resolved on polyethyleneimine-cellulose TLC sheets (Machery-Nagel, Diiren,
Germany.) Chromatography was performed using the following solvents:
Direction (D) 1, 1.0 M sodium phosphate, pH 6.0; D2, 3.5 M lithium formate, 8.5
M urea, pH 3.5; D3 0.8 M LiCl, 0.5 M Tris-HCl 8.5 M urea, pH 8.0, D4, 1.7 M
sodium phosphate, pH 6.0. Chromatograms were visualized by autoradiography
at -80 °C. One-dimensional TLC of [5'-32p]deoxyribonucleosides 3',5'
biphosphates (obtained after enzymatic hydrolysis and 32p.postlabeling) with 0.12
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M Nah^PC^ pH 6.0 (19), of DNA samples extracted from untreated, unstimulated
human peripheral blood lymphocytes, indicated that RNA contamination was
absent since only deoxyribonucleoside derivatives were detected. Adduct levels
were determined by excising areas of the chromatograms and radioactivity was
measured by liquid scintillation counting.
For each experiment, PH](±)-<ZMH-BPDE modified DNA standards with
modification levels of respectively 1 adduct/10?, 10^  and 10^  nucleotides were
included in the procedure described above (20). Experiments from our laboratory,
using the standard with modification level of 1 adduct per 10^ nucleotides,
indicate actual recoveries of 80-100% (determined as RAL (nuclease
PI /modification level [3H](±)-anfi-BPDE modified DNA standard * 100). Linear
calibration curves were prepared from these standards by plotting the number of
DPM, recovered within the area containing the standard (±)-o«h-BPDE-N2-dG
adduct vs. modification level. The number of DPM, recovered within the area
containing the (±)-awf/-BPDE-N2-dG adducts from samples, was directly related
to this calibration curve, whereafter the number of adducts/nucleotide was
calculated by correction for differences in DNA amounts between standards and
samples, assuming that 1 fig DNA is equivalent to 3240 pmol dNp. Adduct spots,
determined in DNA samples obtained from DMSO treated lymphocytes,
chromatographing at a similar position, relative to the origin as the (±)-anfi-
BPDE-N^-dG standards, were termed pufafiue endogenous (±)-anh-BPDE-N2-
dG adducts, and directly related to the (±)-anh-BPDE-N2-dG standards. Average
intra- and interassay (day-to-day) variations in the determination of (±)-anfi-
BPDE-N^-dG adduct levels in DNA samples were respectively 17.8 and 8.9%.
Results and discussion
Figure 2.1 shows chromatograms of DNA samples obtained from lymphocytes of
donor 2 at various time intervals after in i>ifro incubation with (±)-rtnfi-BPDE.
After a 15 minutes incubation period (t=0 hours) of freshly isolated human
peripheral blood lymphocytes with 0.2 uM (±)-an//-BPDE, a major spot is visible,
chromatographing at a similar position relative to the origin as the (±)-awfz-
BPDE-N2-dG standard. The intensity of the (±)-<inh-BPDE-N2-dG spot decreases
with time, indicating removal of (±)-anh'-BPDE-N2-deoxyguanosine adducts.
In Figure 2.2, the level of (±)-anfi-BPDE-N2-dG adducts, expressed as
adducts/10^ nucleotides, at different time intervals after exposure of lymphocytes
to 0.2 |iM (±)-anf j-BPDE i« uifro is shown for 5 donors. In most resting
lymphocyte cultures, almost all adducts are removed within 4 to 7 hours,
followed by a period in which it seems that adduct removal is absent or slow.
Whether a real second slow repair phase in the process of (±)-auh-BPDE-N2-dG
adduct removal actually occurs in these cells is unknown. No cell death was
observed at different time intervals after (±)-a«fi-BPDE exposure of PBLs,
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Figure 2.1. Chromatograms of (±)-anli-BPDE-N2-dG adduct standard (1 adduct per 10« nucleotides) and DNA samples obtained from resting
peripheral blood lymphocytes of donor 2 at various time intervals, after m wfro incubation with 0.2 uM (±)-anfi-BPDE during 15 minutes (or
DMSO, as solvent control). Autoradiography was performed at -80 °C during 70 hours, using Amersham Hyperfilm™-MP X-ray film in
combination with Kodak X-omatic intensifying screens.
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Figure 2.2. Persistence of (±)-rtii(/-BPDE-N^-deoxyguanosine adducts in DNA
obtained from resting peripheral blood lymphocytes of human donors at various
time intervals, after in i>/(ro incubation with 0.2 uM (±)-anfi-BPDE for 15 minutes.
Results represent the mean adduct level (± SD) of duplicate incubations, for each
experiment.
obtained from these donors, with percentage of viable cells ranging from 90-100%
(trypan blue exclusion). This is in agreement with results, reported previously by
Rankin et al. (21). Although total number of cells not was determined at each
time point, it was found that all cultures yielded approximately equal amounts of
DNA. Therefore, it appears unlikely that the observed decrease in adduct levels
is related to preferential selection of a less affected cell population, surviving
after lysis of heavily damaged cells.
A similar repair pattern of total (±)-<7rcf/-BPDE-DNA adduct removal in non-
stimulated human peripheral blood lymphocytes has been reported previously,
measuring the disappearance of total DNA bound pH]-BPDE (4). However, in
contrast to the present study, this observation may be due to removal of not only
(±)-nnfi-BPDE-N2-dG lesions.
Figure 2.2 also illustrates the interindividual differences in both rate and
extent of (±)-rt/ih'-BPDE-N2-dG adduct removal. For example, donor 1 shows a
very rapid decrease in adduct levels, while donor 4 demonstrates a more slowly
removal of adducts. Evident is that a 2-3 fold interindividual variety in
effectivity of adduct removal exists. Previous studies also indicate the existence
of similar interindividual differences in the extent of (±)-anf/-BPDE-DNA
adduct removal in resting human peripheral blood lymphocytes after IM y/fro
treatment with pH](±)-rtnfi-BPDE (4,17).
It is not clear which factors primarily determine an individuals' capacity of
DNA repair. The initial level of BPDE-DNA adduct formation may influence
repair kinetics indirectly, possibly via interference with mRNA expression of
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Table 2.1. Characteristics of the 5 donors, putative endogenous (±)-anfi-BPDE-N*-dG adduct
levels, and removal of m w/ro introduced (±)-<w(i-BPDE-N^-dG adducts.
donor
1
2
3
4
5
smoker/
non-smoker
(S/NS)
NS
NS
NS
NS
NS
sex
M
M
F
F
F
age
24
25
24
23
22
profession
technician
technician
student
office employee
student
% removal
75.5%
52.8%
52.0%
24.0%
58.1%
putative endogenous
(±)-an/i-BPDE-N*-dG
adduct level
(adducts/10' nucleotides)
not detectable
not detectable
0.27 ± 0.24
17.80 ± 6.80
0.12 ± 0.05
repair enzymes. This is reflected by the observation that treatment of human
peripheral blood lymphocytes with 0.3 uM (±)-aMfi-BPDE for 1 hour resulted in
strand breakage and resealing that proceeded until 20 hours after ending of
exposure; at higher concentrations (1.2 uM) however, resealing ceased after 4
hours and breaks were found to accumulate, suggesting saturation of the repair
system (17).
Further, donor 4 who had the highest initial (±)-anfz-BPDE-N2-dG adduct
level, showed the less efficient removal of in fifro introduced (±)-tfHh'-BPDE-
N^-dG adducts. However, no clear tendency was observed between initial (±)-
onfi-BPDE-N^-dG adduct formation and efficiency of (±)-anfi-BPDE-N2-dG
adduct removal, for lymphocytes obtained from all these five donors.
Age has also been negatively and positively associated with repair activity of
different kinds of DNA damage (22,23). In the present study, age hardly varied
between the donors, and could therefore not be related to (±)-flnh-BPDE-N2-dG
adduct removal (Table 2.1). Therefore, it is likely that unknown factors, related to
for example occupational exposure to chemicals as well as dietary and drinking
habits may also be of influence on DNA repair capacity in these individuals
(24,25). Furthermore, interindividual differences in susceptibility to DNA
damaging agents of lymphocytic subsets may attribute to the observed differences
in repair activity, since it has been shown for example that induction of
micronuclei after X-irradiation /« ui'tro differed between subpopulations of
lymphocytes (26).
It was found that the initial adduct formation (t=0 hours) varies between the 5
donors studied (Figure 2.2). Celotti et al. (17) also reported interindividual
differences in initial binding of [3H](±)-flnh'-BPDE to DNA of in uifro treated
resting human PBLs. In their study, treatment of lymphocytes with 0.33 uM
pH](+)-<wfi-BPDE during 40 minutes resulted in BPDE-DNA adduct levels of
approximately 9.3 adducts per 10^  nucleotides (17), which is about 100-1000 times
higher than the (±)-anfi-BPDE-N2-dG adduct levels observed in the present
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study. It is unlikely that this discrepancy is specifically related to the methods
used, since most of total DNA-bound radiolabel was related to the presence of
(±)-anfi-BPDE-N2-dG adducts. Furthermore, it seems unlikely that differences in
duration of (±)-anfi-BPDE treatment (40 minutes vs. 15 minutes in this study)
accounts solely for this discrepancy, since it has been shown in rodent cells, that
maximum DNA binding of pH](±)-flnh-BPDE was already accomplished after 15
minutes of exposure. (27). Thus, it remains unclear what caused the differences
in initial (±)-an/i'-BPDE-N2-dG levels, observed between these studies.
In the present study, in donor 4, a putative endogenous (±)-anfi'-BPDE-N2-dG
adduct level of 17.7±6.8 adducts per 10^  nucleotides was found, which might
reflect a relatively low activity of detoxification pathways for (±)-anfi-BPDE in
vii>o. Alternatively, since this donor also showed the less effective removal of
(±)-a/jfi-BPDE-N2-dG adducts after m i>ifro incubation with (±)-flnh-BPDE, the
presence of these putative endogenous adducts could be due to inefficient repair
m two. In contrast, individuals with undetectable putative endogenous adduct
levels in ui'uo, showed effective (±)-anfi-BPDE-N2-dG removal (donor 1 and 2;
resp. 75.5% and 52.8%) in p/fro. However, the presence of high levels of
putative endogenous (±)-anfi-BPDE-N2-dG levels (donor 4) may interfere with
quantification of the in yi/ro introduced (±)-<infi-BPDE-N2-dG adducts (see
Table 2.1 and Figure 2.2), since it is otherwise unexplainable why in uifro
exposure to (±)-anfi-BPDE of lymphocytes, obtained from donor 4 would not
result in additional formation of BPDE DNA adducts.
Since measurement of PAH-DNA adduct levels by 32p.postlabeling seems to
be useful in monitoring exogenous exposure to PAH, related to occupation, diet,
smoking behaviour as well as environmental factors (28), the protocol described
in the present study may also enable evaluation of the effects of these factors on
the relation between individual differences in endogenous DNA damage and
DNA excision repair, induced in i>ifro.
In conclusion, it is demonstrated that the use of 32p.postlabeling after in uifro
incubation of resting human peripheral blood lymphocytes with (±)-nnfi-BPDE,
allows for the accurate determination of repair of the BPDE-DNA adduct,
generally hypothesized to be involved in BPDE-induced mutagenesis (11-13),
namely the (±)-«nh'-BPDE-N2-dG adduct. Most (±)-fln/i-BPDE-N2-dG adducts
appear to be removed within the first 24 hours after exposure and considerable
interindividual differences exist in both adduct formation, and rate and extent of
adduct removal. Using the method described here, it will be possible to
determine the implications of exogenous and inborn factors on interindividual
differences in DNA damage and repair.
Acknowledgements
The authors wish to thank Dr. F.J. van Schooten for kindly providing pH](±)-
an/i-BPDE modified DNA standards and helpful discussions.
66
32P-posf/abe/mg and (±)-anfi-BPDE-N2-dG nemotja/
References
1. Cleaver, J.E., Thomas, G.H. (1993) Clinical syndromes associated with DNA repair
deficiency and enhanced sun sensitivity. /Irc/i. Dermflfo/., 129, 348-350.
2. Oesch, F., Klein, S. (1992) Relevance of environmental alkylating agents to repair
protein O^-alkylguanine DNA alkyltransferase: Determination of individual and
collective repair capacities of O^-methylguanine. Cancer Res., 52,1801-1803.
3. Pero, R.W., Bryngelsson, T., Widegren, B., Hogstedt, B., Welinder, H. (1982) A
reduced capacity for unscheduled DNA synthesis in lymphocytes from individuals
exposed to propylene oxide and ethylene oxide. MuM. Res., 104, 193-200.
4. Oesch, F., Aulmann, W., Platt, K.L., Doerjer, G. (1987) Individual differences in DNA
repair capacities in man. /\rc/i. Toxf'co/. Swpp/., 10, 172-179.
5. Rogan, E.G., Ramakrishna, N.V.S., Higginbotham, S., Cavalieri, E.L., Jeong, H.,
Jankowiak, R., Small, G.J. (1990) Identification and quantitation of 7-(Benzo[a]pyren-
6-yl)guanine in the urine and feces of rats treated with benzo[a]pyrene. C/iem. Res.
Toxi'co/., 3, 441-444.
6. Dipple, A., Moschel, R.C., Bigger, C.A.H. (1984) Polynuclear aromatic hydrocarbons.
In: Searle, C.E. (eds.), Cftem/cn/ Carcinogens. Am. Chem. Soc, Vol 1, Second edition,
Washington DC: pp. 41-163.
7. Weinstein, I.B., Jeffrey, A.M., Jenette, K.W., Blobstein, S.H., Harvey, R.G., Harris, C,
Autrup, H., Kasai, H., Miura, I., Nakanishi, K. (1976) Benzo[a]pyrene diol epoxides
as intermediates in nucleic acid binding »n urtro and HI y/TO. Science, 193, 592-595.
8. Yang, Li.L., Maher, V.M., McCormick, J.J. (1980) Error-free excision of the cytotoxic,
mutagenic N^-deoxyguanosine DNA adduct formed in human fibroblasts by (±)-
7p,8a-dihydroxy-9a,10a-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene. Proc. Naf/. Acai.
Sci U.S.A., 77, 5933-5937.
9. Norimura, T., Maher, V.M., McCormick, J.J. (1990) Cytotoxic and mutagenic effect of
UV, ethylnitrosourea and (±)-7p,8a-dihydroxy-9a,10a-epoxy-7,8,9,10
tetrahydrobenzo[a]-pyrene in diploid human T lymphocytes in culture: comparison
with fibroblasts. Mufagenesis, 5, 447-451.
10. Yang, Li. L., Maher, V.M., McCormick, J.J. (1982) Relationship between excision repair
and the cytotoxic and mutagenic effect of the 'anf/' 7,8-diol-9,10-epoxide of
benzo[a]pyrene in human cells. Mi/faf. Res., 94, 435-447.
11. Yang, J.-L., Maher, V.M., McCormick, J.J. (1987) Kinds of mutations formed when a
shuttle vector containing adducts of (±)-7p,8a-dihyroxy-9a,10ct-epoxy-7,8,9,10-
tetrahydrobenzo[a]pyrene replicates in human cells. Proc. Naf/. Acorf. Sri. U.S./l., 84,
3787-3791.
12. Yang, J-L., Chen, R-H., Maher, V.M., McCormick, J.J. (1991) Kinds and location of
mutations induced by (±)-7p,8a-dihydroxy-9a,10a-epoxy-7,8,9,10-tetrahydro-
benzo[a]pyrene in the coding region of the hypoxanthine (guanine) phosphoribosyl-
transferase gene in diploid human fibroblasts. Cflrcniogenes;s, 12, 71-
75.
13. Carothers, A.M., Grunberger, D. (1990) DNA base changes in benzo[a]pyrene diol
epoxide-induced dihydrofolate reductase mutants of Chinese hamster ovary cells.
Carrinogenes/s, 11, 189-192.
14. Van Houten, B., Masker, W.E., Carrier, W.L., Regan, J.D. (1986) Quantitation of
carcinogen-induced DNA damage and repair in human cells with the UVR ABC
excision nuclease from Ec/ier/diia co/;\ Gjrcim>genesis, 7, 83-87.
15. Celotti, L, Ferraro, P., Biasin, M.R. (1992) Detection by fluorescence analysis of DNA
unwinding and unscheduled DNA synthesis, of DNA damage and repair induced in
»ifro by direct-acting mutagens on human lymphocytes. Mutaf. Res., 281,17-23.
16. Reddy, M.V., Randerath, K. (1986) Nuclease PI-mediated enhancement of sensitivity
67
Chapter 2 ,' l ; r ^ H», •-:i^Tsv,-',Sv -_
of 32p.postlabeling test for structural diverse DNA adducts. Carc/no^enesis, 7, 1543-
1551.
17. Celotti, L., Ferraro, P., Furlan, D., Zanesi, N., Pavanello, S. (1993) DNA repair in
human lymphocytes treated i« u/fro with (±)-<wfi- and (+)-sy«-benzo[a]pyrene
diolepoxide. Mu/al. Res., 294, 117-126.
18. Warburg, O., Christian, W. (1942) Isolierung und kristallisation des garungsfermente
enolase. B/oc/iem. Z., 310, 348-421.
19. Lutgerink, J.T., van den Akker, E., Smeets, I., Pachen, D., van Dijk, P., Aubry, J.-M.,
Joenje, H., Lafleur, M.V.M., Retel, J. (1992) Interaction of singlet oxygen with DNA
and biological consequences. Mute(. Res., 275, 377-386.
20. Van Schooten, F.J., Kriek, E., Steenwinkel, M.-J.S.T., Noteborn, H.P.J.M., Hillebrand,
M.J.X., Van Leeuwen, F.E. (1987) The binding efficiency of polyclonal and monoclonal
antibodies to DNA modified with benzo[a]pyrene diol epoxide is dependent on the
level of modification. Implications for quantitation of benzo[a]pyrene-DNA adducts
/« p/'vo. Carci/iogenesis, 8, 1263-1269.
21. Rankin, P.W., Jacobson, M.K., Mitchell, V.R., Busbee, D.L. (1980) Reduction of
nicotinamide adenine dinucleotide levels by ultimate carcinogens in human
lymphocytes. Gincer Res., 40, 1803-1807.
22. Wei, Q., Matanoski, G.M., Farmer, E.R., Hedayati, M.A., Grossman, L. (1993) DNA
repair and aging in basal cell carcinoma: A molecular epidemiology study. Proc. Naf/.
/Icflrf. Sci. U.S.A, 90, 1614-1618.
23. Pero, R.W., Ostlund, C. (1980) Direct comparison, in human resting lymphocytes, of
the inter-individual variations in unscheduled DNA synthesis induced by N-acetoxy-
2-acetylaminofluorene and ultraviolet irradiation. Mwfdf. Res., 73, 349-361.
24. Topinka, J., Binkova, B., Sram, R.J., Fojtikova, I. (1991) DNA-repair capacity and
lipid peroxidation in chronic alcoholics. Mufaf. Res., 263, 133-136.
25. Boothman, D.A., Schlegel, R., Pardee, A.B. (1988) Anti-carcinogenic potential of
DNA-repair modulators. MMM. Res., 202, 393-411.
26. Wuttke, K., Streffer, C, Muller, W.U. (1993) Radiation induced micronuclei in
subpopulations of human lymphocytes. Mi/taf. Res., 286, 181-188.
27. Krolewski, B., Little, J.B., Reynolds, R.J. (1988) Effect of duration of exposure to
benzo[a]pyrene diol-epoxide on neoplastic transformation, mutagenesis, cytotoxicity,
and total covalent binding to DNA of rodent cells. Teratog. Care/nog. Mi/fagen., 8,
127-136.
28. dell' Omo, M., Lauwerys, R.R. (1993) Adducts to macromolecules in the biological
monitoring of workers exposed to polycyclic aromatic hydrocarbons. Cn'f. Reu.
Toxico/., 23, 111-126.
68
Increased poly(ADP-ribose) polymerase activity during repair
of (±)-«wfi-benzo[a]pyrene diolepoxide-induced DNA
damage in human peripheral blood lymphocytes i«
R.H. Stierum, M.H.M. van Herwijnen, G.J. Hageman and J.C.S. Kleinjans
Department of Health Risk Analysis and Toxicology, University of Limburg, P.O.
Box 616, 6200 MD Maastricht, The Netherlands
Based on: Cardnogenesi's, 25, 745-751, 2994
Abstract
Poly(ADP-ribose) polymerase, catalyzing the formation of poly(ADP-ribose)
polymers is an enzyme involved in cell proliferation, differentiation and
transformation as well as in recovery from DNA damage. Poly(ADP-ribose)
polymers are rapidly synthesized from the ADP-ribose moieties from
intracellular NAD+, which, as a consequence, is depleted. It has been shown that
DNA strand breaks are required for enzyme activation and it is suggested that
one of the functions of poly(ADP-ribosylation) is to improve accessibility of
damaged sites to other DNA repair enzymes. The aim of this study was to
investigate whether poly(ADP-ribosylation) is involved in repair of (±)-7(i,8a-
dihydroxy-9a,10a-epoxy-7,8,9,10-tetrahydrobenzo[a]-pyrene ((±)-a«/i-BPDE)
induced DNA damage in human lymphocytes in uifro. Results show that (±)-
<mh'-BPDE is capable of inducing poly(ADP-ribosylation), NAD+ depletion and
inhibition of proliferation in PHA-stimulated human peripheral blood
lymphocytes. Also, repair of (±)-a«H-BPDE-induced DNA damage was
confirmed by both unscheduled DNA synthesis and (±)-anh'-BPDE-N2-dG
adduct removal. Based on these findings, it is concluded that poly(ADP-
ribosylation) may be involved in (±)-a«H-BPDE-induced DNA repair in these
cells. In addition, these results confirm the possible relation between poly(ADP-
ribosylation), NAD+ depletion and inhibition of proliferation, after induction of
DNA damage.
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Introduction
The biological functions of the intranuclear polyadenosine diphosphate-ribose
polymer, are still not fully understood. It has been implicated in various
processes like cell proliferation, differentiation, transformation and recovery
from DNA damage (1,2). Synthesis of this polymer is catalyzed by the enzyme
poly(ADP-ribose) polymerase [NAD+ ADP-ribosyltransferase, EC 2.4.2.30]
(abbreviation PADPRT), a zinc-binding nuclear enzyme, which transfers the
ADP-ribose moieties from nicotinamide adenine dinucleotide in a proximal or
distal mode to the ongrowing chains of the poly(ADP-ribose) polymer. The ADP-
ribose moieties are polymerized through ribose a(l'-2') ribose bonds in a linear
and branched structure (3,4)- It is assumed that polymer synthesis is involved in
DNA damage and DNA excision repair, since DNA strand breaks are required for
enzyme activity (5,6,7). Next to the enzyme itself, histones act as main acceptor
proteins for poly(ADP-ribose) molecules (1,2).
It has been postulated that the accessibility of damaged DNA for repair
enzymes is transiently improved through rapid automodification of PADPRT
upon activation by DNA single or double strand breaks, followed by formation of
poly(ADP-ribose) polymers on core and linker histones. The resulting
dissociation of the histone-DNA complexes with local decondensation of the
chromatin, enabling repair enzymes to perform repair synthesis and ligation at
the damaged site. Subsequently, the poly(ADP-ribose) polymers are rapidly
degraded by another enzyme, the poly(ADP-ribose) glycohydrolase, enabling
reassociation of the histones to the DNA, leading to recondensation of the
chromatin (8,9).
Alternatively, direct modification of repair enzymes, e.g. stimulation of ligase
II activity, has been proposed (10), but experiments concerning the direct action of
PADPRT on ligase II yielded contradictory results (11,12). Thirdly, the induction
of poly(ADP-ribose) polymer synthesis after severe DNA damage may represent a
cellular suicide mechanism. Cells subjected to DNA damage showed decreased
intracellular NAD+ and ATP levels (6,7,13), which was found to be related to cell
lysis (7).
Benzo[a]pyrene, a full environmental carcinogen, is metabolized by
cytochrome P450 dependent monooxygenases and epoxide hydrolase to reactive
diolepoxides, as well as via one-electron oxidation to radical cations (14). /n
uifro and in DIDO, (+)-anf/-benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide
mainly results in the formation of an adduct between the N^ position of guanine
and the CIO position of B[a]P ((+)-fl"fi'-BPDE-dG). After treatment of cells with
(±)-rtHfi-BPDE ((±)-7p,8oc-dihydroxy-9a,10a-epoxy-7,8,9,10-tetrahydrobenzo[a]-
pyrene), mutational events occur, mainly GC—>TA transversions. (15-18).
Repair of BPDE-DNA damage in mammalian cells appears to be mediated
through excision repair mechanisms. Recently, (±)-a«(i-BPDE was shown to
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induce UDS and strand breakage in human peripheral blood lymphocytes (19)
and mouse epidermal keratinocytes (20). Also, it was shown that in human
diploid fibroblasts, excision repair of (±)-<nifi-BPDE-DNA adducts may be
preferential and strand-specific (21).
DNA excision repair activity has been reported to show considerable
interindividual variation (19,22), which could be due to differences in
endogenous repair capacity as well as to influences by environmental and life-
style factors. Since BPDE-induced mutagenesis has been found to be inversely
related to repair of BPDE-dG adducts (15,17,23) investigation of repair modulating
factors is pivotal. One of these factors may be the individual niacin status, since
niacin is one of the precursors of nicotinamide adenine dinucleotide. If
ribosylation is involved in repair of benzo[a]pyrene DNA damage, the
availability of intracellular nicotinamide adenine dinucleotide may be a limiting
factor in restoring the integrity of DNA after (±)-fl»h-BPDE-induced damage,
and consequently modulate mutagenesis.
In this study, evidence is presented that poly(ADP-ribosylation) takes place
during (±)-fln/;-BPDE-induced DNA repair in PHA stimulated human
peripheral blood lymphocytes. Also NAD+ depletion, unscheduled DNA
synthesis (UDS) and removal of (±)-anf/-BPDE-N2-dG adducts were examined,
to gain additional evidence for a possible involvement of poly(ADP-ribosylation)
in repair of (±)-fl«fi-BPDE DNA damage.
Materials and methods
Human peripheral blood lymphocytes (PBLs) were isolated from 14 buffycoats
(prepared from 500 ml blood of healthy blood donors). Buffycoats were diluted 1 :
4 (v/v) with RPMI 1640 medium prior to isolation of lymphocytes on
Lymphoprep™ (Nycomed). After centrifugation at 800 g, the interfaces were
collected, washed with RPMI 1640 medium and pooled. In case of obvious red
blood cell contamination, erythrocytes were lysed in 155 mM NH4CI, 10 mM
KHCO3, 10 rnM EDTA, pH 7.4. Mononuclear cells were counted using a
haemocytometer and viability was determined using trypan blue exclusion. In
general, a yield of about 5 x 10& viable cells per buffycoat was obtained.
Cells were adjusted to a density of 1-2 x 10^ cells/ml RPMI 1640 medium
supplemented with 15% (v/v) foetal calf serum (FCS), L-glutamine, 100 U/ml
penicillin, 100 ug/ml streptomycin (complete medium) and grown for 48 h in
presence of 40 ul (± 52 ug) phytohemagglutinin (PHA)/ml medium in culture
flasks in a humidified incubator at 37 °C under 5% CO2.
For synthesis of [ade/nne-i4C]poly(ADP-ribose) (see below), human diploid
fibroblasts were cultured in Ham's F10 medium, supplemented with 20% FCS,
100 U/ml penicillin, 100 ug/ml streptomycin under the conditions described
above. Medium was refreshed every 2-3 days. Cells were trypsinized with 0.3%
71
Diopter 3
20 40
time (minutes)
60
Figure 3.1. Time dependent hydrolysis of (±)-7P,8a-dihydroxy-9a,10ot-epoxy-
7,8,9,10-tetrahydrobenzo[a]pyrene in RPMI 1640 medium without supplements, at
37 °C
trypsin prior to use or reseeding at a density of approximately 1.5 x 10^  cells/162
cm2. All cell culture media and supplements were from Gibco, Europe.
o/ /ymp/ioci/fes a>/f/i carcinogens
After 46-48 hours of culturing, lymphocytes were treated with (±)-<jnf/-BPDE
(Midwest Research Institute) or MNNG (N-methyl -N ' -ni t ro-N-
nitrosoguanidine, Serva), which served as a positive control since treatment of
resting human PBLs with MNNG for 10 minutes has been reported to yield
maximum poly(ADP-ribose) polymer levels (24). Before treatment, adhering cells
were scraped from the culture flask and the resulting suspension was
centrifuged. Medium was saved and stored for post-treatment cell culture, and
cells were suspended in RPMI 1640 medium without supplements.
Hydrolysis of (±)-u?ifi-BPDE in RPMI 1640 at 37 °C was determined as
described by MacLeod and Lew (25) and found to be rapid with a half-life of
approximately 15 minutes (see Figure 3.1). Previously, it was shown that
treatment of two mammalian cell lines with (±)-<nifi-pH]BPDE for 15 minutes
resulted in maximum binding to DNA, while after prolonged treatment no
increased binding was observed (26). Therefore, it is likely that most of the (±)-
flHfi'-BPDE-induced DNA damage in human PBLs occurs within the initial 15
minutes of exposure.
(±)-anfi'-BPDE, dissolved in anhydrous DMSO, was diluted in RPMI 1640 to
the required final concentrations in subdued light just prior to addition to the
cell suspension in order to minimize the effect of hydrolysis on the effective
dose. Cells were incubated at a density of 10 x 10^ cells/ml at 37 °C, during 15
minutes (or longer as indicated below, for determination of NAD+ and
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poly(ADP-ribose) polymer levels at different time points after incubation).
Control cells were exposed to a maximum concentration of 0.6% DMSO.
For UDS determination, the treatment protocol was slightly different. 48
hours after PHA stimulation, (±)-anfi-BPDE dissolved in DMSO (final
concentration: 1%) was added to approximately 1 x 10^  cells by micropipette to the
desired final concentration. Within 15 minutes, [mef/iy/-3H]thymidine
(Amersham, specific activity 82 Ci/mmol) was added to a final concentration of
10 jiCi/ml and cells were cultured for 24 hours at a density of 1-2 x 10^  cells/ml
until harvesting.
Defermi'naf/oH of nbosyZafron m carcinogen freaferf ce//s
Aliquots, containing at least 50 x 10^  cells were transferred to 50 ml culture tubes
on ice at different time points (15, 35, and 55 minutes), after exposure to various
concentrations of (±)-anfi-BPDE or MNNG, in order to determine PADPRT
activity. These time points were selected since other studies indicated that
carcinogen induced (ADP-ribose) polymer formation and breakdown is a
dynamic process, proceeding in general within a period of 1-2 hours (6,24,27). The
material was precipitated in 20% TCA and the amount of poly(ADP-ribose) in the
acid insoluble fraction was determined according to the procedure described by
Jacobson (28). Dihydroxyboryl Bio-Rex 70 chromatography was applied to adsorb
polymeric ADP-ribose, after which enzymatic hydrolysis of the phosphodiester
linkages with snake venom phosphodiesterase (Worthington) and alkaline
phosphatase (Sigma) yielded the adenine derivatives ribosyladenosine and
diribosyladenosine. Fluorescent etheno-derivatives from these nucleosides were
synthesized under acidic conditions with chloroacetaldehyde. A purification step
with Matrex Gel PBA-60 was omitted since under the conditions described below,
a good resolution of the ethenoadenosine and ethenoribosyladenosine peaks was
achieved.
Fluorescent nucleosides derived from poly(ADP-ribose) were separated on a
Hichrom nucleosil 120 5C18 column (250 x 4.6 mm i.d.). The injection volume
was 200 ul. The column was isocratically eluted at room temperature with 85%
methanol/15% 7 mM ammonium formate, pH 5.8 (v/v) delivered by a Kratos
Spectroflow 480 solvent delivery system at a flow rate of 0.8 ml/minute.
Monitoring of the fluorescent nucleosides was performed by a Kratos
Spectroflow 980 programmable fluorescence detector with an excitation
wavelength of 220 nm and an emission wavelength of 370 nm. Reference
samples of e thenoadenosine , e thenoribosyladenosine and
ethenodiribosyladenosine were kindly provided by Dr. Myron K. Jacobson from
the Department of Anatomy and Cell Biology, Texas College of Osteopathic
Medicine, University of North Texas, Forth Worth, Texas, U.S.A. Pure
ethenoadenosine was obtained from Sigma. The detection limit was 1 pmol
absolute.
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To check for overall recovery, DHB-Biorex purified
ribose) was added to each acid insoluble pellet, prior to determination of
poly(ADP-ribose) polymers (28). [ademMe-l4C]poly(ADP-ribose) was prepared
according to Alvarez-Gonzalez (29). Human fibroblasts from 12 to 20 confluent
165 cm2 flasks were permeabilized during 15 minutes at a cell density of 2 x 10*
cells in ice-cold 10 mM Tris-HCl, pH 7.8, 1 mM EDTA, 0.05% Triton X-100, 4 mM
MgCl2, 30 mM P-mercaptoethanol. Subsequently, cells were centrifuged at 1000 g
for 10 minutes at 4 °C and resuspended in assay buffer containing 40 mM Tris-
HCl pH 7.8, 1 mM P-mercaptoethanol, 1 mM phenylmethylsulfonylfluoride, 200
|lg/ml DNase I (Boehringer Mannheim), 0.5 mM NAD+ (Sigma) and 5-10 |iCi
[/We-U-14C]NAD+ (NEN, DuPont). The reaction mixture was incubated at 30 °C,
during 30 minutes. The reaction was stopped by the addition of TCA to a final
concentration of 20% (w/v), and cooling on ice for 15 minutes. Precipitated
material was pelleted by centrifugation and purified on a DHB-Biorex column.
N/4D+
An aliquot of incubation medium, containing at least 5 x 10^  cells, was taken 55
minutes after treatment, since previous studies indicate that carcinogen induced
NAD+ depletion takes place within ± 1 hour after treatment (24,30-32).
Incubation medium was removed after centrifugation of the cell suspension for
10' at 400 g and pyridine nucleotides were extracted from the pellet with 2.0 ml
ice-cold 0.1 M NaOH and 1 mM nicotinamide, followed by a 1.0 ml wash of the
tube. The extract was neutralized to pH 7.3 (± 0.05) and stored at -20 °C prior to
the determination of NAD+. Intracellular NAD+ levels were determined using
the enzymatic cycling assay of Bernofsky and Swan (33). The frozen extract was
thawed and reduced pyridine nucleotides in the extract were oxidized by addition
of 200 ul 2.0 mM phenazine ethosulfate. An aliquot of 200 ul of the extract (or
standard NAD+ in bidest) was added to a preincubated reaction mixture,
containing final concentrations of 1.67 umol/ml phenazine ethosulfate, 0.42
umol/ml MTT, 60 umol/ml bicin pH 7.8, 0.167 mg/ml alcoholdehydrogenase
and 0.5 umol/ml ethanol and incubated for exactly 30 minutes at 30 °C. Assay
chemicals were all from Sigma. Absorption of the reaction mixture was
immediately after incubation measured at 570 nm, at room temperature, using a
Beckman DU 648 spectrophotometer.
o/ persistence o/ C+j-fl
After incubation of lymphocytes with (±)-anh'-BPDE for 15 minutes, at least 15 x
10^ ceils were transferred to 10 ml tubes, which were centrifuged at room
temperature for 10' at 400 g. This time point is indicated as t=0 hours.
Subsequently, the pellet was dissolved in 1 ml 5% SDS, incubated with 136 ug/ml
RNase A and 18 U/ml RNase Tl (both from Boehringer Mannheim) for 30
minutes at 37 °C. Samples were digested overnight with 4.0 ml of 50 ug/ml
proteinase K in 75 mM NaCl, 25 mM EDTA. DNA was extracted once with
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phenol : chloroform : isoamylalcohol (25 : 24 : 1, v/v/v), once with chloroform :
isoamylalcohol (24 : 1, v/v) and precipitated through addition of 1/30 volume 3
M sodiumacetate pH 5.2 and an equal volume of ice-cold isopropanol. DNA was
washed with cold 70% ethanol and dissolved in 2 mM Tris-HCl pH 7.4. DNA
concentration was determined as described by Warburg and Christian (34).
Cultures used for determination of (±)-anfi-BPDE-N2-dG adduct levels at 4 and
24 hours after exposure were subjected to a second incubation in saved RPMI
1640 complete medium containing growth factors, diluted with fresh complete
medium (75 : 25, v/v) at a density of 1-2 x 10^  cells/ml. At the respective time
points, DNA was isolated as described above. The level of BPDE-dG adducts was
determined according to Reddy and Randerath (35), using the nuclease PI
enhanced 32p_pctstlabeling method. Chromatograms were visualized and
quantified using a Molecular Dynamics Phosphor Imager with Image Quant™
software.
The adduct level of (±)-anfi-BPDE-N2-dG per unit DNA was corrected for cell
proliferation by dividing the number of adducts by the amount of DNA minus
the amount of newly synthesized DNA, estimated from the labeling index,
according to the following formula:
Number of adducts
Adduct level = —
(Number of nucleotides - X% * Number of nucleotides)
(where X% = labeling index).
Determination o/ /abe/ing index
In order to determine the effect of cell proliferation on (±)-flnfi-BPDE-N2-dG
adduct levels, 5 x 10^  cells were suspended at a density of 1-2 x 10^  cells/ml in a
mixture of saved complete medium/fresh complete medium (75 : 25, v/v),
immediately after treatment with (±)-anfi-BPDE for 15 minutes, and BrdU was
added to a final concentration of 26.0 uM. After 24 hours, cells were hypotonized
in 75 mM KG and fixed three times in methanol : acetic acid (3 : 1, v/v). Part of
the cell suspension was pipetted on slides, dried and stained using an
immunohistochemical procedure as described elsewhere (36), applying
monoclonal anti-BrdU. Slides were counterstained in 5% Giemsa for 3 minutes.
The labeling index was determined by counting the number of BrdU positive
(brown) nuclei per 1000 nuclei. To determine the direct effect of (±)-anfi-BPDE
treatment on cell proliferation, per concentration at least 5 x 10^ cells were
cultured, treated and processed essentially as described above.
Determination o/ unsdierfu/eri DM4 synthesis
After treatment with (±)-anf i-BPDE and incubation with [met/iy/-
^H]thymidine, cells were harvested as described for determination of the labeling
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index above. Slides were prepared and processed for autoradiography using Ilford
K2 Scientific Emulsion. After 10-14 days, slides were developed and cells were
counterstained for 30 seconds in haematoxilin. The degree of UDS was
determined by counting the number of grains in at least 50 nuclei per culture,
using a normal light microscope with lOOOx magnification. The net number of
grains/nucleus was obtained by correcting the number of nuclear grains for
background grains (by substracting the mean number of grains in two areas equal
to the nucleus situated right and left of it, according to Harbach et al. (37)). Grains
in heavily labeled cells, representing cells in S-phase (in which separate grains
could not be counted), were excluded from the analysis.
Statistical fl«fl/ysis
Associations between parameters of DNA damage and repair were statistically
analyzed by means of simple regression.
Results
To determine whether poly(ADP-ribose) polymer synthesis is involved in DNA
damage and repair of (±)-anfi-BPDE treated PHA-stimulated human peripheral
blood lymphocytes, in a series of experiments the amount of
ethenoribosyladenosine was measured at different time points after treatment
with concentrations (±)-<m/f-BPDE ranging from 2.5 - 40 ptM. In Figure 3.2, for
two separate experiments, a dose dependent induction of poly(ADP-ribosylation)
at two time points after treatment of PHA stimulated human peripheral blood
lymphocytes with (±)-anfi-BPDE is shown. Treatment with 40 uM (±)-artfi-
BPDE during 15 and 35 minutes results in an approximately 2-10 fold increase in
ethenoribosyladenosine (eRado) levels. In Figure 3.3 (experiment 3), the amount
of eRado, measured after 15, 35 and 55 minutes of (±)-anti-BPDE exposure, is
shown for lymphocytes, obtained from three buffycoats. For PBLs from two
donors, an increase in formation of poly(ADP-ribose) polymer was found
proceeding until 35 minutes of exposure to 40 uM (±)-anti-BPDE, after which
polymer synthesis decreased or polymer breakdown by glycohydrolases increased.
In PBLs of one donor, the formation of polymers still increased after 35 minutes
of exposure, although to a lesser extent. In none of the experiments,
ethenodiribosyladenosine was detected.
As a positive control, lymphocytes were incubated with various concen-
trations MNNG, a known inductor of poly(ADP-ribosylation) (27,38). MNNG
treatment was indeed found to induce poly(ADP-ribose) polymer formation in
PHA stimulated human peripheral blood lymphocytes from different buffycoats,
as is shown in Table 3.1 (experiment 4). From Figures 3.2 and 3.3 and Table 3.1 it
is evident that interindividual differences with regard to the extent of
endogenous as well as (±)-anti-BPDE and MNNG induced ribosylation exist.
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Figure 3.2. Induction of poly(ADP-ribosylation), determined as pmol eRado/10* cells, in PHA
stimulated human peripheral blood lymphocytes obtained from two donors, measured after
treatment with (±)-anfi-BPDE for 15 and 35 minutes.
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Figure 3.3. Poly(ADP-ribosylation), determined as pmol eRado/10^ cells in PHA
stimulated human peripheral blood lymphocytes, obtained from three different
donors, after treatment with 40 (iM (±)-a«ti-BPDE for 15, 35 and 55 minutes.
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Table 3.1. Determination of poly(ADP-ribose) polymers, determined as pmol eRado/10^ cells, in
PHA stimulated human peripheral blood lymphocytes, obtained from two different donors, after
treatment with N-methyl-N'-nitro-N-nitrosoguanidine for 10 minutes.
concentration eRado (pmol/1 x 10* cells)
MNNG '
donor 1 donor 2
0.0 67.5 261.9
45.3 442.4 1857.7
136.0 2812.0 10958.3
408.0 4156.3 12806.9
In experiments 5 and 6, pyridine nucleotides were extracted from exposed PBLs
and the amount of NAD+ was determined. The results from these experiments
are shown in Table 3.2. A dose dependent decrease in intracellular NAD+ levels
after (±)-rtttfi-BPDE treatment was observed (although not statistically
significant), indicating (±)-a/Ui-BPDE-induced NAD+ turnover. Already at
concentrations as low as 0.2 uM, (±)-anfi-BPDE caused a decrease in intracellular
NAD+ levels. In addition, in the same experiments, the effect of (±)-anh-BPDE
treatment on the incorporation of BrdU, 48-72 hours after PHA stimulation is
shown in Table 3.2. Exposure to 0.2 |iM (±)-<wifi-BPDE was found to reduce BrdU
incorporation, indicating inhibition of replicative DNA synthesis. The effects of
(±)-«/ifi-BPDE treatment on intracellular NAD+ levels of PBLs showed a
statistically significant dose dependent correlation with labeling indices (r=0.91,
p<0.05), indicating that (±)-<7ttfi-BPDE-induced dose-dependent NAD+ depletion
is concomitant to inhibition of cell proliferation.
Table 3.2. The effect of (±)-anfi-BPDE treatment of PHA stimulated human peripheral blood
lymphocytes on intracellular NAD* levels and labeling index.
concentration
(±)-fl»d-BPDE (uM)
0.0
0.2
0.5
1.0
2.5
*NAD*
(pmol/1 x 10* cells)
164.8 ± 31.3
126.7 ± 45.6
108.0 ± 50.9
121.9 ± 62.7
97.3 ± 50.9
labeling index
(% BrdU positive cells)
10.5 ± 1.1
9.4 ± 2.8
6.9 ± 3.5
6.7 ± 5.8
5.5 ± 0.9
Mean results (± SD) are presented for lymphocytes, obtained from two donors.
"Significant correlation between (±)-anfi-BPDE-induced NAD* depletion and inhibition of BrdU
incorporation (r=0.91, p<0.05).
Unscheduled DNA synthesis (UDS) and (±)-awfi'-BPDE-N2-deoxyguanosine
adduct removal were determined after treatment of PHA stimulated human
PBLs with (±)-anfi-BPDE, to study processes related to excision repair. In Figure
3.4, UDS in lymphocytes obtained from two donors is shown. A linear (r=0.999,
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p<0.02) UDS response was observed, whereas no indication for interindividual
variation was found. While at 1.0 uM a clear UDS response was observed, other
experiments indicated that after treatment with 0.5 uM (±)-anfi'-BPDE, UDS was
undetectable or near the detection limit (results not shown). In contrast, after
exposure to 0.5 uM (±)-anfi-BPDE, a clear time dependent decrease in number of
(+)-fl«h-BPDE-N2-dG adducts was measured, as is shown in Figure 3.5. The
relative number of adducts per nucleotide is shown, since in most samples the
degree of modification after 0.5 uM treatment, which was found to be
approximately 1 adduct per 10^  to 10^  nucleotides, exceeded the highest modified
standard available, which had 1 adduct per 10? nucleotides.
30-
0.5 1.0 1.5 2.0 2.5
concentration (±)-an(i-BPDE (uM)
Figure 3.4. Induction of unscheduled DNA synthesis in PHA stimulated human
peripheral blood lymphocytes 24 hours after treatment with (±)-unfi-BPDE
Results are shown for PBLs, obtained from two donors. Each point represents the
mean net number of grains per nucleus obtained from two cultures of one donor.
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Figure 3.5. Measurement of (±)-anfi-BPDE-deoxyguanosine adduct persistence in
PHA stimulated human peripheral blood lymphocytes, obtained from three
buffycoats, after treatment with 0.5 uM (±)-anfi-BPDE for 15 minutes. Results are
corrected for cell proliferation.
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Discussion
In this study, evidence is presented that poly(ADP-ribosylation) is activated
during (±)-anfj-BPDE-induced DNA damage in PHA stimulated human
peripheral blood lymphocytes. Since two DNA repair related processes, e.g. UDS
and (±)-flMfi-BPDE-deoxyguanosine adduct removal after (±)-anri-BPDE
treatment, were also observed, it might be that poly(ADP-ribosylation) is
involved in repair of (±)-awf!-BPDE-DNA lesions in these cells.
A clear dose-dependent induction of poly(ADP-ribosylation) was observed
after treatment of PHA stimulated human peripheral blood lymphocytes with
(±)-a«f/-BPDE, at different exposure times. At a concentration of 0.5 H.M (±)-
OMfj-BPDE, no clear induction of ribosylation was found, which may be due to
the relatively high detection limit of the assay but at concentrations as low as 0.2
|i.M, a decrease in cellular NAD+ content was observed. These results suggest that
poly(ADP-ribosylation) is a process already active at low carcinogen
concentrations. It is not known however, whether (±)-anfi-BPDE is able to
interfere directly, within 55 minutes, with the NAD+ glycohydrolase, which
converts NAD+ to mono(ADP-ribose) and nicotinamide, or with NAD+
synthesis from extracellular nicotinamide or intracellular nicotinic acid. On the
other hand, other studies have shown that in mammalian cells, which were
NAD + depleted by various carcinogens, complete resynthesis of NAD+
(dependent on type and extent of DNA damage) within one hour hardly occurs
(24,30,39). Therefore, within this time period, the attribution of rfe HODO
synthesized NAD+ to intracellular NAD+ levels in (±)-anfi'-BPDE treated human
PBLs is likely to be limited.
A clear dose-dependent depletion of NAD+ has previously been reported after
treatment of unstimulated human PBLs with high concentrations (±)-anfi-BPDE
(ranging from 9.9 - 66 uM). Other DNA damaging metabolites of polycyclic
aromatic hydrocarbons were also reported to be capable of inducing NAD+
depletion, at concentrations ranging from 39.6 uM - 75.1 uM (30). In the present
study, NAD+ depletion was already observed at concentrations as low as 0.2 uM
(±)-flnfi'-BPDE, which may be explained by the use of proliferating PBLs. PHA
stimulated lymphocytes have been reported to contain higher concentrations of
polymerase molecules as compared to unstimulated lymphocytes and to show
higher [3HJNAD+ incorporation after permeabilization and DNase I treatment
(40). Therefore, (±)-anfi'-BPDE-induced poly(ADP-ribosylation), and consequently
NAD+ depletion, may be expected to occur sooner or at lower exposure levels in
PHA stimulated PBLs. In this respect, X-ray induced poly(ADP-ribose)
polymerase activity in permeabilized cells was reported to be at least twice as
high in proliferating versus quiescent murine tumor cell lines (41).
At increasing concentrations of (±)-anti-BPDE, a correlation was observed
between the decrease in cellular NAD+ levels and the inhibition of BrdU
incorporation during 24 hours after treatment. Inhibition of cloning efficiency to
80
-indured PADPR and DAM repair
about 20% has been reported for human peripheral blood lymphocytes (47,48)
after treatment with low concentrations of (±)-anf/-BPDE ranging from 0.12 u,M-
0.3 uM. This proliferation inhibiting effect has been interpreted as cytotoxicity
and related to the occurrence of DNA adducts (49,50). (±)-anh'-BPDE-DNA
adducts have been shown to interfere with normal cellular processes like
replicative DNA synthesis (62,63) and mRNA transcription (64). Alternatively,
since NAD+ depletion has been related with ATP depletion and cell lysis (7), it
might be that the observed inhibition of DNA synthesis in this study is partially
indirectly related to these events.
At the experimental conditions in the present study, relatively high
concentrations of (±)-flnfi-BPDE were necessary to induce inhibition of DNA
synthesis. In contrast, lower concentrations (±)-anh-BPDE already reduced the
colony forming ability of PHA stimulated human PBLs in other studies (47,48).
This discrepancy may be explained by differences between the methods used:
inhibition of cell proliferation determined as inhibition of DNA synthesis
during 24 hours after exposure, is not necessarily comparable to reduction of T-
cell cloning which is determined over a period of 7-12 days. Also, experimental
factors such as cell density and cell-cycle distribution at the moment of (±)-anh-
BPDE treatment, as well as incubation time (26) differ between the present and
the cited studies (47,48) which may explain differences in (±)-dMf/-BPDE
susceptibility.
After treatment with 0.5 uM (±)-anf/-BPDE, the UDS response was found to
be near the detection limit, which is in agreement with results published
previously for unstimulated human PBLs (19). In contrast, formation and time
dependent decrease of (±)-(n;h'-BPDE-N2-dG adduct levels was detected at this
concentration. Although the absolute adduct levels in the present study were not
determined, it is estimated that after (±)-flnfi-BPDE-induced DNA damage, a
modification level of at least 1 adduct per 10^  to 10^  nucleotides is required to
induce measurable UDS. The higher sensitivity of carcinogen-adduct
determination as compared to UDS in studying DNA damage and repair is
confirmed by other studies, using cultured mouse epidermal keratinocytes,
treated with (±)-flnf/-BPDE and other PAH carcinogens (20) and hepatocytes
from N-acetylaminofluorene treated rodents HI DIM (51,52).
In the present study, only at concentrations higher than 10 uM (±)-anfi-BPDE,
poly(ADP-ribosylation) could be measured after 15 and 35 minutes of exposure.
Other studies, applying either pH]NAD incorporation after permeabilization or
DHB-Biorex chromatography or »n S/7M immunofluorescent detection of
PADPRT activity, also indicate that treatment with relatively high
concentrations, ranging from 50 uM up to 5 mM of carcinogens such as
cumenehydroperoxide, cisplatin, H2O2, and N-methyl-N-nitrosourea, are
required to detect PADPRT activity (6,7,38,53,54,55). Therefore, it is concluded
that as a parameter of DNA damage and repair in (±)-rt«fi'-BPDE treated
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stimulated human PBLs, measurement of poly(ADP-ribose) polymer formation
is less sensitive than the other repair parameters, UDS and DNA adduct
persistence.
The mechanism of carcinogen-induced ribosylation is not clear at present. It
has been demonstrated that the presence of DNA single or double DNA strand
breaks is a prerequisite for induction of ribosylation (6,7,38,42). After (±)-<jnfi-
BPDE exposure in uifro, strand break formation in mammalian cells has been
shown to occur (19,43). The clear UDS response, observed in the present study, is
also in agreement with the transient existence of single-stranded DNA. It appears
that (±Hnfi-BPDE-induced single-strand breaks activate PADPRT, which then
becomes automodified. Activation of PADPRT might occur initially on easy
accessible lesions, perhaps located in transcriptionally active regions, as may be
expected if (±)-anfz'-BPDE-induced repair is preferential for these regions (21).
Subsequently, the automodified PADPRT would dissociate from the DNA,
having higher affinity for histones which results in DNA-nucleosome
dissociation, allowing increased access of repair enzymes to other (±)-anfi-BPDE-
induced lesions (8). After repair at these sites, poly(ADP-glycohydrolase) in turn
would degrade the polymer, allowing reassociation of histone-DNA complexes.
In the present study, a decrease in polymer levels was found in lymphocytes,
obtained from two donors 35 minutes after exposure, indicating poly(ADP-
glycohydrolase) activity.
It remains to be determined which particular excision repair mechanism
involves poly(ADP-ribosylation). Recent studies suggest that poly(ADP-
ribosylation) is specifically related to repair of lesions, that are removed via base
excision repair, such as induced by UV and MNNG (59,60). In contrast, cisplatin
has been shown to induce slow poly(ADP-ribosylation) in mammalian cells (38).
In addition, N-acetoxy-N-acetylaminofluorene has been found to cause NAD+
depletion in human PBLs (30). It is not known whether (±)-anh-BPDE-induced
poly(ADP-ribosylation) is due to nucleotide excision repair of (±)-anf/'-BPDE-N2-
dG adducts. Other lesions, such as phosphotriesters (46) and N7-guanine adducts
(44,45,61) that have been reported to induce apurinic sites in uifro may also be
involved. In proliferating cells (HeLa) treated in uifro, however, (±)-anh-BPDE-
induced lesions were not found to include apurinic sites (43).
Since interindividual differences were observed in both poly(ADP-ribose)
polymer formation, breakdown and (±)-anf/-BPDE-N2-dG adduct removal, it
may be relevant to investigate whether these differences can be explained by
intra-individual relationships between these processes. Interindividual
differences in poly(ADP-ribose) polymerase activity have been reported after
exposure of human mononuclear leukocytes to different oxygen radical
generating systems (56). In addition, it has been found that lower poly(ADP-
ribose) polymerase activities are associated with increased cancer risk (53,57). This
study indicates that the NAD+-dependent post-translational modification
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poly(ADP-ribosylation) takes place during repair of (±)-anfi-BPDE-induced DNA
damage in PHA stimulated human peripheral blood lymphocytes. Furthermore,
nicotinic acid supplementation of humans in uu>o was reported to increase
NAD+ levels in isolated PBLs (58), which was related to a reduction of oxygen
radical-induced DNA strand breaks in uifro in these cells (58). Therefore, further
investigation of the possible relation between interindividual differences in
repair processes and niacin status as an exogenous, dietary related factor appears
to be warranted.
Acknowledgements
The authors wish to thank Dr. Myron K. Jacobson and Dr. Nasreen Aboul-Ela
from the Texas College of Osteopathic Medicine, Forth Worth, Texas, USA for
providing standards and helpful discussions concerning the measurement of
polymeric ADP-ribose. This study is supported by grant no. 28-2124 from the
'Praeventiefonds', The Hague, The Netherlands.
References
1 de Murcia, G., Menissier-de Murcia, J., Schreiber, V. (1991) Poly(ADP-
ribose) polymerase: molecular biological aspects. Bwessays, 13, 455-462.
2. Boulikas, T. (1991) Relation between Carcinogenesis, chrpmatin structure
and poly(adp)ribosylation (review). An/iamcer Res., 11, 489-528.
3. Juarez-Salinas, H., Levi, V., Jacobson, E.L., Jacobson, M.K. (1982) Poly(ADP-
ribose) has a branched structure /'« WOT. /. B;o/. C/iem., 257, 607-609.
4. Alvarez-Gonzalez, R., Jacobson, M.K. (1987) Characterization of polymers
of adenosine diphosphate ribose generated HI wfro and ;n wi/o. Biochemistry, 26,
3218-3224.
5. Satoh, M.S., Lindahl, T., (1992) Role of poly(ADP-ribose) formation in DNA
repair. Nature, 356, 356-358.
6. Lautier, D., Poirier, D., Boudreau, A., Alaoui-Jamali, M.A., Castonguay, A., Poirier,
G. (1990) Stimulation of poly(ADP-ribose) synthesis by free radicals in C3H10T1/2
cells:relationship with NAD metabolism and DNA breakage. B/oc/iem. Ce//. Bio/.,
68, 602-608.
7. Schraufstatter, I.U., Hinshaw, D.B., Hyslop, P.A., Spragg, R.G., Cochrane, C.G.
(1986) Oxidant injury of cells. DNA strand-breaks activate polyadenosine
diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine
dinucleotide. /. C/in. /nwsf., 77, 1312-1320.
8. Althaus, F.R. (1992) Poly ADP-ribosylation: a histone shuttle mechanism in DNA
excision repair. /. CeH. Sri., 102, 663-670.
9. Realini, C.A., Althaus, F.R. (1992) Histone shutling by poly(ADP-ribosylation). /.
Bio/. C/iem., 267, 18858-18865.
10. Creissen, D., Shall, S. (1982) Regulation of DNA ligase activity by poly(ADP)ribose.
Nature, 296, 271-272.
11- Moran, M.F., Ebisuzaki, K. (1985) Inhibition of poly(ADP-ribose)polymerase causes
increased DNA strand breaks without decreasing strand rejoining in alkylated HeLa
cells. FEBS /eft., 190, 279-282.
12. Yoshihara, K., Itaya, A., Tanaka, Y., Ohashi, Y., Ito, K., Teraoka, H., Tsukada, K.,
Matsukage, A., Kamiya, T. (1985) Inhibition of DNA polymerase a, DNA
83
Diopter 3 „
•••• polymerase p, terminal nucleotidyltransferase and DNA ligase II by poly(ADP-
ribosyl)ation reaction in t;/7ro. B/oc/iem. B/op/iys. Res. Commi/n., 128, 61-67.
13. Junod, A.F., Jornot, L., Petersen, H. (1989) Differential effects of hyperoxia and
hydrogen peroxide on DNA damage, polyadenosine diphosphate-ribose polymerase
activity, and nicotinamide adenine dinucleotide and adenosine triphosphate contents
in cultured endothelial cells and fibroblasts. /. Ce//. P/iysio/., 140, 177-185.
14. Rogan, E.G., Ramakrishna, N.V.S., Higginbotham, S., Cavalieri, E.L., Jeong, H.,
Jankowiak, R., Small, G.J. (1990) Identification and quantitation of 7-(Benzo[a]pyren-
6-yl)guanine in the urine and feces of rats treated with benzo[a]pyrene. C/;em .R«.
Toxico/., 3, 441-444.
15. Yang, Li. L., Maher, V.M., McCormick, J.J. (1982) Relationship between excision repair
and the cytotoxic and mutagenic effect of the 'flMfi' 7,8-diol-9,10-epoxide of
benzo[a]pyrene in human cells. Mutof. Res., 94, 435-447.
16. Carothers, A., Grunberger, D. (1990) DNA base changes in benzo[a]pyrene
diolepoxide-induced dihydrofolate reductase mutants of Chinese hamster ovary cells.
Ctfrc/HOgenes/s, 11, 189-192.
17. Chen, R-H., Maher, V.M., McCormick, J.J. (1990) Effect of excision, repair by
diploid human fibroblasts on the kind and locations of mutations induced by (±)-
7(3,8a-dihydroxy-9a,10a-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene in the coding
region of the HPRT gene. Proc. Not/. Acad. Sri. U.S.A., 87, 8680-8684.
18. Yang, J-L., Chen, R.H., Maher, V.M., McCormick, J.J. (1991) Kinds and location of
mutations induced by (±)-7p,8<x-dihydroxy-9a,10a-epoxy-7,8,9,10
tetrahydrobenzo[a]-pyrene in the coding region of the hypoxanthine
(guanine)phosphoribosyltransferase gene in diploid human fibroblasts. G?rcwogeMes/s,
12, 71-75.
19. Celotti, L., Ferraro, P., Biasin, M.R. (1992) Detection by fluorescence
analysis of DNA unwinding and unscheduled DNA synthesis, of DNA damage and
repair induced i» w'/ro by direct-acting mutagens on human lymphocytes. Mutaf.
Res., 281, 17-23.
20. Gill, R.D., Butterworth, B.E., Nettikumara, A.N. DiGiovanni, J. (1991) Relationship
between DNA adduct formation and unscheduled DNA synthesis (UDS) in cultured
mouse epidermal keratinocytes. Ewwron. Mo/. Mutagen., 18, 200-206.
21. Chen, R.-H., Maher, V.M., Brouwer, J., van de Putte, P., McCormick, J. J. (1992)
Preferential repair and strand-specific repair of benzo[a]pyrene diol epoxide
adducts in the HPRT gene of diploid human fibroblasts. Proc. Mjf. Acnd. Sri.
U.S.A., 89, 5413-5417.
22. Oesch, F., Aulmann, W., Platt, K.L., Doerjer, G. (1987) Individual differences in DNA
repair capacities in man. Arc/i. Tox/'co/. Siipp/., 10, 172-179.
23. Yang, L.L., Maher, V.M., McCormick, J.J. (1980) Error-free excision of the
cytotoxic, mutagenic N^-deoxyguanosine DNA adduct formed in human fibroblasts
by (±)-7P,8a-dihydroxy-9a,10ct-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene. Proc.
Miff. Acad. Sci. U.S.A., 77, 5933-5937.
24. Sims, J.L., Sikorski, G.W., Catino, D.M., Berger, S.J. Berger, N.A. (1982)
Poly(adenosinediphosphoribose) polymerase inhibitors stimulate unscheduled
deoxyribonucleic acid synthesis in normal human lymphocytes. Bioc/iemistry, 21,
1813-1821.
25. MacLeod, M.C., Lew, L. (1988) A Rapid, spectrofotometric assay for the
integrity of diol epoxides. Carcwogenesis, 9, 2133-2135.
26. Krolewski, B., Little, J.B., Reynolds, R.J. (1988) Effect of duration of exposure to
benzo[a]pyrene diol-epoxide on neoplastic transformation, mutagenesis, cytotoxicity,
and total covalent binding to DNA of rodent cells, Terafog. Carcinog. MwfageH-, 8,
127-136.
84
6tf-flnfi-BPDE-mdHced PADPR and DM repair
27. Juarez-Salinas, H., Sims, J., Jacobson, M.K. (1979) Poly(ADP-ribose)levels in
carcinogen-treated cells. Nfl/wre, 282, 740-741.
28. Jacobson, M.K., Payne, D.M., Alvarez-Gonzalez, R., Juarez-Salinas, H., Sims, J.L.,
Jacobson, E.L. (1984) Determination of in two levels of polymeric and monomeric
ADP-Ribose by fluorescence methods. Me</iorfs Enzymo/., 106, 483-494.
29. Alvarez-Gonzalez, R., Juarez-Salinas, H., Jacobson, E.L., Jacobson, M.K. (1983)
Evaluation of immobilized boronates for studies of adenine and pyridine nucleotide
- metabolism. /4»m/. Bioc/i«n., 135, 69-77.
30. Rankin, P.W., Jacobson, M.K., Mitchell, V.R., Busbee, D.L. (1980) Reduction of
nicotinamide adenine dinucleotide levels by ultimate carcinogens in human
lymphocytes. Cancer R«., 40, 1803-1807.
31. Jacobson, E.L., Antol, K.M., Juarez-Salinas, H., Jacobson, M.K. (1983) Poly(ADP-
ribose) metabolism in ultraviolet irradiated human fibroblasts. /. Bio/. C/iem., 258,
103-107.
32. Rankin, P.W., Jacobson, E.L., Benjamin, R.C., Moss, J., Jacobson, M.K. (1989)
Quantitative studies of inhibitors of ADP-ribosylation in p/fro and in PIPO, /. Bio/.
C/icm., 264, 4312-4317.
33. Bernofsky, C , Swan, M. (1973) An improved cycling assay for nicotinamide
adenine dinucleotide. /Inn/. Bi'oc/iem., 53, 452-458.
34. Warburg, O., Christian, W. (1942) Isolierung und kristallisation des Garungsferments
enolase. Bioc/iem. Z., 310, 348-421.
35. Reddy, M.V., Randerath, K. (1986) Nuclease Pl-mediated enhancement of
sensitivety of 32p_postlabeling test for structural diverse DNA adducts.
Gircinogenesis, 7, 1543-1551.
36. Stierum, R.H., Hageman, G.J., Welle, I.J., Albering, H.J., Schreurs, J.G.M., Kleinjans,
J.C.S. (1993) Evaluation of exposure reducing measures on parameters of genetic risk
in a population occupationally exposed to coal fly ash. M//taf. Res., 319, 245-255.
37. Harbach, P.R., Rostami, H.J., Aaron, C.S., Wiser, S.K., Grzegorczyk, C.R. (1991)
Evaluation of four methods for scoring cytoplasmic grains in the /'// wfro unscheduled
DNA synthesis (UDS) assay, Mi/fa/. Res., 252, 139-148.
38. Burkle, A., Chen, G., Kupper, J.H., Grube, K., Zeller, W.J. (1993) Increased
poly(ADP-ribosyl)ation in intact cells by cisplatin treatment. Carcinogenesis, 14, 559-
561.
39. Sims, J.L., Berger, S.J., Berger, N.A. (1983) Poly(ADP-ribose) polymerase inhibitors
preserve nicotinamide adenine dinucleotide and adenosine 5'-triphosphate pools in
DNA-damaged cells: mechanism of stimulation of unscheduled DNA synthesis,
Bioc/iemisfry, 22, 5188-5194.
40. Yamanaka, H., Pennin, C.A., Willis, E.H., Wasson, D.B., Carson, D.A. (1988)
Characterization of human poly(ADP-ribose)polymerase with autoantibodies. /.
Bio/. C/iem., 263, 3879-3883.
41. Sweigert, S.E., Marston, J.M., Dethlefsen, L.A. (1990) Poly(ADP-ribose)
metabolism in proliferating versus quiescent cells and its relationship to their
radiation responses, /nf. /. Rfld/af. Bio/., 58, 111-123.
42. Jacobson, E.L., Jacobson, M.K. (1993) A Biomarker for the assessment of niacin
nutriture as a potential preventive factor in carcinogenesis. /. /nfern. Med., 233, 59-62.
43. Moran, M.F., Ebisuzaki, K. (1991) /n two benzo[a]pyrene diol epoxide-induced
alkali-labile sites are not apurinic sites. MMtof. Res., 262, 79-84.
44. Osborne, M.R., Jacobs, S., Marvey, R.G., Brookes, P. (1981) Minor products from
the reaction of (+) and (-) benzo[a]pyrene-anfi-diolepoxide with DNA.
Ctfrci'nogenesz's, 2, 553-558.
45. Osborne, M., Merrifield, K. (1985) Depurination of benzo[a]pyrene-diolepoxide
treated DNA. C/iem. Bio/. Interact., 53, 183-195.
85
Oiflpfer 3
46. Gamper, H.B., Tung, A.S.-C, Straub, K., Bartolomew, J.C. Calvin, M., (1977) DNA
strand scission by Benzo[a]pyrene diol epoxides, Science, 197, 671-674.
47. Norimura, T., Maher, V.M., McCormick, J.J. (1990) Cytotoxic and mutagenic effect of
UV, ethylnitrosourea and (±)-7p,8a-dihydroxy-9a,10a-epoxy-7,8,9,10-
tetrahydrobenzo[a]pyrene in diploid human T lymphocytes in culture: comparison
with fibroblasts. Mutagenesis, 5, 447-451.
48. Andersson, B., Lambert, B. (1990) Mutations induced by benzo[a]pyrene
diolepoxide at the hprt locus in human T-lyphocytes /« w'fro. Mufaf. Res., 245, 75-
82.
49. McCormick, J.J., Maher, V.M. (1985) Cytotoxic and mutagenic effects of specific
carcinogen-DNA adducts in diploid human fibroblasts. Environ. He<j/f/i Perspecf., 2,
145-155.
50. Maher, V.M., McCormick, J.J. (1983) Relationship between excision repair and the
cytotoxic and mutagenic action of chemicals and UV radiation. Basic Li/e Sa'., 23,
271-290.
51. Gallagher, J.E., Shank, T. Lewtas, J., Lefevre, P.A., Ashby, J. (1991) Relative
sensitivity of 32p-postlabeling of DNA and the autoradiographic UDS assay in the
liver of rats exposed to 2-acetylaminofluorene (2AAF). MMM. Res., 252, 247-257.
52. Ashby, J., Lefevre, P.A., Shank, T. Lewtas, J., Gallagher, J.E. (1991) Relative
sensitivity of ^p.postlabeling of DNA and the autoradiographic UDS assay in the
liver of mice exposed to 2-acetylaminofluorene (2AAF). M«to/. Res., 252, 259-268.
53. Markowitz, M.M., Johnson, D.B., Pero, R.W., Winawer, S.J., Miller, D.G. (1988)
Effects of cumene hydroperoxide on adenine diphosphate ribosyltransfrease in
mononuclear leukocytes of patients with adenomatous polyps in the colon.
Cara'nogenesis, 9, 349-355.
54. Skidmore, C.J., Davies, M.I., Goodwin, P.M., Halldorsson, H., Lewis, P.J., Shall, S.,
2/a'ee, A.-A. (1979) The involvement or poly(ADP-ribose) polymerase in the
degradation of NAD caused by y-radiation and N-methyl-N-nitrosourea, Eur. /.
Bioc/iem., 101, 135-142.
55. Pero, R.W., Jonsson, G.G., Persson, L. (1983) Unscheduled DNA synthesis
induced by N-acetoxy-2-acetylaminofluorene is not sensitive to regulation
by ADP-ribosyl transferase, C/iem. Bio/, /nferacf., 47, 265-275.
56. Pero, R.W., Roush, G.C., Markowitz, M.M., Miller, D.G. (1990) Oxidative stress,
DNA repair, and cancer susceptibility. Cancer Defecf. Pra;., 14, 555-561.
57. Pero, R.W., Johnson, D.B., Miller, D.G., Zang, E., Markowitz, M., Doyle, G.A., Lund-
Pero, M., Salford, L., Sordillo, P., Raskin, N., Beattie, E.J. (1989) Adenosine
diphosphate ribosyl transferase responses to a standardized dose of hydrogen
peroxide in the mononuclear leukocytes of patients with a diagnosis of cancer.
Carcinogenesis, 10, 1657-1664.
58. Weitberg, A.B. (1989) Effect of nicotinic acid supplementation in uiuo on oxygen
radical-induced genetic damage in human lymphocytes. Mutof. Res., 216,197-201.
59. Satoh, M.S., Poirier, G.G., Lindahl, T., (1993) NAD+-dependent repair of
damaged DNA by human cell extracts. /. Bio/. Chem., 268, 5480-5487.
60. Molinete, M., Vermeulen, W., Burkle, A., Menissier-de Murcia, J., Kiipper, J.H.,
Hoeijmakers, J.H.J. de Murcia, G. (1993) Overproduction of the poly(ADP-ribose)
polymerase DNA-binding domain blocks alkylation-induced DNA repair synthesis in
mammalian cells. EMBO /., 12, 2109-2117.
61. King, H.W.S., Osborne, M.R., Brookes, P. (1979) The in w'fro and in w'w reaction at
the N7-position of guanine of the ultimate carcinogen derived from benzo[a]pyrene.
Diem. Bio/, /nferacf., 24, 345-353.
62. Kaufmann, W.K., Boyer, J.C, Smith, B.A., Cordeiro-Stone, M. (1985) DNA repair and
replication in human fibroblasts treated with (±)-r-7,t-8-hihydroxy-t-9,10-epoxy-
86
induced PADPR and DNA repair
7,8,9,10-tetrahydrobenzo[a]pyrene. B/ocfizm. Biophys. /Icta, 824, 146-151.
63. Co'rd'iero-Stone, M., Boyer, J.C., Smith, B.A., Kaufmann, W.K. (1986) Effect of
benzo[a]pyrene-diol-epoxide-l on growth of nascent DNA in synchronized human
fibroblasts. Curc/nogenesis, 7, 1775-1781.
64. Shah, G.M., Bhattacharya, R.K. (1992) Modulation of transcription in rat
liver nuclei m i«rro by a diol epoxide of benzo[a]pyrene. /. Bzocfem. Toxico/., 7, 13-
17.
87

Effect of nicotinic acid supplementation on niacin status in
relation to cytogenetic damage and ex i?it?o (±)-a«f£-
benzo[a]pyrene diolepoxide-induced DNA repair in smoking
humans
R.H. Stierum, G.J. Hageman, M.H.M. van Herwijnen, M.S.E. van der Veer,
A.P.H. Vankan and J.C.S. Kleinjans
Department of Health Risk Analysis and Toxicology, University of Limburg, P.O.
Box 616, 6200 MD Maastricht, The Netherlands
Based on « mnnuscnpf submitted fo: Cancer Ep/demio/ogy, B/omarfcers and
Abstract
One of the processes supposed to be involved in DNA repair is poly(ADP-
ribosylation). In response to DNA strand breaks, the enzyme poly(ADP-ribose)
polymerase catalyzes the rapid transfer of ADP-ribose moieties from
nicotinamide adenine dinucleotide (NAD+) to poly(ADP-ribose) polymers. As a
consequence of extensively occurring damage, intracellular NAD+ is depleted.
Since niacin is a precursor of NAD+, it has been proposed that nutritional niacin
intake influences poly(ADP-ribosylation) and thus poly(ADP-ribosylation)-
dependent DNA repair. Sub-optimal niacin intake may therefore be a risk factor
in carcinogenesis. The purpose of this study was to investigate whether nicotinic
acid supplementation of healthy human smokers can be effective in reducing in
PIDO cytogenetic damage caused by cigarette smoking, as a consequence of an
improved niacin status and DNA repair. Supplementation of human male
smokers with nicotinic acid in doses of 50-100 mg/day during 14 weeks resulted
in elevated blood nicotinamide levels and moderately increased lymphocytic
NAD+ levels. Frequencies of sister chromatid exchanges (SCE) were increased in
the individuals receiving nicotinic acid. However, no significant correlations
were found between alterations in lymphocytic NAD+ levels or blood
nicotinamide levels, and alterations in mean SCE frequencies. No distinct
positive or negative effect of nicotinic acid intake on the frequency of
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hypoxanthine guanine phosphoribosyltransferase variants and micronuclei, or
on the degree of ex iwo (±)-7|3,8a-dihydroxy-9a,10a-epoxy-7,8,9,10-
tetrahydrobenzo[a]pyrene-induced DNA repair, as indicated by poly(ADP-
ribosylation) and (±)-anh-BPDE-N2-deoxyguanosine adduct removal, was found.
It is concluded that supplementation of human male smokers with nicotinic
acid at doses higher than 50 mg/day is moderately effective in improving niacin
status. Nicotinic acid intake resulted in elevated sister chromatid exchanges, but
this was not related dose-dependently to alterations in niacin status and does
therefore not likely modulate poly(ADP-ribosylation)-dependent repair of
smoking-induced DNA damage. In conclusion, no evidence was found for a
beneficial effect of nicotinic acid supplementation in healthy humans on
mutagenesis and micronuclei formation /'« ui'uo, as caused by cigarette
smoking.
Introduction
The introduction of mutations into DNA is considered to represent one of the
first steps in carcinogenesis. Formation of mutations may be caused by lesions,
induced by exposure to genotoxic chemicals and physical agents like radiation, or
by endogenous mutagens such as reactive oxygen species, formed during normal
metabolic processes (1). Cells possess various DNA repair systems which enable
them to restore the integrity of their genetic material constantly, thereby
preventing the onset of mutagenesis.
One of these processes, actively involved in DNA repair, is poly(ADP-
ribosylation). This nuclear, enzymatic process is catalyzed by the enzyme
poly(ADP-ribose) polymerase (NAD+ ADP-ribosyltransferase, E.C. 2.4.2.30), which
transfers the adenosine diphosphate ribose units from intracellular NAD+ to
linear and branched poly(ADP-ribose) polymers. Consequently, intracellular
NAD+ is depleted. In recent years, considerable work has been done to elucidate
«« i>i7ro and ex u/yo the action of poly(ADP-ribosylation) in relation to DNA
repair mechanisms. Thus, it is known that DNA strand breaks are required for
enzyme activation (2-4) and it has been proposed that the accessibility of damaged
DNA for other repair enzymes is transiently improved by poly(ADP-ribosylation)
via modification of histone-DNA interactions (5,6). Recently, it was suggested
that poly(ADP-ribose) polymerase is involved only in the process of base excision
repair, during which the enzyme, temporarily bound to DNA strand breaks,
might protect DNA against recombinational events (7-9).
Little is known about the role of poly(ADP-ribosylation) in human
carcinogenesis in general, and in particular with respect to the recovery from
DNA damage in i>ii>o. It may be hypothesized that poly(ADP-ribosylation) is
impaired if intracellular NAD+ is decreased, as a consequence of sub-optimal
niacin intake. Weitberg (10) showed that blood lymphocytic NAD+ levels are
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elevated after supplementation of two healthy human volunteers with 100 mg
nicotinic acid per day during 8 weeks. In lymphocytes obtained from these
persons, the occurrence of ex i>ri>o oxygen-radical induced DNA strand breaks
was lower than in lymphocytes obtained from non-supplemented persons.
The aims of the present study were two-fold; to investigate whether nicotinic
acid intake reduces DNA damage in healthy smoking humans, as a function of
improved endogenous niacin status and improved DNA repair as well as to
investigate whether correlations exist between markers of ex iwo (±)-flMh-
BPDE-induced DNA repair processes and biomarkers of cytogenetic damage,
reflecting endogenous DNA damage. Smoking male persons were supplemented
with nicotinic acid during 14 weeks. Alterations in niacin status were monitored
by determination of levels of two main nicotinic acid metabolites, e.g.
nicotinamide in blood and NAD+ in peripheral blood lymphocytes (PBLs). As
indicators for DNA repair activity, changes in poly(ADP-ribose) polymer
metabolism and (±)-anfi-BPDE-N2-dG adduct removal in peripheral blood
lymphocytes were determined after ex ZMUO treatment with (±)-7(3,8a-dihydroxy-
9a,10a-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene ((±)-«nfi-BPDE). To evaluate
whether DNA damage is affected by nicotinic acid intake, sister chromatid
exchanges, hypoxanthine guanine phosphoribosyltransferase (/iprf) variant
frequencies and micronuclei (MN) frequencies were determined in peripheral
blood lymphocytes, prior to and at the end of the nicotinic acid supplementation
period.
Materials and methods
All chemicals were purchased from Merck Europe, unless otherwise specified.
Cell culture media and supplements were obtained from Gibco Europe, Breda,
The Netherlands.
Sfurfy
21 healthy male human smokers, smoking at least 10 cigarettes per day, were
included into this study, which was performed from April 1993 till September
1993. Data on age, weight, length, alcohol and coffee consumption, smoking
habits and use of medication were obtained using a standard questionnaire. The
characteristics of the subjects are shown in Table 4.1.
M'cofin/c acid supp/emenfflfion o/irf measuremercf sc/iedu/e
In order to study whether dose-dependent effects of nicotinic acid intake on
parameters of DNA damage and repair occur, subjects were divided into several
dose groups as shown in Table 4.1. The 50 mg/day dose group consisted of 3
individuals receiving 1 x 50 mg/day and 3 individuals receiving 3 x 16.7 mg/day,
in order to study the possible effect of daily intake frequencies. In order to reduce
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Table 4.1. Characteristics of the study population.
nicotinic acid intake
(mg/day)
age
(years)
smoking habit
(cigarettes/day)
pack years
0
(n=6)
31.8 ±
18.8 ±
11.7 ±
13.1
8.9
8.4
25
(n=3)
42.0 +
21.6 ±
28.0 ±
9.5
2.8
7.2
50
(n=6)
36.2 +
19.7 +
15.7 ±
9.2
3.3
8.7
100
(n=6)
28.3 ±
18.5 ±
8.6 ±
9.1
5.8
7.6
(packs of cigarettes smoked/day
» smoking years)
alcohol consumption 10.8 + 5.9
(glasses /week)
coffee consumption 3.8 + 2.5
(cups/day)
14.3 ±14.0 11.2 ± 11.9 14.2 ± 8.0
8.0 ± 2.0 5.7 + 2.9 5.5 ± 1.9
determination of NAD
levels in lymphocytes and
blood nicotinamide levels,
every two weeks
determination of NAD
levels in lymphocytes and
blood nicotinamide levels,
every two weeks
determination of NAD
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blood nicotinamide levels,
every two weeks
^ ^ ^ ^ ^k ^u Vu ^u ^u ^u ^v \v
t t
determination of SCE, MN,
VF, (±)-flM(/-BPDE-induced
poly(ADP-ribosylation),
(±)-<in(i-BPDE-induced
adductremoval
determination of SCE, MN,
VF, (±)-anfi-BPDE-induced
poly(ADP-ribosylation),
(±)-an/i-BPDE-induced
adductremoval
Figure 4.1. Experimental design of nicotinic acid supplementation study.
possible side effects (e.g. flushing and itching), individuals within the highest
dose group (100 mg/day) received 3 x 33.3 mg/day. Capsules containing nicotinic
acid (C.A.S. #: 59-67-6) were obtained from the Pharmacy Unit of the Academic
Hospital Maastricht. Identical capsules were used for placebo administration.
Supplementation was performed according to a double-blind protocol design and
subjects were advised to eat and to drink sufficient water or soft drinks during
intake of the capsules.
The nicotinic acid supplementation period lasted 14 weeks, since this was
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expected to be long enough to detect measurable changes in the degree of in
twi'o DNA damage. It has been shown that nicotinic acid supplementation of
humans during 8 weeks already resulted in a maximum elevation of
lymphocytic NAD+ levels (10).
In Figure 4.1, the experimental design is outlined. In the 8 weeks before
nicotinic acid intake, (±)-flnfz'-BPDE-induced poly(ADP-ribosylation), (±)-anfi-
BPDE-induced adduct removal, sister chromatid exchange frequencies (SCE),
/ipf variant frequencies (VF), and micronuclei frequencies were determined in
a sample of peripheral blood lymphocytes, twice for each individual. Also, on at
least two different days during the pre-supplementation period, the levels of the
main nicotinic acid metabolites, nicotinamide and NAD+, were determined in
blood and isolated lymphocytes respectively, to assess niacin status before
nicotinic acid administration. In order to monitor niacin status during the
supplementation period, every two weeks blood nicotinamide levels and
lymphocytic NAD+ levels were determined for each individual. Finally, at the
end of nicotinic acid supplementation, blood nicotinamide levels, lymphocytic
NAD+ levels and SCE, MN, VF and parameters of (±)-o«h-BPDE-induced DNA
repair were again determined at two different time points.
Participants were informed about possible side effects of nicotinic acid intake
and all persons officially agreed to participate to this study by giving their written
informed consent. The study protocol was approved by the Medical Ethical
Commission of the University of Limburg, Maastricht, The Netherlands.
o/ N/4D+ /eue/s /« iso/nferf penpJiern/ Wood /ympfrocyfes
Within 2 h after collection of the blood sample, 10 ml of blood were diluted by an
equal volume of phosphate buffered saline and layered onto 3/4 volume of
Lymphoprep™ (Nycomed, Oslo, Norway) in 50 ml culture tubes, prior to
centrifugation during 20 min at 800 g. Interphases containing PBLs, were
collected, pooled in 50 ml culture tubes and washed twice with PBS. Cells were
counted, using a haemocytometer and dissolved in RPMI 1640 medium to a final
density of 100 x 10^ cells/ml. Then, 60 ul of cell suspension were resuspended in
540 |o.l of ice cold RPMI 1640 medium in 10 ml tubes, in duplicate, and 100 ul of
this solution were stored at -20 °C for protein determination. Subsequently,
pyridine nucleotides were extracted with 2 ml ice-cold 0.1 M NaOH, 1 mM
nicotinamide (Sigma, Axel, The Netherlands) followed by a 1 ml wash of the
tube. The period of time between withdrawal of blood samples and extraction
procedure was held as constant as possible. Then, samples were neutralized with
0.37 M H3PO4, to pH 7.3 and stored at -20 °C. For determination of intracellular
NAD+ levels, an enzymatic cycling assay was applied (11). Frozen extracts were
thawed and reduced pyridine nucleotides in the extract were oxidized by addition
of 200 ul of 2.0 mM phenazine ethosulfate (Sigma, Axel, The Netherlands). An
aliquot of 200 ul of the extract (or standard NAD+ in bidest, Sigma, Axel, The
Netherlands) was added in duplicate to a preincubated reaction mixture,
93
Chapter 4 ,-, , . : . : .
containing final concentrations of 1.67 umol/ml phenazine ethosulfate, 0.42
|imol/ml 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-2H-tetrazolium bromide, 60
umol/ml bicin pH 7.8, 0.167 mg/ml alcoholdehydrogenase (all from Sigma, Axel,
The Netherlands) and 0.5 umol/ml ethanol, and incubated for exactly 30 min at
30 C. Absorption of the reaction mixture was measured at 570 nm immediately
after incubation, at room temperature, using a Beckman DU 648
spectrophotometer.
Profem
Frozen samples were thawed and in order to dissolve the cellular material, an
equal volume of 0.2% sodium dodecylsulfate (SDS) was added and samples were
mixed vigorously for at least 30 min. Then, 20 ul of the dissolved material were
added to 780 ul bidest and protein was determined, using the Bio-Rad™ (Bio-
Rad, Europe) protein assay kit. Standard bovine serum albumine (BSA) solutions
were prepared in 2.5 * 10'^ % SDS, which did not interfere with the linearity of
the calibration curve.
o/ nicotinamide in venous /lepan'm'zed b/oorf
Nicotinamide levels in venous heparinized blood were determined according to
the procedure developed by Shibata et al. (12). Blood samples were collected
according to the experimental design (Figure 4.1) and stored at -20 C. 300 ul of
blood were added to 1700 ul of bidest in glass tubes, in duplicate. 10 ul of 1.0
mg/ml 1-methylnicotinamide (Sigma, Axel, The Netherlands) [C.A.S. #: 114-33-
0] as internal standard were added and samples were heated at 100 °C for 10 min.
Subsequently, samples were cooled on ice during 10 min and 1500 ul were
transferred to Eppendorf vials, and centrifuged at 4 °C at 1200 rpm during 30 min.
The supernatant was filtered through a 0.45 uM filter and 500 ul were added to
600 mg KCO3 on ice. Tubes were vortexed and subsequently incubated at room
temperature during 5 min. Then, samples were three times extracted with 2.5 ml
of diethyl ether. Pooled diethylether fractions were evaporated under nitrogen at
room temperature and the residue was dissolved in 500 ul of bidest.
Nicotinamide and 1-methylnicotinamide were separated on a Supelco
supelcosil/™ LC-18S column (250 x 4.6 i.d.). The injection volume was 100 ul.
The column was eluted isocratically at a flow rate of 1.00 ml/min at room
temperature with 97% 10 mM KH2PO4, 2.5% acetonitril, 0.5% tetrahydrofurane
(v/v/v) pH 4.5, delivered by a Kratos Spectroflow 400 solvent delivery system.
Monitoring of nicotinamide (and 1-methylnicotinamide) was performed at 260
nm, using a Waters 994 programmable photodiode array detector. The detection
limit of nicotinamide was 0.05 ug absolute, corresponding to approximately 3.3
ug nicotinamide/ml blood. Overall recoveries of 80-90% were obtained.
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0/ (+)-<iHfi-BPDE induced
In a previous study, we showed that (±)-an/i-BPDE treatment of PHA-stimulated
lymphocytes during 15 minutes resulted in elevated levels of
ethenoribosyladenosine (eRado), the unique nucleoside derived from poly(ADP-
ribose) (13), which increased further upon prolonged treatment (14). According to
the experimental design (Figure 4.1), 110 ml venous heparinized blood were
diluted by an equal volume of phosphate buffered saline and lymphocytes were
isolated as described above for determination of NAD+ levels. Next, cells were
incubated at 37 °C at a density of 10 x 10<> cells/ml RPMI 1640 medium with 40
HM (±)-<JH/»-BPDE (Midwest Research Institute, Missouri, USA) (final
concentration DMSO: 0.18%). After 15 minutes, half of the cell suspension was
added to an equal volume of ice-cold 40% trichloroacetic acid (TCA) and
incubated on ice for at least 30 minutes. 100 ul of cell suspension were used for
protein determination, prior to TCA precipitation. The other half of the cell
suspension was incubated for another 20 minutes and subsequently TCA-
precipitated. TCA-insoluble material from both time points (at 15 and 35
minutes) was pelleted by centrifugation at 3600 rpm, during 15 minutes at 4 C.
Pellets were stored at -20 °C prior to determination of eRado, according to the
procedure of Jacobson (13) with minor modifications as described elsewhere (14),
except that [adeniMe-l'*C]poly(ADP-ribose) was obtained from permeabilized
lymphocytes.
o/ (ir)-anf/-BPDE-N2-dG addi/cf
According to the experimental design, 40 ml of blood were diluted with an equal
volume of PBS and lymphocytes were isolated as described. Cells were
resuspended in RPMI 1640 medium at a density of 10 x 10^ cells/ml and
incubated for 15 min at 37 °C with 0.5 uM (±)-a«f/-BPDE. Half of the cell
suspension was diluted ten-fold in RPMI 1640 complete medium in culture
flasks (final cone. FCS 15%) and cultured for 24 h (T = 24 h). The other part of the
suspension (T= 0 h) was centrifuged, medium was discarded and the pellet was
dissolved in 1 ml 5% SDS and incubated with 136 ug/ml RNase A and 18 U/ml
RNase Tl (both from Boehringer Mannheim) for 30 minutes at 37 C. Samples
were digested overnight with 4.0 ml of 50 ug/ml proteinase-K in 75 mM NaCl, 25
mM EDTA. DNA was extracted as described elsewhere (15) and (±)-a«fi-BPDE-
N -^dG adduct levels were determined using standard adduct labeling, according
to the procedure of Reddy et al. (16). Chromatograms were visualized and
quantified using a Molecular Dynamics Phosphor Imager with Image Quant™
software. The extent of (±)-anfi-BPDE-N2-dG adduct removal was calculated as
follows:
(±)-o«fi-BPDE-N -^dG = IQ0% -1 (±)-fl»r»-BPDE-N'-dG at T = 24 h
adduct removal (%) ^ (tJ-flnfi-BPDE-N^-dG at T = 0 h
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0/ sister c/iromaf/'d
SCE frequencies in human peripheral blood lymphocytes were determined as
described previously (17). According to the experimental design, outlined in
Figure 4.1, 0.4 ml of blood were added to 5.0 ml of RPMI 1640 medium,
supplemented with 10% foetal calf serum (FCS), 100 ug/ml streptomycin, 100
U/ml penicillin, 5 mM L-glutamine, 50 U/ml heparin (RPMI 1640 complete
medium). 0.2 ml of phytohemagglutinin (PHA) were added (final concentration:
52 )xg/ml) and cells were cultured for 24 h at 37 °C as described above.
Bromodeoxyuridine (BrdU) (Serva, Europe) was added (final concentration: 58
uM) and cultures were incubated for another 48 h. 1 h prior to harvesting, 100 JJ.1
of colcemid were added. Then, cells were hypotonized in 75 mM KC1 for 10-15
min and fixed with methanol : acetic acid (3 : 1; v/v). Metaphase slides were
prepared and were stained by means of the Hoechst-plus-Giemsa technique (18).
Before microscope evaluation, the slides were encoded. Slides were evaluated by
a well-trained observer, and SCE scores were checked by a second independent
observer. From one person,-for each time point, at least 20 metaphases,
containing 40 chromosomes as a minimum, were analyzed for SCEs.
0/ in uiuo /iprf parianf
In IWO induced /iprf variant frequencies in peripheral blood lymphocytes were
analyzed by assessment of 6-thioguanine resistance (TC), according to the
procedure developed by Hageman et al. (19). 5 ml of venous heparinized blood
was diluted tenfold in RPMI 1640 medium, and stored for 24 h at 4 °C to inhibit
the confounding effect of possible spontaneously cycling lymphocytes. Then, cells
were collected by centrifugation and part of the cells was divided into eight
cultures, in such a way that each culture contained the equivalent of 0.5 ml
whole blood, 5.0 ml RPMI complete medium, 0.2 ml PHA (final concentration: ±
52 ug/ml), and 2 x 10-4 M 6-thioguanine (TG) (Sigma, Axel, The Netherlands). To
determine the labeling index of the TG control cultures (Lie), two cultures were
set up, containing RPMI 1640 complete medium, without TG. After culturing for
24 h at 37 °C, BrdU was added to a final concentration of 1 x 10'5 M. After an
additional 16 h of culturing, cells were hypotonized in 75 mM KC1 and harvested
as described above for determination of sister chromatid exchanges. During
harvesting, four TG cultures were pooled and cells were finally resuspended in
200-300 ul of fixative. Special care was taken to avoid contamination of TG
cultures by BrdU-labeled cells from control cultures. Microscope slides were
prepared, containing the material of the TG cultures or two drops of 10-25 |il of
the control cultures. The number of nuclei in the TG cultures was counted in
triplicate in 1 ul of a 1:10 dilution on a microscope slide after Giemsa staining
(BDH, Poole, Dorset, UK). For staining and scoring of the slides containing BrdU-
labeled cells, DNA was denaturated by incubating the slides during 25 min in 4 N
HC1. Then, slides were rinsed twice during 10 min in 0.1 N Borax buffer, pH 8.5
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and once in PBS, pH 7.4. After rinsing, the slides were incubated for 1 h in a
humidified atmosphere, with mouse monoclonal anti-BrdU IgG antibodies (a
generous gift from Dr. Bert Schutte, Department of Molecular Cell Biology,
University of Limburg, The Netherlands), diluted in PBS, containing 1% BSA
and subsequently rinsed twice in PBS. Next, slides were incubated with
peroxidase-conjugated rabbit anti-mouse IgG antibodies (RAMPO, P161,
Dakopatts, Glostrup, Denmark) and BrdU-labeled nuclei were stained brown by
incubating the slides for 10 min in the dark in a 3,3'-diaminobenzidine (Fluka
Chemie, Buchs, Switzerland) solution in 0.05 M Tris-HCl, pH 7.6 containing
0.01% (w/v) H2O2. The number of brown nuclei on TG slides was counted using
normal light microscopy, with magnification of 400x. The labeling index of the
TG cultures (Lit) was calculated as the number of BrdU-containing (brown)
nuclei on all TG slides divided by the total number of nuclei on the TG slides. TG
control slides were counterstained with Giemsa and the labeling index (Lie) was
determined as the number of brown nuclei per 1000 nuclei in the TG control
culture, the total number of nuclei evaluated for determination of the Lie was
2000. The VF of TC" lymphocytes was calculated as LIt/LIc. Slides were encoded
prior to microscopic analysis, and scored by a well-trained observer.
0/ 7M/crom<c/e/
Before and at the end of nicotinic acid supplementation, the micronuclei
frequencies were determined twice using the assay of Fenech and Morley (20). 0.4
ml of venous heparinized blood were cultured in 5 ml RPMI 1640 complete
medium and 0.2 ml PHA (final concentration: ± 52 ug/ml), to stimulate T-cell
proliferation. To block cytokinesis, 44 h after culturing, cytochalasin B (Sigma,
Axel, The Netherlands) was added to a final concentration of 6 ug/ml. After an
additional culture period of 28 h, cultures were harvested as described above and
slides were prepared and stained with 3% Giemsa for 20 min. Prior to
microscopic analysis, slides were encoded. Per individual, for each time point,
1000 binucleated cells were analyzed for the presence of micronuclei by a well-
trained observer and checked by a second observer.
Sfafisficfl/
Possible differences between parameters of DNA repair, DNA damage and
parameters of niacin status before and at the end of the nicotinic acid
supplementation period were statistically analyzed by means of the non-
parametric Wilcoxon signed rank test. Possible correlations between nicotinic
acid intake, changes in parameters of niacin status and changes in parameters of
DNA damage and repair were statistically analyzed by means of the non-
parametric Spearman's Rank Correlation test. Possible effects of age and smoking
habits on parameters of DNA damage and repair, and possible associations
between parameters of DNA repair and DNA damage, were statistically analyzed
by means of simple and multiple regression.
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Results
One person (#7) became ill during the nicotinic acid supplementation period and
therefore, results from this person were omitted from the statistical analysis.
For two individuals within the 50 mg/day dose group and for two individuals
within the 100 mg/day dose group, a clear increase in lymphocytic NAD* levels
(expressed as pmol » 10"^  per mg protein) was observed during supplementation.
In Figure 4.2, mean NAD+ levels, expressed as pmol » 10~2/mg protein, are
shown for every dose group, before and at the end of the nicotinic acid
supplementation period. Each mean value has been calculated from at least two
determinations of lymphocytic NAD+ per person. A significant increase in
NAD+ levels was observed at the end of the nicotinic acid supplementation
period in the dose group receiving a total amount of 50 mg nicotinic acid per day
(mean NAD+ levels are shown for all individuals, receiving either 1 x 50 mg or 3
x 16.7 mg nicotinic acid /day; Wilcoxon signed rank, p<0.05). Further, within the
highest dose group and within the group of all individuals receiving nicotinic
acid, NAD+ levels tended to be higher at the end of the supplementation period.
A positive, nearly significant correlation (Spearman Rank Correlation, ^=0.43;
p=0.063) was observed between daily nicotinic acid intake and differences of
mean lymphocytic NAD+-levels from each individual before and at the end of
the supplementation period (Table 4.2).
dose group (mg/day)
supplemented
persons
Figure 4.2. NAD* levels in isolated human PBLs. Results represent the group mean
of NAD* levels, determined before and at the end of the nicotinic acid supplemen-
tation period.
* Statistical significant difference between NAD* levels before and at the end of
the nicotinic acid supplementation period (Wilcoxon signed rank, p<0.05).
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Table 4.2. Spearman Rank Correlation coefficients at the individual level between niacin intake,
mean differences in niacin status and mean differences in parameters of cytogenetic damage and (±)-
flii/i-BPDE-induced DNA repair, before and at the end of the nicotinic acid supplementation
period.
A mean A mean A mean A mean A mean A mean
NAD* nicotinamide (+)-anri-BPDE- SCE VF MN
N^-dGadduct
removal
rs = 0.51 rs=-0.07 rs=-0.08
p<0.05 NS. NS.
rs = 0.05 rj= 0.01 rs= 0.14
NS. NS. NS.
nicotinic acid
intake
4 mean
NAD*
4 mean
nicotinamide
rj= 0.43
0.05<p<0.10
. . .
rj= 0.23
N.S.
rs= 0.76
p<0.001
rs= 0.23
NS.
Ts= -0.11
NS.
rs= -0.24
NS.
rs= -0.08
NS.
rj= -0.07 rs= 0.11
NS. NS. N.S.
dose group (mg/day)
supplemented
persons
Figure 4.3. Nicotinamide levels in venous heparinized blood samples. Results
represent the group mean of nicotinamide levels, determined before and at the end
of the nicotinic acid supplementation period.
* Statistical significant difference between nicotinamide levels before and at the
end of the nicotinic acid supplementation period (Wilcoxon signed rank, p<0.05).
** Statistical significant difference between nicotinamide levels before and at the
end of the nicotinic acid supplementation period (Wilcoxon signed rank, p<0.01).
At the individual level, an increase in blood nicotinamide level was observed
during the supplementation period in 9 of the 11 individuals receiving a total
amount of 50 or 100 mg nicotinic acid per day. In Figure 4.3, mean blood
nicotinamide levels are shown for all dose groups, before and at the end of the
supplementation period. While blood nicotinamide levels tended to decrease in
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the placebo group, in all the groups receiving nicotinic acid, mean nicotinamide
blood levels were higher at the end of the supplementation period, with a
significant increase in the dose group receiving 100 mg/day (Wilcoxon signed
rank, p<0.05). Also, when individual mean nicotinamide blood levels were
averaged for all supplemented persons, a significant increase was observed
between mean levels before and at the end of the supplementation period
(Wilcoxon signed rank, p<0.01). Furthermore, a statistically significant
correlation was observed between daily nicotinic acid intake and differences of
mean nicotinamide levels from each individual before and at the end of the
supplementation period (Spearman Rank Correlation, ^=0.76, p<0.001) (Table
4.2).
In Figure 4.4, mean eRado levels, determined after ^x fi'uo exposure of
lymphocytes to (±)-flnfz'-BPDE for 15 and 35 minutes, before and at the end of the
nicotinic acid supplementation period, are shown. For 12 individuals, sufficient
cell material for eRado analysis was available. While mean eRado levels for 3
individuals in the placebo group tended to be lower at the end of the
supplementation period, no differences were observed in mean eRado levels
before and at the end of the supplementation period within the groups receiving
nicotinic acid.
In Table 4.3 mean group values of (±)-anfi-BPDE-N2-dG adduct removal are
shown, determined before and at the end of intake after e.r y/fo exposure of
lymphocytes to (±)-<7Mfj'-BPDE. High intra- and inter-individual differences were
observed in the extent of (±)-anfz'-BPDE-N2-dG adduct removal and in some
individuals, lymphocytic adduct levels even accumulated after cessation of (+)-
<j/if7-BPDE exposure. No significant differences were observed in any of the dose
groups between mean rate of (±)-a/7fi-BPDE-N2-dG adduct removal before and at
the end of the nicotinic acid supplementation period (Wilcoxon signed rank).
Nicotinic acid intake and changes in parameters of niacin status for each
individual were not significantly correlated with changes in removal of (±)-
<wf/-BPDE-N2-dG adducts (Table 4.2).
In Table 4.4, results of cytogenetic parameters for each dose group before and at
the end of the supplementation period are shown. SCE frequencies tended to
increase after supplementation (significantly in the group receiving 100 mg
niacin per day, and in all supplemented persons, Wilcoxon signed rank, p<0.05),
while in the non-supplemented group mean SCE frequencies tended to decrease
(Table 4.4). The increase in SCE frequencies within the two highest dose groups,
however, was within the control range of SCE frequencies, as determined for the
non-supplemented persons. Daily nicotinic acid intake and alterations of mean
SCE frequencies for each individual during nicotinic acid supplementation were
significantly correlated (Spearman Rank Correlation, ^=0.51, p<0.05) (Table 4.2).
Alterations of mean individual SCE frequencies were not correlated with
alterations of mean individual nicotinamide blood levels (see Table 4.2)
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50 100 all
supplemented
dose group (mg/day) persons
Figure 4.4. Poly(ADP-ribosylation) in isolated PBLs, determined after e* DIDO exposure to 40 |iM
(±)-(JH(I-BPDE. Results represent the group mean levels (+ SD) of eRado/mg protein, determined
before the nicotinic acid supplementation period after 15 (CD ) and 35 ( B ) minutes of (±)-anfi-
BPDE exposure, and at the end of the nicotinic acid supplementation period after 15 (E3 ) and 35
( H ) minutes of (±)-an//-BPDE exposure.
Table 4.3. Mean removal of (±)-fln(i-BPDE-N^-dG adducts in peripheral blood lymphocytes,
determined before and at the end of nicotinic acid supplementation period. Group means ± standard
deviations are shown.
dose group
(mg nicotinic
acid/day)
0
25
50
100
all supplemented
persons
(+)-0/ifi-BPDE-N2-dG
adduct removal (%)
before
intake
9.4 ± 23.6
-20.2 ± 64.3
20.5 ± 19.3
6.7 ± 49.3
6.9 ± 42.2
end of
intake
-23.6 ± 89.2
-4.4 ± 55.1
-10.6 ± 39.9
-14.6 + 32.4
-10.7 ± 37.7
(Spearman Rank Correlation, ^=0.33, p=0.15). Furthermore, no statistically
significant correlation between changes of mean individual SCE frequencies
during the supplementation period and changes of mean individual
lymphocytic NAD+ levels during supplementation was observed.
A significant decrease in mean /iprf variant frequencies before and at the end
of the supplementation period was observed only within the dose group
receiving 100 mg nicotinic acid per day (Wilcoxon signed rank, p<0.05).
Alterations in lymphocytic NAD+ levels (in pmol * 10~2/mg protein) and blood
nicotinamide levels, however, were not significantly correlated with alterations
in VF frequencies (see Table 4.2).
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Table 4.4. Mean variant frequencies (VF), micronuclei frequencies (MN) and sister chromatid
exchange frequencies (SCE) in peripheral blood lymphocytes, determined before and at the end of
the nicotinic acid supplementation period. Group means ± standard deviations are shown.
dose group
(mg nicotinic
acid/day)
0
25
50
100
all supplemented
persons
SCEs/cell
before
intake
6.3 ± 1.1
6.9 ± 1.0
6.2 ± 0.7
5.2 ± 0.6 •
6.0 ± 0.9*
end oif
intake
5.8 ±
7.5 ±
6.8 ±
6.2 ±
6.7 ±
0.9
0.2
1.3
0.7
1.0
VF. 1
befor<
10"*
intake
8.98
10.64
13.63
16.40
13.98
±
±
±
±
±
6.94
11.24
18.46
12.04 •
14.14
endo f
intake
3.38
10.68
38.19
3.20
19.80
±
±
±
±
±
2.53
6.77
47.54
1.78
34.03
MN/
1000 binucleated
before
intake
4.6 ± 1.7
6.0 ± 1.0
6.6 ± 2.2
4.0 ± 1.6
5.5 ± 2.1
endo:
cells
f
intake
6.2 ±
6.2 ±
5.7 ±
4.7 ±
5.4 ±
2.6
1.8
2.2
1.6
1.9
* Statistical significant difference between parameter before and at the end of the nicotinic acid
supplementation period (Wilcoxon signed rank, p<0.05).
No significant differences were observed between mean micronuclei frequencies
in any of the dose groups, measured before and at the end of the nicotinic acid
supplementation period. At the individual level, no statistically significant
correlations were found between nicotinic acid intake, parameters of niacin
status and alterations in MN frequencies.
No significant correlations were observed between any of the parameters,
related to niacin status and cytogenetic damage, versus (±)-«nf/-BPDE-induced
adduct removal or poly(ADP-ribosylation) before intake. Changes in repair
parameters during the supplementation period were not significantly correlated
to any changes in parameters of cytogenetic damage.
No effect of smoking was observed on parameters of DNA repair. Further,
concerning the effect of smoking on DNA damage, a significant positive
correlation was found between the number of pack years and SCE frequencies,
determined before the nicotinic acid supplementation period (simple regression,
r=0.52, p=0.018). Age also correlated significantly with SCE frequencies (simple
regression, r=0.45, p=0.044). The number of packyears and age were significantly
correlated (simple regression, r=0.77, p<0.0001). When the correlation between
packyears and SCE frequencies was adjusted for age, the positive correlation
between pack years and SCE frequencies disappeared; the regression model was
only nearly significant (Multiple regression: R=0.53, p=0.061; regression equation:
SCE frequencies = (0.011 » age) + (0.043 * number of pack years) + 5.095).
A positive correlation was found between the number of pack years and
logarithmically transformed VF, determined before the nicotinic acid
supplementation period (simple regression, r=0.36, p=0.12), which reached
statistical significance after exclusion of two highest VF values. The number of
pack years also correlated positively, nearly significant with MN frequencies,
determined before the nicotinic acid supplementation period (simple regression,
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r=0.43, p=0.06). Age, coffee consumption and alcohol consumption did not
correlate significantly with logarithmically transformed VF and MN frequencies,
determined before nicotinic acid supplementation.
Discussion
Recently, the possible importance of an individual's niacin status in relation to
repair of DNA damage and carcinogenesis has been considered (21). It was
proposed that the activity of the DNA repair-related enzyme poly(ADP-ribose)
polymerase and consequently the degree of DNA damage occurring m y/uo
might be very sensitive to fluctuations in cellular NAD+ content (21). In rats,
niacin deficiency resulted in decreased tissue NAD+ levels, decreased hepatic
poly(ADP-ribose) polymerase activity (22,23) and increased ex ui'uo oxygen
radical-induced strand breaks formation in hepatocytes and lymphocytes (22).
Further, it has been shown that NAD+ levels were elevated in blood lym-
phocytes obtained from two healthy human individuals receiving nicotinic acid
during a period of eight weeks, and that these cells were more resistant to ex
DII>O induced DNA strand break formation (10). Thus, despite the fact that
estimated daily niacin-intake (in The Netherlands: at least 14 mg NE/day (as
nicotinic acid); in the USA: 16-34 mg NE/day) is sufficient to prevent niacin-
deficiency-related disorders like Pellagra (occurring when intake < 9-12 mg
NE/day) (24), minor alterations in niacin status may modulate carcinogenesis
given the potential important role of poly(ADP-ribosylation) in DNA repair.
Therefore, the aim of the present study was to investigate whether cytogenetic
damage caused by smoking, and its repair in healthy humans was affected by
alterations in niacin status, as a consequence of nicotinic acid supplementation.
A positive association was found between smoking habits and parameters of
cytogenetic damage in peripheral blood lymphocytes, determined before nicotinic
acid supplementation. Supplementation during 14 weeks of human volunteers
with nicotinic acid resulted in an elevated niacin status as judged from increases
in blood nicotinamide levels and lymphocytic NAD+ levels. Mean lymphocytic
NAD+ levels appeared to be approximately 10-20% higher at the end of
supplementation in comparison to baseline levels, within the 50 mg (statistical
significant, p<0.05) and 100 mg dose groups, and within the group composed of
all individuals receiving nicotinic acid. Not every individual showed an increase
in lymphocytic NAD+ levels during nicotinic acid supplementation.
It has been shown that both nicotinic acid and nicotinamide can act as
precursors for NAD+ synthesis in resting lymphocytes in ui'fro (25). Since in
humans, nicotinic acid is nearly completely absorbed in stomach and small
intestine (26), increased plasma nicotinic acid levels likely resulted in moderately
increased lymphocytic NAD+ levels, via the Preiss-Handler Pathway (see Figure
4.5, pathway I.). Alternatively, via the Preiss-Handler Pathway and subsequent
103
nicotinic acid nrcormic add
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nicotinic acid
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nicotinic acid adenine
dinucleotide
1 NAD synf/iase (3J
nicofmamide e I
p/iospfeoribosy/- nicotinamide mononuc/eoti'dg I nicotinamide adenine
frans/erass C4J mononucleotide adeny/y/frans/erase (5J i dinucleotide (NAD +)
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poly(ADP-ribose)
quinolinic acid
i
tryptophan
Nl -methy lnicotinamide
NJ-mef/iy/ni'cofinamide oxidas^s Nl-methyl-4-pyridone-3-carboxamide
- • +
Nl-methyl-2-pyridone-5-carboxamide
Figure 4.5. Major routes in niacin metabolism.
I. represents the Preiss-Handler Pathway. II. represents the Dietrich pathway.
(1.): EC 2.4.2.11; (2.): EC 2.7.1.23; (3.): EC 6.3.5.1; (4.): EC 2.4.2.12; (5.): EC 2.7.7.1; (6.): EC 3.2.2.5; (7.): EC 2.4.2.30; (8.): EC 2.1.1.1.
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NADase activity, plasma nicotinic acid may be converted into nicotinamide in
the liver, as was proposed for mammals (26,27). The present observation that
increased nicotinic acid intake is associated with elevated blood nicotinamide
levels (Table 4.2), is in agreement with the possible existence of such a metabolic
pathway for nicotinic acid in humans in z>/uo (28). As a consequence, elevated
plasma nicotinamide levels may be another cause of increased NAD+ synthesis
(or decreased NAD+ catabolism, via poly(ADP-ribose) polymerase inhibition) in
lymphocytes, via the Dietrich Pathway (Figure 4.5, pathway II.)(25). In fact, it has
been proposed that nicotinamide at physiological concentrations is the main
circulating precursor for NAD+ in human red blood cells (29), Balb 3T3 cells (30)
and human lymphocytes (25). In conclusion, NAD+ may be synthesized in
peripheral blood lymphocytes in humans either from directly absorbed nicotinic
acid, or from nicotinamide after metabolism of nicotinic acid in other tissues.
Weitberg (10) reported a more evident increase in NAD+ levels (from 4 pmol
to 23 pmol/lO^ cells) in lymphocytes obtained from two individuals, receiving
100 mg nicotinic acid/day during 8 weeks, as compared to results from the
present study. This is not likely to be explained by differences in experimental
procedures, since in both studies similar methods were used for isolation of
lymphocytes and for determination of NAD+ (11)- In the present study,
lymphocytic NAD+ levels as determined before intake, ranged from 31.1 to 107.9
pmol per 10^  cells. In other studies, comparable or higher cellular NAD+ levels
were reported for freshly isolated human lymphocytes (31), cultured resting
human lymphocytes (25) and other cultured mammalian cells (2,32-35).
Lymphocytic NAD+ levels, measured by Weitberg (10) prior to nicotinic acid
supplementation, were much lower. Thus, it might be that in that study,
lymphocytes were obtained from individuals with a relatively low niacin status,
in whom a supplemention effect could be more easily established.
Concerning the effects of nicotinic acid supplementation on cytogenetic
damage and ex fifo induced DNA repair, the present study shows that in the
individuals receiving nicotinic acid, mean SCE frequencies tended to increase
during supplementation, although this increase was within the range of SCE
frequencies, found in the non-supplemented persons. Thus, it appears that the
repair of SCE-causing DNA lesions might not be influenced by elevated
lymphocytic NAD+ levels, in contrast to ex uiro oxygen-radical induced DNA
strand breaks (10).
In the present study, at the individual level, increases of mean nicotinamide
levels before and at the end of the supplementation period, as a consequence of
elevated nicotinic acid intake, were positively correlated with increases of mean
SCE frequencies before and at the end of the supplementation period, but this
result was not statistically significant (Table 4.2). Moreover, blood nicotinamide
levels appeared to be not significantly correlated with SCE frequencies both
before and at the end of nicotinic acid intake. When the ratio of lymphocytic
NAD+ levels and blood nicotinamide levels decreases, it may be expected that
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poly(ADP-ribosylation) will be inhibited. However, no statistically significant
correlation at the individual level was found between changes in this ratio and
changes in SCE frequencies, during nicotinic acid supplementation. In addition,
in lymphocytes obtained from 9 individuals, no effect of nicotinic acid
supplementation was found on (±)-anh-BPDE-induced poly(ADP-ribosylation)
ex u/'uo (Figure 4.4). Thus, although nicotinamide has been shown to act as
competitive inhibitor of poly(ADP-ribose) polymerase (31) and to induce SCEs in
human lymphoblastoid cells and CHO cells m uifro (36,37), we conclude that in
humans in u/fo, an elevation of blood nicotinamide levels, as a consequence of
elevated nicotinic acid intake, does not appear to represent a causal factor in the
observed increase of SCE frequencies. At present, it remains unknown what
might have caused the relative elevation of SCE frequencies within the
individuals, receiving additional nicotinic acid.
Little is known about the role of poly(ADP-ribosylation) in preventing
mutagenesis. Conflicting results have been reported concerning the ex PIUO
action of poly(ADP-ribose) polymerase inhibitors in relation to carcinogen-
induced mutations which depended on the carcinogenic agents used, the genetic
loci used for mutant screening, as well as cellular progression at the time of
carcinogen and poly(ADP-ribose) polymerase inhibitor treatment (38-40). When
the /iprf variant frequency data are considered, no clear positive or negative
effect of nicotinic acid intake and of niacin status on mutagenesis has been
demonstrated. Only within the dose group receiving 100 mg/day, VF was
significantly lower at the end of supplementation, but when all individuals
receiving nicotinic acid were considered, VF tended to be even higher at the end
of intake. Since considerable intra- and inter-individual variations in VF
appeared to exist in these individuals, the biological relevance of these
observations may be limited. Thus, it is concluded that prevention of
mutagenesis by nicotinic acid supplementation in humans has not clearly been
demonstrated. Furthermore, results from the present study indicate neither a
preventive nor a potentiating effect of nicotinic acid intake on the presence of
micronuclei, which is of relevance since micronuclei frequencies probably
inversely relate to poly(ADP-ribosylation)-dependent repair of smoking-induced
DNA strand breaks.
Age correlated positively with SCE frequencies, which might be an indication
that, with increasing age, decreased repair capacity results in increased
chromosomal damage. Previous studies also report positive associations between
age and parameters of cytogenetic damage (41,42), although no association has
also been reported (43).
In conclusion, results from the present study show that supplementation of
human male smokers with nicotinic acid in doses of 50-100 mg/day results in
elevated blood nicotinamide levels, and to a minor degree, in increased
lymphocytic NAD+ levels. Sister chromatid exchange frequencies were elevated
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in individuals receiving nicotinic acid which however, could not be clearly
attributed to alterations in niacin status or parameters of DNA repair, and which
are therefore not likely related to modulation of poly(ADP-ribosylation)-
dependent repair of smoking related DNA damage.
Finally, it is concluded that this improved niacin status failed to increase
NAD+-dependent poly(ADP-ribosylation)-mediated lymphocytic DNA repair,
and consequently did not influence peripheral lymphocyte mutagenesis or
chromosomal damage.
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Abstract
Chemical or physical modification of DNA may cause an increase in genomic
mutations or other genetic alterations, which may ultimately result in the onset
of cancer. To avoid these deleterious effects of DNA damage, humans possess
DNA repair mechanisms. Decreased DNA repair, induced ex u/t>o by ultraviolet
light or ionizing radiation in human peripheral blood lymphocytes (PBLs), has
been associated with aging. The aim of this study was to investigate whether
repair of DNA damage, induced ex iwo in PBLs obtained from smokers (n=20)
by (±)-anf/-benzo[a]pyrene diolepoxide ((±)-<JMf/-BPDE), reactive metabolites
from the environmental carcinogen benzo[a]pyrene, could also be associated
with age. Further, age-related associations between ex two (±)-anfi-BPDE-
induced DNA repair and the frequency of cytogenetic damage (sister chromatid
exchange frequencies and micronuclei frequencies) in PBLs were evaluated. A
statistically significant negative association was observed between ex i;ii;o (±)-
anh'-BPDE-induced unscheduled DNA synthesis (UDS) and age of the donors.
Also, parameters of lymphocytic DNA damage were negatively associated with
ex iwo (±)-anh-BPDE-induced UDS and positively associated with age in this
population. It is concluded that with increasing age, the decrease of lymphocytic
excision repair capacity may be responsible for increased lymphocytic DNA
damage. Further, the phenomena observed here, may resemble processes in
two that may result in age-related increased risk for cancer development in
target organs of human smokers.
Ill
Oiap/er 5
Introduction
Humans are continuously exposed to various agents that may chemically or
physically modify cellular DNA. It is believed that such modifications result in
an time-dependent accumulation of genomic mutations or other genetic
alterations (1,2). If these alterations take place in proto-oncogenes or tumour
suppressor genes, cell-cycle control may be lost, ultimately resulting in the onset
of cancer. To protect cellular DNA from these deleterious effects of DNA damage,
eukaryotic and prokaryotic cells, including human cells, possess DNA repair
mechanisms. The importance of adequate DNA repair mechanisms in
preventing carcinogenesis is exemplified by the DNA-repair defective autosomal
recessive disease xeroderma pigmentosum. Cells obtained from individuals
having this disease are deficient in nucleotide excision repair of large DNA
adducts, for example ultraviolet light (UV)-induced cyclobutane pyrimidine
dimers. Moreover, these individuals develop skin cancer even at early age and
have a 2000-fold increased risk- of cancer compared with normal individuals (3).
Recently, decreased UV-induced DNA repair capacity of peripheral blood
lymphocytes (PBLs) was associated with development of sunlight-induced skin
cancer in the normal human population (4). Further, this decrease in DNA
repair capacity was negatively associated with age. Other studies also report
negative associations between the extent of DNA repair, induced by various
DNA damaging agents ex i>i'i>o in PBLs, and age of the donor (5-7). Thus, it can
be hypothesized that the ability to perform adequate DNA repair declines with
increasing age. In turn, reduced repair capacity would result in increased
persistence of DNA damage and increased cancer risk. At present, the potentially
negative association between the capacity of DNA repair mechanisms and DNA
damage in y/yo has not yet been investigated in detail in carcinogen-exposed
human populations. In a previous study (Chapter 4), the effects of in DIDO
nicotinic acid supplementation on niacin status, poly(ADP-ribosylation),
cytogenetic damage and DNA repair in smoking humans were described. Aim of
the present study was to investigate whether age-related associations exist
between DNA repair and DNA damage in this carcinogen-exposed population of
smokers. As parameter of DNA repair, (±)-ant/-benzo[a]pyrene diolepoxide ((±)-
(HiH-BPDE)-induced unscheduled DNA (UDS) synthesis was determined ex
DIDO in PBLs, obtained from these smokers. (±)-anfi-BPDE, a mixture of
benzo[a]pyrene metabolites, including the most reactive and mutagenic (+)-anfi-
enantiomer (8), induces a variety of DNA lesions that may activate base or
nucleotide excision repair mechanisms (BER; NER) (9,10). To estimate the extent
of in DIDO DNA damage, sister chromatid exchange frequencies (SCE) and
micronuclei frequencies (MN) were determined in PBLs, after stimulation to
proliferation ex
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Materials and methods
20 healthy male human smokers, smoking at least 10 cigarettes per day, were
included into this study. Age of this population ranged from 21 to 55 years.
Averaged (± SD) number of cigarettes smoked per day, pack years, alcohol- and
coffee consumption were 19.6 ± 5.8 cigarettes/day; 14.8 ± 9.8 pack years; 12.3 ± 9.3
glasses/week; 5.3 ± 2.6 cups/day, respectively. All volunteers agreed to participate
to this study by giving their written informed consent. The study protocol was
approved by the Medical Ethical Commission of the University of Limburg,
Maastricht, The Netherlands.
Heparinized venous blood was collected from each donor at two different
days, within a period of 8 weeks. The method of lymphocytic SCE and MN
frequencies determination in whole blood cultures, in individuals from this
population, has been described elsewhere (11 and Chapter 4). (±)-awf/-BPDE-
induced UDS was determined in whole blood cultures. (±)-fl«f/'-BPDE ((±)-7p,8a-
dihydroxy-9a,10a-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene, Midwest Research
Institute, USA) stock solutions were prepared in anhydrous DMSO and stored at
-20 °C in the dark prior to one-off use. (±)-flwfi-BPDE (or DMSO for solvent
control-treated cultures) were added to a large volume of RPMI 1640 medium,
supplemented with 10% foetal calf serum, 100 ug/ml streptomycin, 100 U/ml
penicillin, 5 mM L-glutamine and 50 U/ml heparin, of which 2.5 ml were
subsequently added to 0.2 ml of blood, to a final concentration of 1.0 nM (final
concentration DMSO: 0.4%). Medium and supplements were obtained from
Gibco, Europe. Within 10 minutes after addition of the carcinogen, [meffty/-
^Hjthymidine (Amersham, sp. act. ~ 80 Ci/mmol) was added to a final
concentration of 10 uCi/ml. 24 h after initiation of the cultures, cells were
hypotonized in 75 mM for 10-15 minutes and fixed with methanol : acetic acid (3
: 1; v/v). Part of the cell suspension was pipetted on slides. Autoradiography and
determination of the number of net grains/nucleus were performed as described
elsewhere (12), except that quantification was done with the aid of an Artek
Counter™ model 880 (New Brunswick Scientific, USA) (adjusted to count mode)
in combination with a Sony CCD/RGB Videocamera (Sony, Japan), interfaced to
a Zeiss Axioskop microscope. Results are presented as (±)-a«h'-BPDE-induced
UDS (in net grains/nucleus), after correction for the number of net grains, found
in cells obtained from solvent control-treated cultures. Possible age-related
correlations between ex y/yo (±)-a?;f/-BPDE-induced UDS and parameters of
cytogenetic damage were statistically analyzed by means of simple and multiple
regression.
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Results and discussion
In Table 5.1, average and range of SCE, MN and (±)-anf/-BPDE-induced UDS,
determined at two different days in peripheral blood lymphocytes obtained from
male human smokers, are shown. In Figure 5.1, results of simple regression
analysis between age of the donor and (±)-anf/-BPDE-induced UDS are shown. A
significantly negative correlation was observed between age and (±)-anf/-BPDE-
induced-UDS (simple regression, r=-0.52, p=0.019). Based on the regression
equation, average decrease in the extent of (±)-anh'-BPDE-induced DNA repair
was 1.1% per year between 20 and 60 years of age. Other studies also report
negative associations between repair, induced ex p/uo in PBLs with UV, and age
(5-7). Pero and Ostlund (5) and Lambert et al. (6) observed in a healthy population
of non-smokers an average decrease in ex y/yo UV-induced UDS of
approximately 0.75% and 0.43% per year, respectively, between 20 and 60 years of
age. Wei et al. (4) reported a reduction in removal of ex y/'uo UV-induced DNA
damage of approximately 0.6% per year, within similar range of age. However,
positive and no associations between DNA repair, determined as UV- or N-
acetoxy-N-acetylaminofluorene-induced UDS, and age have been reported as
well (5,13-15). This may be attributed to differences in duration of exposure of
PBLs to carcinogens or in treatment of exposed cells with radiolabeled nucleotide
precursors, thus in fact to differences in observed repair kinetics.
(±)-rtnfz'-BPDE treatment of mammalian cells ex uiyo, including human
PBLs, has been shown to result predominantly in formation of N^-
deoxyguanosine adducts ((±)-<nif/-BPDE-N2-dG) (9,16-18). Repair of these (±)-
an/i-BPDE-N^-dG adducts may proceed through transcription-coupled NER
mechanisms (9,10,19). Recently, a mechanism for transcription-coupled human
NER has been proposed (20). It is assumed that at least 17 proteins are involved
in damage recognition, local DNA unwinding, dual incision around the lesion,
release of the damaged oligonucleotide and refilling of the excision gap. In
addition, (±)-o»ifj-BPDE treatment of isolated DNA has been shown to cause
formation of base adducts like N7-guanine and its unstable imidazole ring open
product (21), which may be substrates for base excision repair proteins m two.
With increasing age, DNA repair may decline as a consequence of intracellular
decrease in activity or levels of one or more of these proteins involved in NER
or BER. In this study population, no significant association was observed
between age of this population and the rate of (±)-anfi-BPDE-N2-dG adduct
removal, determined in isolated PBLs after ex uizw treatment with (±)-a«f/-
BPDE (Chapter 4). Given the fact that UDS reflects the activity of all enzymes
involved in excision repair, it may be that proteins which are involved in those
steps of repair, following the initial recognition and removal of (±)-anf/-BPDE-
induced DNA damage, are affected by aging.
Associations between age and initial (±)-<»ifi-BPDE-N2-dG adduct formation
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Table 5.1. Mean (+ standard deviation) and range of sister chromatid exchange frequencies,
micronuclei frequencies and (±)-anfi-BPDE-induced unscheduled DNA synthesis determined in
peripheral blood lymphocytes, obtained from male human smokers.
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Figure 5.1. Correlation between ex two (±)-anti-BPDE-induced UDS in periphe-
ral blood lymphocytes obtained from male human smokers, and age of the donor.
(within 15 minutes after ex uii>o exposure of PBLs to (±)-anfi-BPDE) have also
not been observed in this population (Chapter 4). Thus, it can be excluded that
the observed age-dependent decrease in UDS is related to decreased initial (±)-
anfi-BPDE-DNA adduct formation. Besides, since it is conceivable that aging
results in decreased efficiency of detoxification mechanisms, rather an increase in
initial (±)-<inh-BPDE-DNA binding with aging would have been expected.
With regard to possible effects of smoking on DNA repair, number of
cigarettes smoked per day did not correlate significantly with (±)-anfi-BPDE
induced UDS. Pack years correlated positively with (±)-anf/-BPDE-induced UDS
(simple regression: r=0.46; p=0.042). When the positive correlation between pack
years and (±)-a«h-BPDE-induced UDS was adjusted for age, this significant
correlation disappeared. Alcohol and coffee consumption were not significantly
correlated with (±)-onh-BPDE-induced UDS. Furthermore, the negative
correlation between (±)-«Mf;-BPDE-induced UDS and age was not influenced by
smoking habits (cigarettes/day).
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Figure 5.2. Correlation between SCE frequencies and ex two (±)-an/i-BPDE-
induced UDS in peripheral blood lymphocytes, obtained from male human
smokers. Numbers represent the age of each individual donor.
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Figure 5.3. Correlation between MN frequencies and ex I>IDO (±)-an(i-BPDE-
induced UDS in peripheral blood lymphocytes, obtained from male human
smokers. Numbers represent the age of each individual donor.
Both SCE (simple regression: r=-0.45; p=0.048) and MN (simple regression: r=-
0.44; p=0.052) negatively correlated with the extent of (±)-rt»f/-BPDE-induced
UDS (Figure 5.2 and Figure 5.3). After exclusion of two high MN values (> 9
MN/1000 binucleated cells), the negative correlation between MN and (±)-flnfi-
BPDE-induced UDS became highly significant (p<0.001). Smoking habits
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(cigarettes/day) did not influence these associations. Thus, the capacity of an
individual's DNA repair, as determined ex y/yo in (±)-tfHf/-BPDE-treated
resting PBLs, is indicative for the capacity of those repair mechanisms in resting
PBLs /» two, which are responsible for removal of lesions that otherwise
would have resulted in the induction of cytogenetic damage, in PHA-stimulated
PBLs ex iwo.
In the same population, SCE frequencies were significantly positively
correlated with age (simple regression: r=0.45, p=0.044; regression equation: SCE =
(0.041 * age) + 4.70). MN also correlated positively (non-significantly) with age
(simple regression: r=0.39, p=0.09; regression equation: MN = (0.072 * age) + 2.81).
After exclusion of the two highest MN values (> 9 MN/ 1000 binucleated cells),
this correlation reached statistical significance. Smoking habits (cigarettes/day)
did not influence these associations. Previous studies also report positive
associations between SCE or MN, respectively, and age (1,2), although no
association has also been reported (22). Since ex iwo (±)-<JHfi-BPDE-induced
UDS was negatively correlated with age (Figure 5.1), it is suggested that, with
increasing age, a decrease in lymphocytic excision repair capacity is responsible
for accumulation of (smoking-induced) DNA lesions in these cells. These lesions
could have been responsible for the observed age-associated increase in
cytogenetic damage. Adjustment for age resulted in disappearance of the
significant correlation between SCE and (±)-rtHf/-BPDE-induced UDS, suggesting
again that the negative association between (±)-<JHf/-BPDE-induced UDS and
SCE is age-dependent.
In conclusion, age-related decrease in the capacity of an individual's DNA
repair, determined ex y/yo in (±)-fl«fi-BPDE-treated unstimulated PBLs, may
resemble age-related decrease in the capacity of repair mechanisms i« iwo.
Consequently, those (smoking-induced) lesions that are responsible for the
induction of SCE and MN in PBLs may accumulate with increasing age. PBLs do
not represent themselves target organs for carcinogenic factors m uiw.
However, in a recent study, increased peripheral blood lymphocytic chromosome
aberrations were found to be associated with increased overall risk for cancer (23).
Therefore, age-dependent decreased DNA repair and increased cytogenetic
damage in PBLs may reflect similar processes that are involved in age-related
development of cancer in target organs in human smokers.
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Abstract
The adaptive response in human peripheral blood lymphocytes (PBLs) can be
characterized as the reducing effect of pre-exposure to low levels of ionizing
radiation or genotoxic chemicals on the extent of chromosomal damage, induced
by exposure to high levels of these agents. It has been postulated that the DNA
repair related enzyme poly(ADP-ribose) polymerase is necessary for the
induction of an adaptive response in PBLs. The aim of the present study was to
investigate whether (±)-7p,8a-dihydroxy-9a,10cc-epoxy-7,8,9,10-tetrahydro-
benzo[a]pyrene ((±)-<JMti-BPDE), from which the (+)-enantiomer represents the
ultimate carcinogenic form of the environmental pollutant benzo[a]pyrene,
induces an adaptive response in PBLs. Moreover, the possible involvement of
poly(ADP-ribosylation) and DNA repair synthesis in the (±)-flnti-BPDE-induced
adaptive response was assessed. In PBLs obtained from 4 out of 10 healthy male
humans, pre-exposure to 2.5 nM (±)-<inti-BPDE resulted in reduced micronuclei
formation, as marker for chromosomal damage, induced by 2.5 uM (±)-a/iti-
BPDE. The degree of adaptation was found to depend on the concentration of (±)-
fl»iti-BPDE applied during pre-exposure and varied between as well as within
individuals. No associations were however found between the adaptive
response, determined as decrease in micronuclei formation, and the effects of
pre-exposure on challenge-induced poly(ADP-ribosylation) or unscheduled DNA
synthesis.
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Introduction
The adaptive response (AR), first described by Samson and Cairns (1) for MNNG-
induced DNA mutations in £. coil, has originally been defined as the
preventive effect of pre-exposure to low levels of an alkylating agent on
formation of mutations and decrease in cell survival, caused by exposure to a
high level of the alkylating agent at later time.
Olivieri et al. (2) showed that a comparable phenomenon existed in human
peripheral blood lymphocytes (PBLs). They observed a reduction in the number
of chromosome aberrations when PBLs were pre-treated with low levels of
radioactive thymidine which was followed by a challenge of X-rays, in
comparison to the number of chromosome aberrations induced by X-ray
exposure alone.
Subsequently, the existence of an inducible AR in human PBLs for X-ray
induced cytogenetic damage has been confirmed by others, measuring various
cytogenetic end-points, and using as pre-conditioning agents X-radiation (3-9),
bleomycin (10,11), hydrogen peroxide (12,13), radioisotopes (5,14) and
hyperthermia (15).
Further, AR-like phenomena in human PBLs have also been observed with
respect to damage induced by challenge treatments with other agents than X-rays,
such as radon (16), mitomycin C (17-19), bleomycin (11,19), MNNG (20) and
tritiated thymidine (19).
The mechanism underlying the adaptation in PBLs to ionizing radiation and
other agents, is little understood. Cycloheximide, a protein synthesis inhibitor,
has been found to inhibit the AR to ionizing radiation (15,21), suggesting that
synthesis of certain proteins is necessary for induction of an AR. Olivieri et al. (2)
proposed that AR involves the induction of a chromosomal repair mechanism.
Indeed, the DNA repair-related nicotinamide adenine dinucleotide (NAD+)-
dependent enzyme poly(ADP-ribose) polymerase might be involved in AR, since
3-aminobenzamide, an inhibitor of this enzyme (22,23), has been found to inhibit
the pH]thymidine-, X-ray- and bleomycin-induced AR for X-rays in PBLs
(6,10,14,24). In addition, the pH]-thymidine-induced AR for X-rays did not occur
when PBLs were grown in absence of nicotinamide (24), one of the precursors of
NAD+ in PBLs (25).
In a previous study, we showed that in isolated human PBLs, poly(ADP-
ribosylation) increased and intracellular NAD+-levels decreased during repair of
DNA damage caused by exposure to high levels of (±)-nnf/-benzo[a]pyrene
diolepoxide ((±)-anf;-BPDE) (26). Given the possible involvement of poly(ADP-
ribose) polymerase in the AR in human PBLs induced by ionizing radiation and
radio-mimetic agents, it became of interest to assess whether pre-exposure of
PBLs to low doses of (±)-<JH(I-BPDE could also induce a similar protection against
cytogenetic damage induced by higher doses of (±)-a»if/-BPDE.
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Dominguez et al., (13) showed that the cytokinesis-block micronucleus method
of Fenech and Morley (27) can be applied to detect the AR to ionizing irradiation
in human PBLs. Within this context, the purpose of this study was to evaluate
whether pre-exposure of isolated human peripheral blood lymphocytes, obtained
from 10 non-exposed individuals, to low doses of (±)-anf/-BPDE prevents the
formation of micronuclei (MN), as marker of chromosomal loss or
fragmentation, caused by exposure to higher doses of (±)-aMf/-BPDE. To
determine if a preventive effect of pre-exposure on the extent of MN formation
was related to DNA repair capacity, unscheduled DNA synthesis (UDS) was
determined after (±)-a«h-BPDE-challenge. In order to assess the possible role of
poly(ADP-ribose) polymerase in an AR, poly(ADP-ribose) formation, as well as
decrease in lymphocytic NAD+ levels were determined after high (±)-anf/-BPDE
exposure. In PBLs, obtained from a limited number of individuals, (±)-anH-
BPDE-N^-deoxyguanosine ((±)-aM<i'-BPDE-N2-dG) adduct levels were measured
in order to assess whether pre-exposure reduces initial (±)-anfi-BPDE-DNA
binding.
Materials and methods
10 healthy non-smoking male humans who were not occupationally exposed to
genotoxic agents, were included into this study. All persons officially agreed to
participate by giving their written informed consent. The study protocol was
approved by the Medical Ethical Commission of the University of Limburg.
Averaged (± SD) age, alcohol and coffee consumption were 24.6 ± 3.2 years; 4.1 ±
2.9 glasses/week; 2.7 ± 2.1 cups/day, respectively.
o/ penp/iera/ Wood /ymp/iocyres and ce// cn/fure
Heparinized venous blood samples were collected and diluted by an equal
volume of RPMI 1640 medium, prior to isolation of PBLs on Lymphoprep™
(Nycomed, Norway). After centrifugation for 15 min at 800 g, interfaces were
collected and washed twice with RPMI 1640 medium. Mononuclear cells were
counted and cell suspensions were adjusted to a density of 1-2 x 106 cells/ml
RPMI 1640 medium which was supplemented with 15% (v/v) fetal calf serum, L-
glutamine, 100 U/ml penicillin, 100 ng/ml streptomycin. For the determination
of MN frequencies, UDS, NAD+-levels, poly(ADP-ribose) polymer formation and
relative (±)-anh'-BPDE-N2-dG adduct levels, cultures contained respectively at
least 3 x 10*, 1 x 106,3 x 106,35 x 106 and 15 x 10* cells.
Cells were grown in presence of 40 ul (approximately 52 ug)
phytohemagglutinin (PHA)/ml medium in culture flasks and tubes in a
humidified incubator at 37 °C under 5% CO2. All cell culture media and
supplements were obtained from Gibco, Europe.
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0/ ce//s wit/i f±)-a/if/-BPDE
(±)-anti'-BPDE (Midwest Research Institute, USA) stock solutions were prepared
in anhydrous dimethylsulfoxide (DMSO) and stored at -20 °C in the dark prior to
use. 24 h after initiation of the cultures, cells were given a priming dose of (±)-
rtnfi-BPDE, by adding stock solution by micropipette to the desired final
concentrations. PBLs were cultured for another 24 h and subsequently given a
challenge dose of (±)-<7Hf/-BPDE (t = 48 h), again by adding stock solution. PBLs
used for determination of poly(ADP-ribose) polymer formation were challenged
by 40.0 uM (±)-anti-BPDE. It cannot be excluded that this incubation
concentration may be cytotoxic to a certain degree, but we have shown in a
previous study (26) that concentrations of (±)-anti-BPDE in the order of 10-100
uM are required in order to detect carcinogen-induced poly(ADP-ribose) polymer
formation.
Adhering cells from cultures used for determination of relative (±)-fl«fi-
BPDE-N^-dG adduct levels and poly(ADP-ribose) polymer formation were gently
scraped off the culture flask, already before (±)-anfi'-BPDE challenge. This
enabled the processing of treated cultures for determination of poly(ADP-ribose)
polymer formation and (±)-rmfi-BPDE-N2-dG adduct levels as rapid as possible.
Determination 0/ wncronuc/ei
For determination of MN, cells were cultured in duplicate and cytochalasin B (cyt
B) (Sigma, Axel, The Netherlands) was added to a final concentration of 6 Hg/ml,
immediately after addition of the challenge dose. Cells were cultured for another
20 h prior to harvesting. In some experiments, cells were allowed to recover for
both 20 h and 30 h in presence of cyt B, prior to harvesting, in order to evaluate
whether the expression of an AR is influenced by asynchronicity of cell-
populations.
At the respective time points at the end of the culturing period, cultures were
hypotonized for 10 min in 75 mM KC1 and fixed with methanol : acetic acid (3 : 1,
v/v). Slides were prepared and stained for 20-30 min with 3% Giemsa. Prior to
microscopic analysis, slides were encoded and for each variable, at least 1000
binucleated cells were analyzed for the presence of MN. No distinction was made
between binucleated cells with one or more than one MN: multinucleated cells
were scored as one binucleated cell with one MN. The expected number of MN
for combined treatment was calculated according to the following formula:
[number of MN (expected)] = [number of MN primer treatment] + [number of
MN challenge] - [number of MN solvent control].
Results were considered as indicative for a preventive effect when the
observed number of MN was lower than the expected number.
Determination 0/ i/nscnedu/ed DAL4 synthesis
For determination of UDS (from duplicate cultures), within 15 min after
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addition of the challenge dose of (+)-flnf/-BPDE, [metfty/-3H]thymidine
(Amersham, England, sp. act. 83 Ci/mmol) was added to a final concentration of
10 (iCi/ml. Cells were cultured for another 24 h, prior to harvesting as described
above. The degree of (JDS was determined as described previously (26).
Processing of all slides was done with the same batch of Ilford K2 Scientific
Emulsion. Expected number of net grains/nucleus was calculated similarly as
described under 'Determination of micronuclei frequencies'. Results were
considered to indicate a protective mechanism when the observed UDS was
higher than the expected UDS.
For determination of lymphocytic NAD+ levels (in duplicate), 55 min after
challenge, cultures were centrifuged for 10 min at 400 g. Extraction of pyridine
nucleotides and determination of NAD+-levels were performed as described
elsewhere (26).
The expected decrease in NAD+-levels was calculated according to the
following formula:
[expected decrease in NAD+-levels] =
[NADMevels solvent control - NAD+-levels primer treatment] + [NAD+-levels
solvent control - NAD+-levels challenge].
When the observed decrease in NAD+-levels was higher than the expected
decrease, this was considered to represent a potentiation of pre-exposure on
challenge-induced lowering of NAD+-levels, and thus probably on poly(ADP-
ribosylation).
Defermz';iafi'oM o/ po/y(y4DP-n'bose) po/ymer /ormotion
At 15 and 35 min after challenge, aliquots of the cell suspension were transferred
to 50 ml culture tubes on ice and the material was precipitated for at least 30 min
in 20% TCA. The amount of ethenoribosyladenosine (eRado), which is the
characteristic nucleoside derived from poly(ADP-ribose) polymers, was
determined according to the procedure of Jacobson (28) with minor
modifications as described previously (26).
Because it was necessary to withdraw already at least 200 ml of blood from
each donor to perform singular experiments, it was impossible to culture cells in
duplicate for each variable. However, intra-assay variation, as judged from
triplicate determinations of eRado from purified [nrfen/n(?-l4C]poly(ADP-ribose),
using the same batches of purified [flrfeni«e-i4C]poly(ADP-ribose), DHB-Biorex,
enzymes and chemicals as used for all samples in these experiments, was ~ 3%.
Expected amounts of eRado, and thus the extent of poly(ADP-ribose) polymer
formation, were calculated according to the following formula:
[amount of eRado (expected)] = [amount of eRado primer treatment] + [amount
of eRado challenge] - [amount of ERado solvent control).
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Determination 0/ re/ofii;e (±)-anfi-BPDE-N2-dG addwcf feuds
15 min after challenge, duplicate cell cultures were transferred to 50 ml culture
tubes on ice and centrifuged for 10 min at 400 g. Extraction and digestion of
DNA was performed as described elsewhere (29) and (±)-nnh-BPDE-N2-dG
adduct levels were determined using standard adduct labeling, according to the
procedure of Reddy et al. (30). Chromatograms were visualized and quantified
using a Molecular Dynamics Phosphor Imager with Image Quant™ software. All
enzymes were from Boehringer Mannheim, Almere, The Netherlands.
To determine whether a protective effect of pre-exposure on MN formation
could be associated with induction of repair mechanisms, Spearman Rank
Correlation analysis was performed between all parameters, with calculated
differences between expected and observed values.
Results
In Figure 6.1, the induction of MN in isolated PHA-stimulated peripheral blood
lymphocytes obtained from two donors is shown after challenge with (±)-rj«h-
BPDE. A dose dependent induction of MN was observed in which the number of
MN reached a maximum at (±)-rtMtz'-BPDE concentrations higher than 1.0 |iM.
Also, at least for this experiment, the number of MN increased when cells were
held in presence of cyt B for 30 h, as compared to 20 h of cyt B incubation (not
shown). In our previous study (26), induction of UDS and decrease in NAD+-
levels were observed when in PBLs were exposed to (±)-anh-BPDE in a similar
concentration range. Therefore, a challenge concentration of 2.5 uM was applied
in subsequent experiments (except for determination of poly(ADP-ribose)
polymer formation as explained in the Methods section).
Figure 6.2 shows the effect of 24 h (±)-anfi-BPDE-pre-exposure on (±)-anM-
BPDE challenge-induced MN in PBLs, obtained from the same two donors. Cells
were allowed to recover for 20 h in presence of cyt B. Results are expressed as the
difference between expected and observed number of MN. For both donors,
when cells were pre-treated with 2.5 or 5.0 nM (±)-anf/-BPDE, differences
between expected and observed number of MN for combined treatment were
greater than zero. These findings are indicative for a preventive effect of (±)-
onti-BPDE pre-exposure on challenge-induced MN. When a higher pre-
exposure concentration (±)-anti'-BPDE was chosen, the preventive effect was no
longer present for donor 1, but still occurred for donor 2. Based on the
observation that the preventive effect of pre-exposure was highest, when cells
were treated with 2.5 nM (±)-a«/i-BPDE, this concentration was chosen in
subsequent experiments.
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Figure 6.1. Induction of micronuclei in isolated PHA-stimulated peripheral blood
lymphocytes, obtained from two donors, after challenge with (±)-an//-BPDE, 48 h
after initiation of cultures. PBLs were allowed to recover for 20 h in presence of
cytochalasin B. Donor 1: (A); donor 2: (O ).
5.0 10.0 15.0 20.0 25.0
concentration (±)-anri-BPDE of
pre-treatment (nM)
Figure 6.2. Effect of pre-exposure with low concentrations of (±)-anfi-BPDE on
induction of micronuclei in peripheral blood lymphocytes with 2.5 |iM (±)-a«/i-
BPDE. Donor 1: (A ); donor 2: (O ). PBLs were allowed to recover for 20 h in
presence of cytochalasin B. When the difference between the expected and
observed number of micronuclei is greater than zero, pre-exposure induces an
adaptive response (AR).
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Table 6.1. Effect of (±)-<infi-benzo[a]pyrene diolepoxide exposure on induction of micronuclei, induction of unscheduled DNA synthesis and NAD+-
levels, in isolated peripheral blood lymphocytes, with or without pre-exposure to 2.5 nM (±)-flnf;-benzo[a]pyrene diolepoxide. Mean values are shown,
obtained from duplicate cultures.
n
donor MN/
1000 binucleated cells*
(±)-anr/-
BPDE
(uM)
f = 24ft: 0.0 2.5x10'' 0.0 2.5x10''
r = 4Sft: 0.0 0.0 2.5 2.5
(expected)
2 "
3
4
5
6
7
8
9
10
UDS
(net grains/nucleus)
0.0 2.5x10"' 0.0 2.5x10"'
0.0 0.0 2.5 2.5
(expected)
5
5
4
4
8
17
9
21
10
8
4
4
4
2
3
20
6
16
9
17
17
4
10
8
33
31
72
45
24
54
6
(16)
7
(3)
8
(10)
8
(6)
51
(28)
38
(34)
56
(69)
40
(40)
32
(23)
27
(63)
1.4
1.8
1.0
1.8
1.9
1.5
0.9
1.9
1.2
1.2
1.4
1.6
1.3
1.6
1.0
0.8
0.5
0.8
0.9
0.4
8.7
6.1
4.1
3.3
6.2
3.6
4.4
4.9
4.8
3.3
6.3
(8.7)
6.3
(5.9)
4.6
(4.4)
6.1
(3.1)
5.1
(5.3)
4.1
(2.9)
6.9
(4.0)
6.8
(3.8)
4.4
(4.5)
3.6
(2.5)
NAD*
(pmol/lxlO* cells)
0.0
0.0
134.0
171.9
139.3
170.5
84.1
127.6
111.8
131.4
97.9
56.1
2.5x10"'
0.0
162.1
124.5
183.9
211.1
106.3
144.4
98.4
117.1
79.0
47.7
0.0
2.5
105.8
118.8
139.0
130.1
91.1
124.4
136.4
117.7
62.7
50.6
2.5x10"'
2.5
145.6
151.4
133.9
173.5
116.0
129.9
119.1
182.4
81.5
58.6
NAD* | 4
observed
(expected)
-11.6
(0.1)
20.5
(100.5)
5.4
(-44.3)
-3.0
(-0.2)
-31.9
(-29.2)
-2.3
(-13.6)
-7.3
(-11.2)
-51.0
(28.0)
16.4
(54.1)
-2.5
(13.9)
* PBLs were allowed to recover after challenge for 20 h in presence of cytochalasin B.
• " Three repeated measurements (day-to-day variation) with regard to the effect of (±)-<mfi-BPDE pre-exposure on (±)-i7rtii-BPDE challenge-induced MN were performed on PBLs obtained from donors 1 and 2.
Donor 1: mean (±SD) observed number of MN: 11.014.4; mean (±SD) expected number of MN: 18.7 ±25. Donor 2: mean (± SD) observed number of MN: 12.0 ± 5.0; mean (± SD) expected number of MN: 8.7 ±6.0.
In Table 6.1, the effects of (±)-o«/i-BPDE pre-exposure on challenge-induced MN,
UDS and decrease of NAD+-levels are shown for PBLs obtained from all 10
donors. For each donor, MN, UDS and NAD+-values were obtained within the
course of the same experiment. For donor 1 and donor 2, repeated measurements
were performed on different days with regard to the effect of pre-exposure on
challenge-induced MN (Table 6.1, legend). A preventive effect of pre-exposure to
2.5 nM (±)-flnfi'-BPDE on (±)-anh'-BPDE-induced MN formation was repeatedly
observed for PBLs obtained from donor 1. For PBLs, obtained from donor 2, a
minor preventive effect of pre-exposure was detectable once out of three
experiments (which is shown in Figure 6.2). In the two other experiments
performed with PBLs from this donor, pre-exposure potentiated more or less the
challenge-induced MN formation.
Concerning the effect of pre-exposure on challenge-induced MN for all
donors, a very clear preventive effect of pre-exposure on MN formation was
observed for PBLs obtained from donors 1, 3, 7 and donor 10. Pre-exposure
tended to have no (donor 8) or even a more or less additive or synergistic effect
on challenge-induced MN in PBLs obtained from other donors (donors 2, 4, 5, 6,
9). In general, pre-exposure by itself had no or little effect on induction of MN
frequencies.
PBLs obtained from donor 1 up to and including 4 were also allowed to
recover for 30 h in presence of cyt B, after challenge. No preventive effect of pre-
exposure was observed after recovery for 20 h in presence of cyt B (donors 2 and
4), nor after recovery for 30 h. With this prolonged recovery time however,
cytotoxic effects became apparent, as indicated by an increase in cellular debris
and reduction in the number of binucleated cells.
Pre-exposure by itself had little effect on the induction of UDS. Concerning the
effect of pre-exposure on (+)-<7Hfi-BPDE-induced DNA repair, for 6 donors UDS
levels were higher than expected (donors 2, 4, 6, 7, 8 and 10). For the other
donors, pre-exposure decreased challenge-induced UDS levels (donor 1) or had
little or no effect (donors 3, 5, 9).
In PBLs obtained from most donors, NAD+-levels were decreased after
challenge for 55 min in comparison to solvent control treated cells (donors 1, 2, 4,
8, 9,10). The effect of pre-exposure itself on lymphocytic NAD+-levels is unclear.
In pre-exposed PBLs, NAD+-levels were found to be higher (donors 1, 3, 4, 5, 6) as
well as lower (donors 2, 7, 8, 9, 10) in comparison to levels found in solvent
controls. The difference between observed decrease in NAD+-levels and
calculated expected decrease in NAD+-levels was only positive for donors 3, 6
and 7. When the actual values were considered for these individuals, no clear
decrease in NAD+-levels was observed as a consequence of (±)-fl«f/-BPDE
challenge.
In Table 6.2, results on the effect of pre-exposure on (±)-fl«f/-BPDE-induced
poly(ADP-ribosylation) are shown. In PBLs obtained from most individuals, pre-
exposure to (±)-fl«f/-BPDE or DMSO alone did not result in formation of
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Table 6.2. Effect of (±)-a«(i-BPDE exposure, during 15 and 35 minutes, on induction of poly(ADP-ribosylation), in isolated peripheral blood Q
lymphocytes, with or without pre-exposure to 2.5 x 10-3 uM (±)-anri-BPDE. ERado represents ethenoribosyladenosine. Results of 10 healthy donors are •§
shown. J
donor
1
2
3
4
5
6
7
8
9
10
(+)-anf/-BPDE
(uM)
r = 24 ft:
f = 45 ft:
poly(ADP-ribosylation)
after 15 minutes challenge treatment
(pmol eRado/1 x 10» cells)
0.0
0.0
12.3
43.0
N D *
ND
ND
ND
ND
22.8
2.5x10'
0.0
4.5
65.9
N D
N D
ND
ND
ND
ND
0.0
40.0
120.2
121.4
35.4
52.2
92.4
63.5
ND
23.3
2.5x10"'
40.0
(expected)
273.4
(112.4)
159.1
(1443)
25.2
(35.4)
31.7
(52.2)
66.5
(92.4)
45.6
(63.5)
ND
(ND)
50.7
(0.5)
poly(ADP-ribosylation)
after 35 minutes challenge
(pmol eRado/1 x 108 cells)
0.0
0.0
13.8
37.3
ND
ND
ND
ND
ND
ND
2.5x10"'
0.0
6.5
26.1
N D
ND
' ND
ND
ND
N D
treatment
0.0
40.0
109.4
148.8
141.4
88.9
129.9
83.8
118.9
10.9
2.5x10"*
40.0
(expected)
225.2
(102.1)
124.0
(137.6)
105.0
(141.4)
82.1
(88.9)
104.8
(129.9)
74.3
(83.8)
107.3
(118.9)
71.9
(10.9)
' not detected
iw? response
detectable poly(ADP-ribose) polymers, determined 48 h after initiation of the
cultures. Challenge with 40.0 |iM (±)-anf/-BPDE resulted in evidently elevated
poly(ADP-ribosylation), in comparison to solvent control treated cultures. An
exception are PBLs, obtained from donor 8, in which polymer formation could
not be detected after 15 min of (±)-anfi-BPDE challenge. When the effect of pre-
exposure on challenge-induced poly(ADP-ribosylation) is considered, only in
PBLs obtained from donor 1 and donor 10 observed eRado levels were
considerably higher than expected eRado levels. In PBLs obtained from other
donors, the degree of poly(ADP-ribosylation), determined in cultures after
combined (±)-flnh'-BPDE-treatment, was lower than or approximately equal as
expected, taken into account the intra-assay variation of ~ 3%.
In PBLs obtained from these 10 donors, no significant associations were
observed between MN, UDS, NAD+ and poly(ADP-ribosylation), using the
calculated differences between expected and observed values (Spearman Rank
Correlation).
In PBLs, obtained from donor 1 and donor 2, the effect of (±)-a«h-BPDE pre-
exposure on challenge-induced (±)-onf/-BPDE-N2-dG adduct formation was
determined. No adducts were visible in DNA obtained from PBLs treated only
with DMSO or with 2.5 nM (±)-fl«fi-BPDE. Results, obtained from all challenged
cultures are shown in Figure 6.3, and expressed as relative (±)-a«fi-BPDE-N2-dG
adduct levels. In PBLs, obtained from both donors, pre-exposure to 2.5 nM (±)-
fliifi-BPDE did not alter significantly the formation of (±)-tf)if/-BPDE-N2-dG
adducts, induced by the challenge.
o
Q
5
120 -
100 •
8 0 -
6 0 -
40 -
2 0 -
o-
• •
• •
• •
• •
T
t = 24h: 0.0 2.5x10-3 0.0 2.5x10-3
t = 48h: 2.5 2.5 2.5 2.5
concentration (±)-anfi-BPDE (|iM)
Figure 6.3. Effect of pre-exposure with 2.5 nM (±)-nn(i-BPDE on adduct formation
by exposure to 2.5 uM (±)-anfi-BPDE. Donor ! : ( • ) ; donor 2: ( • ).
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Results from the present study indicate that pre-exposure of PBLs, obtained from
some but not all donors, to (±)-n«f/-BPDE seems to prevent MN formation,
induced by a higher concentration of (±)-n«h'-BPDE at a later time point. Thus,
for a subpopulation of responders, pre-exposure of human PBLs with
enantiomers of the reactive metabolite from the ultimate carcinogen
benzo[a]pyrene is capable of inducing protective mechanisms similar as observed
for ionizing radiation and radiomimetic agents.
The fact that (±)-anti-BPDE induces MN in human PBLs, indicates that DNA
double strand breaks must have been formed sometimes between the time point
of initial (±)-n>ih'-BPDE-DNA interaction and block of cytokinesis at the end of
mitosis. It is unlikely that interaction directly leads to helix distortion in such a
way that double-strand breaks arise. Instead, (±)-anf/-BPDE has been found to
induce single-strand breaks in PBLs and Hela cells (31-33), which could be the
consequence of action of AP endonucleases on unstable N7-G adducts. In ui/ro,
(±)-anfi'-BPDE treatment of isolated DNA resulted in formation of this adduct
(34-36). Alternatively, nucleotide excision repair of covalent (±)-flnfi-BPDE-N2-
dG adducts temporarily causes formation of single-strand breaks. Nucleotide
excision repair-related processes occur in (±)-n/ih-BPDE-treated normal human
cells (Table 6.1,26,29,31,32,37), but not in (±)-anf/-BPDE-treated XP-cells (37).
When gap-filling and ligation of base excision repair and/or nucleotide excision
repair is not completed prior to the onset of the S-phase, single strand breaks may
be converted to daughter strands with double-strand breaks which, when left
unrepaired, finally can be demonstrated as MN (38).
As is clear from Figure 6.1, interindividual differences exist in (±)-anf»-BPDE-
induced MN, which may be related to interindividual differences in repair
capacity. Alternatively, in response to stimulation to proliferation by PHA,
interindividual differences may arise in cell-cycle distribution. This could result
in differential loss of cell populations, which are in an earlier phase than G2, and
which are perhaps more sensitive at time of challenge. The occurrence of
asynchronous cell-populations, at time of challenge, may also explain the
increase in number of MN, when cells were allowed to recover for an additional
10 h in presence of cyt B (data not shown).
Results show that, whenever (±)-fl«f/-BPDE pre-exposure induces a
preventive effect with regard to challenge-induced MN, it is concentration-
dependent. Other studies applying various cytogenetic endpoints, such as
chromosomal aberrations and MN, also indicate that the AR in human PBLs,
induced by for example MNNG, X-ray, hydrogen peroxide and mitomycin C
depends on the concentration during pre-exposure (8,13,17,20).
In PBLs obtained from 2 out of 4 donors, an AR was neither detected after
recovery for 20 h nor after 30 h in presence of cyt B. Further, with prolonged
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recovery time in presence of cyt B, cytotoxic effects were observed. Therefore,
despite the fact that we cannot exclude the possibility that an eventual AR may
remain undetected by sampling different subpopulations only at on time point
after challenge treatment, no prolonged recovery times in presence of cyt B were
applied for the other 6 donors.
When all donors are considered, it is evident that intra- and inter-individual
differences exist with regard to the protective effect by (±)-flHf/-BPDE pre-
exposure on challenge-induced MN formation. Inter-individual differences exist
in the degree of AR induced by various pre-conditioning agents for X-rays (13,39)
mitomycin C (17,18) and MNNG (20,40). Moreover, Bauchinger et al., (41)
reported the absence of an AR for X-rays in PBLs obtained from two donors.
These data suggest that induction of different protective DNA repair
mechanisms acting on various kinds of DNA damage in PBLs, may be partially
genetically predisposed. Given the results obtained from donor 2 (Table 6.1,
legend), in whom the preventive effect of pre-exposure was only observable in
one out of three repeated experiments, non-genetic factors may also explain part
of the recognized intra-individual differences in (±)-flnh'^ BPDE-induced AR.
Only in PBLs, obtained from donor 1 and donor 10, formation of poly(ADP-
ribose) polymers after challenge during 15 and 35 min with 40.0 uM (±)-awti-
BPDE was considerably higher as a consequence of pre-exposure. Also, pre-
exposure resulted in a reduction in the number of MN induced by 2.5 uM (±)-
rt/!f!-BPDE in PBLs obtained from these two donors. In these two individuals,
the potentiating effect of pre-exposure on induction of poly(ADP-ribosylation)
was not reflected by an enhanced decrease of lymphocytic NAD+ levels after
exposure for 55 min to 2.5 uM (±)-n«fi-BPDE. In addition, in PBLs obtained from
donor 7, a small preventive effect of pre-exposure with regard to challenge-
induced number of MN was observed, while pre-exposure had no potentiating
effect on challenge-induced poly(ADP-ribosylation) or reduction in lymphocytic
NAD+-levels. Moreover, when results from all individuals are considered, no
associations were found for the differences between expected and observed
number of MN versus the differences between expected and observed induction
of poly(ADP-ribosylation) and reduction in NAD+-levels, respectively. Thus,
results indicate that induction of an AR by pre-exposure to low levels of (±)-
(7Mh'-BPDE might not be linked to induction of processes indicative for
poly(ADP-ribose) polymer formation. However, it has to be considered that this
may be explained by the difference in challenge doses of (±)-anh-BPDE, required
for the induction of detectable poly(ADP-ribosylation) (40.0 uM) and MN
frequencies (2.5 uM).
In contrast, poly(ADP-ribose) polymerase inhibitors were found to inhibit the
PH]thymidine- X-ray- and bleomycin-induced AR for X-rays in PBLs (8,10,14,24).
However, it must be mentioned that in these studies high concentrations of
poly(ADP-ribose) polymerase inhibitors were applied which may cause
additional cellular metabolic effects (42).
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In some donors, the extent of UDS after combined (±)-<?nfi-BPDE treatment
tended to be higher than expected, while no adaptation with regard to MN was
observed (donor 2, 4, 6). Also in PBLs, obtained from donor 1, an adaptation with
regard to MN was repeatedly noticed, while the extent of DNA repair synthesis,
measured by UDS after combined treatment, even tended to be lower than
expected. This suggests that the induction by pre-exposure of certain
mechanism(s) involved in excision repair of certain lesions which can be
observed as UDS, e.g. long-patch repair of covalent (±)-rt«f/-BPDE-DNA adducts,
is not responsible for prevention of (±)-flnh-BPDE-induced MN formation. In
addition, pre-exposure did not interfere substantially with challenge-induced (±)-
<i«f/-BPDE-N2-dG adduct formation, indicating that the observed AR is likely
not due to reduction of initial (±)-<JM//-BPDE-DNA binding.
In conclusion, pre-exposure of PHA-stimulated human PBLs obtained from
some but not all individuals, to low levels of (±)-flnh'-BPDE results in a decrease
in micronuclei frequencies, induced by high (±)-awH-BPDE-exposure.
Adaptation of DNA repair processes in relation to low environmental exposure
to polycyclic aromatic hydrocarbons may therefore occur in human
subpopulations m i>ii>o. The preventive mechanism was found to depend on
the concentration of (±)-anh'-BPDE used during primer treatment. Finally, no
clear associations were found between the reducing effects of pre-exposure on
micronuclei formation, and the modulation of processes related to DNA excision
repair and poly(ADP-ribosylation).
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Abstract
In response to DNA damage, in particular DNA strand breaks, the proposed roles
for normal tumour suppressor protein p53 are to increase the period of time
available for DNA repair prior to replication, or to direct damaged cells into
programmed cell-death. Since treatment of mammalian cells with (±)-a/ifi-
benzo[a]pyrene diolepoxide ((±)-anfz'-BPDE) -a mixture of metabolites
comprising the most reactive (+)-a«fi-enantiomer of the full environmental
carcinogen benzo[a]pyrene- has been shown to result in DNA strand break
formation, aim of the present study was to investigate whether p53
accumulation is induced in (±)-arcfi-BPDE-treated phytohemagglutinin-
stimulated human peripheral blood lymphocytes (PBLs). Both
immunocytochemical and immunoblot analysis indicated that treatment of PBLs
with (±)-fl«fj'-BPDE results in p53 accumulation. Optimal accumulation was
observed at 2.5 uM, while no increase of p53 levels was observed at
concentrations lower than 2.5 uM and higher than 10 ^M. Further, (±)-anfi-
BPDE-induced p53 accumulation in PBLs was found to be dependent of the
exposure duration, with accumulation up to 24 h of treatment. Treatment of
PBLs with 2.5 uM of (±)-anH-BPDE and 1 mM of 3-aminobenzamide, an
inhibitor of the DNA strand break-dependent enzyme poly(ADP-ribose)
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polymerase, resulted in increased p53 levels, in comparison to cells treated with
(±)-anf/'-BPDE alone. This combination also potentiated the frequency of (±)-
<wf/-BPDE-induced micronuclei. These findings suggest that (±)-anfi-BPDE-
induced DNA strand break formation is responsible for the observed p53
accumulation. It is concluded that p53 accumulation may implicate a protective
mechanism in polycyclic aromatic hydrocarbon-treated human peripheral blood
lymphocytes. It is unlikely that poly(ADP-ribose) polymer formation is a
prerequisite in the process of p53 accumulation, as triggered by DNA strand-break
inducing agents like (±)-anf/-BPDE.
Introduction
The p53 protein was initially identified as part of a protein complex with large T
antigen in SV-40 transformed cells (1). Later, it was demonstrated that p53 is a
tumour suppressor gene. First, approximately 60% of all human cancers have
p53 gene mutations. In most cases, these alterations consist of missense
mutations with loss of heterozygosity (2), thus resulting in loss of normal
functional p53 protein during tumorigenesis. Especially individuals with Li-
Fraumeni syndrome (3), having inherited defects in one of the p53 alleles, are
predisposed to cancer. Secondly, mice with mutant or absent p53 gene alleles
develop tumours at higher frequency that normal mice (4).
When treated with agents that cause DNA damage, for example UV radiation
(5-7); y-rays (8-10); bleomycin, actinomycin D (11); MMS (12); mitomycin C,
cisplatin and nucleotide analogues (13-14), mammalian cells respond by
enhancement of intranuclear p53 protein levels. The introduction of strand
breaks into DNA is assumed to initiate this process (11).
Accumulation of p53 levels, under conditions of DNA damage, may result in
increased transcription of at least three downstream effector genes with p53
responsive elements: W/\F2/C/P2 (15); G«rfrf45 (10,16-17) and mrfm2 (18-20).
The 21 kDa gene product of W/4F2/C/P2 inhibits the activity of cyclin-dependent
kinases (21) which in turn prevents Gl to S-phase transition. Activation of this
mechanism could provide more time for repair of DNA damage prior to DNA
replication (9). In line, cells lacking p53 fail to undergo Gl arrest in response to y-
ray-induced DNA damage (8,22). Also, enhanced p53 levels may contribute to
DNA damage-induced programmed cell-death (9,13,23), by repressing other genes
like bd-2 the products of which inhibit apoptosis. Thus, p53 accumulation may
prevent the onset of carcinogenesis by selection against heavily damaged cells, in
favour of efficiently repaired cells (24).
Treatment of mammalian cells with (±)-flnfi-benzo[a]pyrene diolepoxide ((±)-
flHfi-BPDE), a mixture of metabolites comprising the most reactive enantiomer
of the full environmental carcinogen benzo[a]pyrene, results in DNA strand
break formation and induction of DNA repair processes (25-34). In a previous
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study, we have shown that, after treatment of isolated human peripheral blood
lymphocytes with (±)-anfi-BPDE, the activity of the DNA repair enzyme
poly(ADP-ribose) polymerase [NAD+ ADP-ribosyltransferase, EC 2.4.2.30]
(PADPRT) is rapidly induced (35). This enzyme catalyzes rapid transfer of
adenosine diphosphate ribose units from nicotinamide adenine dinucleotide to
linear and branched poly(ADP-ribose) polymers. Histones and other proteins,
including PADPRT itself, are acceptor molecules for poly(ADP-ribose) polymers.
An absolute requirement for this enzyme activation is the presence of DNA
single or double strand breaks (36).
Thus, it seems likely that, besides ionizing radiation and chemotherapeutic
agents, reactive metabolites of polycyclic aromatic hydrocarbons can also trigger
p53 dependent DNA-damage inducible pathways. As indicated, poly(ADP-
ribosylation) and p53 accumulation both require the presence of DNA strand
breaks. Further, in mammalian cells treated with DNA damaging agents,
poly(ADP-ribose) polymer formation occurs within minutes (35,37) while
accumulation of p53 can only be demonstrated after one to several hours (7,13).
Therefore, poly(ADP-ribosylation) may represent one of the first steps in the
cascade leading to DNA damage-induced p53 accumulation. At present, it is
unknown which process(es) translate(s) the signal of DNA strand breaks into p53
protein accumulation.
Aim of the present study was therefore to investigate whether (±)-flwf/-BPDE
treatment induces nuclear p53 accumulation in isolated human peripheral blood
lymphocytes. Further, the possible involvement of poly(ADP-ribose) polymer
formation in this process, in relation to DNA strand breaks and chromosomal
damage as determined by micronuclei frequencies, was studied.
Materials and methods
All chemicals were from Sigma (Axel, the Netherlands), unless otherwise
specified. All cell culture media and supplements were obtained from Gibco
(Europe) (for PBLs) and Life Technologies (Europe) (for BEAS-2B).
Sub/ecfs, ;so/ah'o« o/ pm'p/iera/ Wood /ymp/iocytes a«rf ce// cu/furing
10 ml of heparinized venous blood samples were collected from 8 healthy non-
smoking male human volunteers. All subjects had officially agreed to donate
blood by giving their written informed consent. Average age, alcohol and coffee
consumption of the subjects were respectively: 25.1 ± 3.4 years; 4.0 ± 3.0
glasses/week; 2.9 ± 2.3 cups/day (mean ± SD). Blood was diluted by an equal
volume of RPMI 1640 medium, prior to isolation of PBLs on Lymphoprep™
(Nycomed, Norway). After centrifugation for 15 min at 800 g, interfaces were
collected and washed twice with RPMI 1640 medium. Mononuclear cells were
counted and cell suspensions were adjusted to a density of 1-2 x 10*> cells/ml
RPMI 1640 medium which was supplemented by 15% (v/v) FCS, L-glutamine,
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100 U/ml penicillin, 100 Hg/ml streptomycin. Cells were cultured in presence of
40 ul (± 52 ng) PHA/ml medium in 10 ml culture tubes in a humidified
incubator at 37 °C under 5% CO2.
SV40-immortalized BEAS-2B human bronchial epithelial cells (BEAS) (38)
were kindly provided by Dr. C. C. Harris (NCI, Bethesda, U.S.A.). Cells were
cultured in serum-free keratinocyte growth medium, supplemented with 50
(ig/ml bovine pituitary extract, 5 ng/ml epidermal growth factor, 5 (ig/ml
human transferrin, 50 ug/ml gentamicin, 250 ug/ml fungizone, 50 ng/ml
hydrocortisone. BEAS-2B cells were grown in plastic cell culture flasks in a
humidified incubator at 37 °C under 5% CO2.
fragment 0/ ce//s
PDE ((+)-7p,8a-dihydroxy-9a,10a-epoxy-7,8,9,10-tetrahydrobenzo[a]-
pyrene, Midwest Research Institute, U.S.A.) stock solutions were prepared in
anhydrous DMSO and stored at -20 °C in the dark prior to one-off use. 48 h after
initiation of the cultures, cells were treated with (±)-anh'-BPDE or DMSO. PBLs
treated with act D served as a positive control. This topoisomerase-targeted
compound has been reported to induce p53 accumulation in human myoblastic
leukemia cells (8), immortalized mouse fibroblasts (13), and human prostatic
adenocarcinoma cells (11). As an additional positive control, SV40-immortalized
human bronchial epithelial cells, BEAS-2B, (38) were used. These cells have been
shown to contain detectable wild-type p53 protein (39).
In order to study the potential role of poly(ADP-ribosylation) in (±)-anfi-
BPDE-induced DNA damage and p53 accumulation, the PADPRT inhibitor 3-
aminobenzamide (37,40) was added to PBLs, prior to addition of (±)-fl«r/-BPDE.
For determination of p53 induction, at the respective time points after treatment,
cells were washed twice with ice-cold PBS and processed for
immunocytochemical staining and immunoblotting. For determination of
micronuclei frequencies, PBLs were cultured in duplicate and cytochalasin B was
added to a final concentration of 6 ug/ml, immediately after addition of (±)-<niH-
BPDE and 3-aminobenzamide. Cells were cultured for another 20 h prior to
harvesting as described under Determination 0/ microm/c/ei /re(yuenci'es.
Rabbit polyclonal antibody CM-1, raised against a full-length recombinant
human p53, was kindly provided by Prof. D. Lane (Medical Sciences Institute,
Dundee, Scotland). Mouse monoclonal IgG2b antibody DO7, raised against
recombinant human p53 protein, was obtained from Novocastra Laboratories
(Newcastle upon Tyne, UK).
For immunocytochemical staining a biotinylated goat anti-rabbit IgG (Vector
Laboratories, Burlingame, California, U.S.A.) was used as secondary antibody. For
immunoblotting, an alkaline phosphatase-conjugated goat anti-rabbit IgG
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(against CM-1) (Vector Laboratories, Burlingame, California, U.S.A.), or a
mixture of alkaline-phosphatase-conjugated rabbit anti-mouse antibodies
(DAKO, Denmark) (against DO-7) were applied as secondary antibodies.
After washing, ethanol (-20 °C) was added drop-wise to a final concentration of
70% (v/v), while cultures were gently vortexed. Cultures were stored for 30 min
at -20 °C and resuspended in a small volume of 70% (v/v) ethanol. Part of the
suspension was pipetted on slides and air-dried.
Slides were dehydrated and incubated for 15 min in 0.3% H2O2 in methanol,
rinsed with bidest and boiled for 10 min in 10 mM sodium citrate pH 6.0. Then,
slides were incubated in a humidified atmosphere at room temperature for 1 h
with CM-1 (diluted 1 : 500, v/v) in 1.5% normal goat serum in PBS, rinsed in PBS
and incubated for 30 min with secondary antibody. After washing with PBS,
slides were incubated for 30 min with fluorescein avidin D (Vector Laboratories,
Burlingame, California, U.S.A.) (diluted 1 : 500 in 1.5% normal goat serum in
PBS, v/v) washed, dehydrated, counterstained by propidium iodide and
examined for nuclear immunostaining, using a Zeiss Axioskop fluorescence
microscope.
After treatment and washing, PBLs were lysed, at a density of 1 x 10^/40 |il lysis
buffer containing 6 mM Tris-HCl pH 6.8, 2 mM EDTA, 10% glycerol, 0.1% sodium
azide, 2 mM phenylmethylsulfonylfluoride, 0.1% aprotinin, 3.3% SDS and 5% fi-
mercaptoethanol. Ureum (final concentration: 6% w/v) and bromine phenol
blue (final concentration: 0.1% w/v) were added, and lysates were boiled for 10
min. Lysates were centrifuged and proteins in supernatants (equivalent to 8 x 10^
cells) were separated on a 10% SDS-polyacrylamide gel and transferred on to
GenescreenP/us™ nitrocellulose membrane (NEN Research Products, Dupont,
Boston, U.S.A.), using a Biorad mini protean IF" (Biorad, Europe) system. After
drying, membranes were washed for 30 min with 0.5% (w/v) Non Fat Dry Milk
(Nutricia, The Netherlands) in 10 mM Tris, 150 mM NaCl, 0.05% Tween, pH 8.0
(NFDM/TBST), rinsed in TBST and incubated for 60 min with primary antibody
(CM-1 or DO7) (diluted 1 : 1500, v/v in NFDM/TBST). Then, membranes were
incubated with secondary antibody for 30 min (1 : 500, v/v in NFDM/TBST).
Thereafter, membranes were washed with 0.1 M Tris, 0.1 M NaCl, 50 mM MgC^,
pH 9.0 (B3) and incubated for 1 h with 22 ul 4-nitro blue tetrazolium chloride
(Boehringer Mannheim, 100 mg/ml) and 17 |il 5-bromo-4-chloro-3-indolyl-
phosphate (Boehringer Mannheim, 50 mg/ml) in 5 ml B3, in the dark. To stop
precipitation, membranes were washed in 20 mM Tris, 5 mM HC1 pH 8.0 and
airdried.
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At the end of the culturing period, cultures were hypotonized for 10 min in 75
mM KC1 and fixed with methanol : acetic acid (3 : 1, v/v). Slides were prepared
and stained for 20-30 min with 3% Giemsa. Prior to microscopic analysis, slides
were encoded and for each variable, at least 1000 binucleated cells were analyzed
for the presence of micronuclei. No distinction was made between binucleated
cells with one or more than one micronuclei. Slides were analyzed by one well-
trained observer and double-checked by an independent second observer.
Results
PBLs obtained from two healthy human donors were treated with (±)-anfi-BPDE
in concentrations ranging from 0.0 uM to 40.0 fiM and harvested 24 h after
addition of the carcinogen. In solvent-control treated PBLs obtained from both
donors, a faint background staining covering both cytoplasma and nucleus was
observable in all cells. When .cells were treated with 0.01 or 0.1 |iM (±)-anh-
BPDE, only an extremely small increase in nuclear immunofluorescence could
be seen. Treatment with higher concentrations of (±)-anfi-BPDE (2.5 uM and 10.0
uM) evidently resulted in increased immunofluorescence, in comparison to
solvent control treated cells, within nuclei of some, but not all lymphocytes.
(Figure 7.1). Also, treatment of PBLs with 2.5 uM (±)-anfi-BPDE resulted in
increased micronuclei frequencies (Figure 7.5). When PBLs were treated with 40.0
uM (±)-nnfi-BPDE, no positively stained cells were visible anymore. A repeated
experiment, within a period of two months, performed on PBLs from one of
these donors, yielded similar results. Immunoblotting of lysates from (±)-fl«fi-
BPDE-treated PBLs confirms detectable induction of p53 accumulation after
treatment of PBLs with 2.5 or 10 uM (±)-<mh-BPDE, for 24 h (Figure 7.2).
Concerning the positive controls, treatment of PBLs with 2.0 uM act D during
24 h resulted in all 8 donors in increased nuclear accumulation of p53 (Figure 7.3,
data shown for one donor). Further, in untreated SV-40 transformed BEAS-2B
cells, p53 protein was detected (Figures 7.2-7.4). No immunocytochemical
staining was detectable in (±)-anh'-BPDE-treated PBLs, when incubation with
primary antibody was omitted.
In PBLs, obtained from donor 1 and donor 2, induction of nuclear p53
accumulation was found to depend on the exposure duration. After treatment
for 35 min with 2.5 uM (±)-a»ifi-BPDE, only minor nuclear p53 accumulation
was visible in a few PBLs. With incubation periods up to 24 h, both intensity of
nuclear staining and number of stained nuclei increased. At any time point
cellular heterogeneity was observed with regard to nuclear p53 accumulation.
Immunoblot analysis (Figure 7.3) confirms the time-dependency of (±)-flnfi-
BPDE-induced p53 accumulation in human PBLs.
In PBLs obtained from the 6 additional donors, increased nuclear
accumulation of p53 was again observed when cells were treated with 2.5 |iM
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(magnification lOOOx)
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Figure 7.1. Cellular heterogeneity in induction of nuclear p53 accumulation in PHA-stimulated PBLs
after treatment for 24 h with DMSO or 2.5 uM (±)-an/i-BPDE. Cells were processed for
immunocytochemistry as described under Materui/s nnd mef/iods, using antibody CM-1.
DMSO 0.01 0.1 2.5 10 40 BEAS
•L •p53
Figure 7.2. Determination of p53 accumulation in PHA-stimulated PBLs after
treatment for 24 h with various concentrations (uM) of (+)-an(i-BPDE. Cellular
proteins (equivalents of 8 x 1CP cells/lane) were separated by SDS-polyacrylamide
gelelectrophoresis, transferred to GenescreenP/ns™ nitrocellulose, incubated with
CM-1 and alkaline phosphatase-conjugated goat anti-rabbit IgG, and developed.
Right lane shows basal p53 levels in untreated SV40-immortaIized human
bronchial epithelial cell line BEAS-2B.
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Figure 7.3. Time-dependency of p53 accumulation in PHA-stimulated PBLs, after treatment with 2.5
uM (±)-an(i-BPDE. Immunoblot analysis was performed similarly as described in Figure 7.2. Two
right lanes show p53 levels in PBLs treated for 24 h with 2.0 (iM act D and p53 levels in untreated
SV40-immortalized human bronchial epithelial cell line BEAS-2B.
donor I
0 0.1 10
2.5 uM (±)-an/i-BPDE p53
donor 2
0 0.1 10
2.5 MM (±)-flMii-BPDE p53
0.1 10 BEAS
0 uM (±)-a«ti-BPDE p53
Figure 7.4. Effect of inhibition of PADPRT on (±)-an!i-BPDE-induced p53 accumulation. PBLs
obtained from two donors were treated for 24 h with 2.5 uM (±)-anti-BPDE, in combination with
various concentrations (mM) of 3-AB. Determination of p53 levels was performed similarly as
described in Figure 7.2, except that DO-7 was used as primary antibody, in combination with
alkaline-phosphatase-conjugated rabbit anti-mouse antibodies. 3-AB treatment alone did not
result in detectable p53 accumulation (lower lanes). Lower right lane shows basal p53 levels in
untreated SV40-immortalized human bronchial epithelial cell line BEAS-2B.
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(±)-anfi'-BPDE for 24 h and processed for immunocytochemistry.
Figure 7.4 displays the effect of inhibition of poly(ADP-ribosylation) on (±)-
anfi-BPDE-induced p53 accumulation. When PBLs were treated with 3-AB
alone, no induction of p53 accumulation was detected. Combined treatment of
PBLs, obtained from two donors, with 2.5 fiM (±)-anfi-BPDE and low
concentrations of 3-AB (up to 1-2 mM) for 24 h resulted in increased
accumulation of p53 in comparison to treatment with (±)-<2nf/-BPDE alone.
When higher concentrations of 3-AB were applied (5-10 mM), (±)-awf/-BPDE-
induced p53 accumulation gradually decreased below levels found in PBLs,
treated with (±)-fl«h'-BPDE alone. A similar effect of 3-AB treatment on (±)-
<inf/-BPDE-induced p53 accumulation was observed when PBLs, obtained from
donor 1, were treated for a shorter period, e.g. 5 h (not shown).
In Figure 7.5, the effect of PADPRT inhibition on (±)-rtH;/-BPDE-induced
micronuclei, as marker of DNA strand breakage and chromosomal damage, is
shown. Treatment of PBLs with 2.5 uM (±)-anfi'-BPDE evidently resulted in
increased micronuclei frequencies, in comparison to solvent control treated
PBLs. When PBLs were treated with 2.5 uM (±)-anf/-BPDE in combination with
1 mM 3-AB, a more than 2-fold increase in micronuclei frequencies was
observed, in comparison to treatment with (±)-a«f;-BPDE alone. When higher
concentrations 3-AB were used in combination with 2.5 |iM (±)-rt»ifi-BPDE, the
number of micronuclei was approximately equal to or slightly higher than the
number found in cultures, treated only with (±)-a/7f/-BPDE. Treatment of PBLs
with 3-AB alone did not result in increased micronuclei frequencies. No direct
association was observed between the concentration-dependent effects of 3-AB
treatment on the extent of (±)-anf/-BPDE-induced p53 accumulation and the
extent of (±)-<mfz-BPDE-induced MN induction (Figure 7.4 and Figure 7.5).
0.0 2.0 4.0 6.0 8.0 10.0
concentration 3-aminobenzamide (mM)
Figure 7.5. Effect of inhibition of PADPRT on (±)-«Mli-BPDE-induced micronuclei
in PHA-stimulated PBLs. Cells were treated with DMSO (O ) or 2.5 |iM (±)-anfi-
BPDE ( • ) in combination with various concentrations of 3-AB. Results are obtained
from duplicate cultures and expressed as number of micronuclei per 1000 binucleated
cells.
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Discussion
In this study, evidence is presented that treatment of isolated human peripheral
blood lymphocytes with (±)-arcf/-benzo[a]pyrene diolepoxide results in nuclear
accumulation of tumour suppressor protein p53. A dose dependent induction of
p53 accumulation was observed. Maximal induction of p53 accumulation was
observed when cells were treated with 2.5 |iM (±)-flnf/-BPDE, while treatment
with lower concentrations did not induce detectable p53 accumulation. p53
accumulation was absent when PBLs were treated with concentrations of (±)-
anf/-BPDE higher than 10 nM. In addition, treatment with 2.5 nM (±)-anfi-
BPDE caused a clear increase in micronuclei frequencies in cytokinesis-blocked
PBLs.
(±)-an//-BPDE treatment of naked DNA HI t'/fro and of mammalian cells ex
p/i>o has been shown to cause formation of several DNA adducts, including
stable N^-deoxyguanosine, unstable N7-guanine as well as deoxycytidine and
deoxyadenosine adducts (26,27,41-43). Action of AP-endonucleases on unstable
N7-guanine adducts or action of nucleotide excision repair mechanisms on
covalent N^-dG adducts may result in DNA single strand break formation. In (±)-
0H//-BPDE treated mammalian cells, DNA excision repair phenomena and
DNA strand break formation have been observed (26,29,31,33,34,44). Besides
being related to possible carcinogen-disturbed mitotic spindle formation, (±)-
flufi'-BPDE-induced micronuclei may therefore reflect unrejoined single strand
breaks that may have been converted to double strand breaks during the S-phase
that precedes the cytokinesis-blocked mitosis.
Treatment of PBLs with 2.5 nM (±)-fl«fi-BPDE resulted both in p53
accumulation and increased micronuclei frequencies. Further, treatment of PBLs
with 1.0 mM 3-AB in combination with 2.5 ^M (±)-a«*i-BPDE resulted both in
increased p53 accumulation and increased micronuclei frequencies in
comparison to treatment with (±)-n«f/-BPDE alone. Other studies also report
potentiation of the extent of DNA strand break formation and chromosomal
damage induced by DNA damaging agents, in presence of PADPRT inhibitors
(45-48). Taken together, the present findings are in line with the concept that
carcinogen-induced p53 accumulation requires the presence of DNA strand
breaks (11).
The number of micronuclei may be a resultant of initial DNA strand break
formation and of adequate rejoining of these breaks prior to the S-phase, that
precedes the particular mitosis at the end of which cytokinesis is blocked. Since
p53 accumulation may trigger a Gl cell-cycle arrest (24), it can be hypothesized
that, despite the fact that initial single strand breaks may accumulate with
increasing concentrations of (±)-nnf/-BPDE, increased time provided for strand
break-rejoining prior to DNA replication prevents the eventual conversion of
these breaks to micronuclei. When PBLs, obtained donor 1 and donor 2 were
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In a previous study, using the same experimental model and donors,
induction of poly(ADP-ribosylation) and decrease in NAD+-levels were observed
in PBLs, already within 15 min of treatment with 2.5 jiM (±)-«nfi-BPDE (35). In
the present study, induction of p53 accumulation in PBLs was not substantially
detected after exposure for 35 minutes to 2.5 uM (+)-anfi-BPDE. /« iwo in
C3H10T1/2 cells, 50 |iM 3-AB already resulted in nearly complete inhibition of
PADPRT activity (40). Hence, with the experimental protocol applied here for
PBLs, it is likely that induction of poly(ADP-ribosylation) precedes p53
accumulation and that 3-AB treatment results in efficient inhibition of
poly(ADP-ribosylation). As is clear from Figure 7.4, treatment of PBLs with 2.5
UM (±)-fl«fi-BPDE in combination with 0.1 mM 3-AB resulted even in increased
(±)-fl«ff-BPDE-induced p53 accumulation. Therefore, it is not likely that
poly(ADP-ribose) polymers constitute a signal between translation of
accumulated DNA strand breaks, and elevated p53 levels.
Instead, inhibition of PADPRT may indirectly contribute to the observed
association between (±)-a/j£/-BPDE-induced DNA strand breaks and increased
p53 accumulation. First, 3-AB treatment will prevent poly(ADP-ribose) polymer
formation on PADPRT itself. In absence of auto-poly(ADP-ribosylation), the
PADPRT remains persistently bound to DNA strand breaks (52,53), preventing
these from being rejoined. In turn, this could result in upregulation of other
cellular signals involved in DNA-strand break-inducible pathway(s) of p53
accumulation. Kastan et al. (16) found absence of p53 accumulation and Ga<M45
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mRNA expression in y-ray exposed cells, obtained from patients with the cancer-
prone disease Ataxia-Telangiectasia. Canman et al. (12) reported suboptimal
induction of p53, p21 W/4FI/CJP^ G ^ 4 5 and »idm2 proteins in AT cell-lines
when exposed to single-strand-break inducing agents but not when exposed to
UV-C or topoisomerase inhibitors. Thus, gene products absent in AT cells are
required in the cascade from DNA strand-breaks, induced by agents that cause
initial strand break formation in a non-enzymatic manner, for example via
unstable adduct formation, to p53 accumulation. Whether inhibition of
poly(ADP-ribosylation) results in upregulation of these gene products is
unknown.
Secondly, inhibition of PADPRT has been shown to prevent NAD+ and
concomitant ATP depletion after carcinogen treatment (54), thus preserving
ATP-pools required for adenylation of amino acids and protein synthesis itself.
p53 accumulation, induced by DNA-damaging agents, is not related to enhanced
mRNA expression but instead to increased protein stability and ongoing protein
synthesis (8,13). Thus, inhibition of poly(ADP-ribosylation) during (±)-<jHfi-
BPDE-induced DNA strand break formation could permit prolonged energy-
dependent p53 synthesis. Vice i>ersn, (±)-n«/i'-BPDE-induced intracellular
energy-depletion could explain the absence of p53 accumulation when PBLs are
treated for several h up to 24 h with 40 uM (±)-a«fi-BPDE alone (Figure 7.2). The
latter observation may also be explained in terms of preferential rapid removal
of damaged cells, prior to harvesting, by cytotoxicity or p53-mediated apoptosis.
In HL-60 cells, (±)-fl>ifi-BPDE treatment has been shown to cause apoptosis
within 2 h (50), which is in agreement with the present observed time-dependent
p53 accumulation.
Cellular heterogeneity was observed with regard to (±)-««h'-BPDE-induced
p53 accumulation, with p53 accumulation even being absent in some PBLs. This
is unlikely explained by the existence of asynchronous cell populations, since p53
accumulation was found to be inducible at any point of the cell cycle, at least for
UV-treated human fibroblasts (7) and cisplatin treated rodent and monkey cells
(13). Applying immunocytochemistry in combination with a polyclonal antibody
raised against (±)-<infj-BPDE treated DNA, Van Schooten et al. (55) reported
cellular heterogeneity in (±)-<7»rti-BPDE-DNA adduct formation in lymphocytes,
when human white blood cells were treated ex iwo with 2.5-10 uM (±)-anfi-
BPDE. Therefore, inter-cellular differences in initial adduct formation may
explain the observed heterogeneity in p53 accumulation.
The phenomenon observed here may implicate that, in humans exposed to
environmental polycyclic aromatic hydrocarbons, p53 accumulation represents a
protective mechanism. Recently, Bjelogrlic et al. (56) reported increased putative
p53 protein in mouse skin, concomitantly with increased BPDE-DNA adduct
levels, when B[a]P was applied to the skin. It has to be taken into account that in
the present study rather high doses (2.5 |iM) of (±)-nnf/-BPDE were required to
elicit detectable p53 accumulation, which are expected to cause formation of
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DNA adducts far beyond levels generally found in PBLs in humans. Based on the
results of a previous study, it is estimated that approximately one (+)-0H*/-BPDE-
N^-dG adduct per lO -^lO^ nucleotides is formed in PBLs, exposed to 2.5 |iM (±)-
a;!f/-BPDE (35). Further, Bjelogrlic et al. (56) did not observe any substantial
putative p53 accumulation when B[a]P-induced adduct levels in mouse skin
were below 1-2 per 10^ nucleotides. In humans, in coke oven workers
substantially exposed to PAH, rather low mean lymphocytic (±)-anri'-BPDE-N2-
dG adduct levels of 4.7 per 10" nucleotides have been reported (57). Lewtas et al.
(58) observed in human smokers higher adduct levels in lung and heart tissues
in comparison to adduct levels in PBLs. Therefore, pathways involving the
accumulation of p53 in humans may be limited to metabolically more active
cells from target organs exposed to high levels of PAH, like lung, heart and skin.
In conclusion, p53 accumulation may represent a protective mechanism in
human peripheral blood lymphocytes exposed to reactive metabolites of
benzo[a]pyrene. Further, it is suggested that formation of DNA strand breaks is
responsible for the observed p53 accumulation. However, results of this study
indicate that it is unlikely that DNA strand break-induced poly(ADP-ribose)
polymer formation is required in the cascade of events between intracellular
recognition of DNA damage and onset of p53 accumulation. Finally, the
significance of this mechanism for humans exposed in u/uo to polycyclic
aromatic hydrocarbons may be limited to cells from highly exposed target organs.
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General discussion
As has been outlined in Chapter 1, detailed understanding of DNA repair
mechanisms is required in order to gain insight into mechanisms of human
carcinogenesis. Further, given the pivotal role of adequate DNA repair in
preventing the occurrence of irreversible genetic alterations, upregulation of
DNA repair mechanisms by modulating factors may prevent the onset of human
carcinogenesis.
Aim of the studies described in this Thesis was therefore to explore the
influence of exogenous and endogenous factors on human DNA repair in
relation to DNA damage. Especially, the role of the DNA repair-related enzyme
PADPRT was investigated. As explained, this nuclear enzyme is activated by
carcinogen-induced DNA strand breaks and transfers the ADP-ribose units from
NAD+ to poly(ADP-ribose) polymers. As a consequence of continued PADPR,
intracellular NAD+ becomes depleted. PADPR may serve to facilitate DNA repair
or to reduce the chance of accumulation of cells with irreversible genetic
alterations by: temporarily increasing the access of damaged condensed
chromatin structures for other repair enzymes; direct modulation of the activity
of other repair enzymes; temporarily protecting strand breaks that arise during
the repair process; contribute to or inducing a mechanism of cell suicide.
Therefore, it has been hypothesized that modulation of the activity of PADPRT
may modulate the extent of adequate DNA repair and consequently modulate
the extent of persistent DNA damage in humans. In line of this hypothesis, in
the preceding Chapters studies have been described which:
(i) Evaluate whether nicotinic acid (one of the niacin precursors of NAD+)
supplementation of humans iw two is effective in improving an
individual's niacin status and, consequently, results in increased PADPRT
activity and DNA repair, and in reduction of in uiuo DNA damage.
(ii) Evaluate whether exposure of human cells to low doses of carcinogens
can result in induction of PADPRT and other repair mechanisms, which
would render these cells less susceptible to the DNA damaging effects of
subsequent exposure to a higher dose.
(iii) Evaluate whether PADPR is involved in DNA damage-inducible
pathway(s) that result in accumulation of p53.
As outlined in detail in Chapter 1, ex zwo (±)-anfi-BPDE-treated human
peripheral blood lymphocytes can be used as a model to estimate human DNA
damage and DNA repair processes «« ZHIXJ. Subsequent paragraphs summarize
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the main findings and conclusions, obtained from experiments described in
previous Chapters in which this model has been applied, regarding modulating
factors on DNA damage and DNA repair in humans.
Measurement of repair of (±)-a«ri-benzo[a]pyrene diolepoxide-induced DNA
damage in cultured human peripheral blood lymphocytes
Prior to the investigation of the effects of modulating factors on human DNA
repair, in particular on PADPR, measurements of (±)-fl/z/i-BPDE-induced DNA
repair and PADPR in PBLs have been operationalized (Chapter 2 and Chapter 3).
In Chapter 2, the nuclease Pl-enhanced 32p-postlabeling technique of Reddy and
Randerath (1) has been applied to measure the persistence of N^-deoxyguanosine
adducts in PBLs, treated ex two with (±)-n;i//-BPDE. Exposure of resting PBLs
for 15 min to 0.2 uM (±)-anfi-BPDE resulted mainly in formation of (±)-a«fi-
BPDE-N^-dG adducts. Formation of similar adducts has been previously
reported, when mammalian cells, including PBLs, were treated ex i>iuo with
(±)-anf;-BPDE (2,3). In PBLs obtained from 5 donors, most (±)-nnfi-BPDE-N2-dG
adducts were removed within 4 to 7 h after treatment, followed by a period in
which adduct removal seemed to be slow or absent. Interindividual differences
were observed in both rate and extent of removal of (±)-<JHf;-BPDE-N2-dG
adducts, with approximately a 2-3 fold interindividual variety. In Chapter 3,
similar results with regard to the rate of removal were found when PHA-
stimulated lymphocytes were treated with 0.5 uM (±)-nnfi-BPDE (Chapter 3,
Figure 3.5). The use of 32p.postlabeling in repair studies of (±)-a«f/-BPDE-
induced DNA damage is of advantage since removal of the main BPDE-DNA
adduct, involved in B[a]P-induced mutagenesis and carcinogenesis, namely (±)-
fliif/'-BPDE-N^-dG, can be measured.
To determine the resultant of all excision repair processes induced by (±)-
nn/i-BPDE, measurement of UDS in PBLs was operationalized. A dose-
dependent induction of UDS was observed when PHA-stimulated PBLs were
treated with 0-2.5 uM (±)-anfi-BPDE (Chapter 3, Figure 3.4), which is in
agreement with a previous observation by Celotti et al., (4) who reported a linear
induction of UDS when unstimulated PBLs were treated with concentrations of
(±)-<nifi-BPDE up to 2.5 uM.
Poly(ADP-ribosylation) is induced during repair of (±)-rt«r«-benzo[a]pyrene
diolepoxide-induced DNA damage in human peripheral blood lymphocytes
Aim of studies described in Chapter 3 was to investigate whether the activity of
PADPRT increased during repair of (±)-n?!f/-BPDE induced DNA damage.
Previous studies have shown that PBLs contain PADPRT (5) and rapidly respond
to MNNG treatment with poly(ADP-ribose) polymer formation (6). Moreover,
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treatment of PBLs with (±)-anf/-BPDE has been shown to result in induction of
DNA strand breaks (4). Since the presence of DNA strand breaks is a prerequisite
for induction of PADPR (7-9) and intracellular NAD+ is depleted, it was
hypothesized that (±)-OHh'-BPDE treatment of PBLs resulted in induction of
PADPR and in a decrease in NAD+ levels. As shown in Chapter 3 (Chapter 3,
Figure 3.2 and Figure 3.3) induction of PADPR was observed in PBLs within 15
minutes of treatment with (±)-«nf/-BPDE. Treatment with relatively high
concentrations (higher than 10 uM) of (±)-anfi-BPDE was necessary to induce
clearly detectable poly(ADP-ribose) polymer formation in PBLs. However, a
decrease in lymphocytic NAD+ levels was observed after treatment with
concentrations as low as 0.2 uM (±)-anh'-BPDE. These findings indicate that
PADPR is a process already active at low carcinogen concentrations. Since
unscheduled DNA synthesis (at 1.0 uM (±)-<JHfi-BPDE) and (±)-nnf/-BPDE-N2-
dG adduct removal (at 0.5 uM (±)-anh-BPDE) were also observed in this test
system, it was concluded that PADPR might be involved in repair of (±)-anfi-
BPDE-induced DNA damage in PBLs. In this study, inter-individual differences
were observed with respect to poly(ADP-ribose) polymer formation and other
parameters of DNA repair, which could have been attributable to interindividual
differences in an individual's niacin status.
Nicotinic acid supplementation of smoking humans <n vivo results in an
improved niacin status but not in increased poly(ADP-ribosylation) and DNA
repair, and decreased »i un>o DNA damage
As is clear from Chapter 1, considerable efforts have been made to elucidate the
action of PADPR in relation to DNA repair, induced in u/fro and ex uiuo.
However, little is known with respect to the role of PADPR during repair of
DNA damage in relation to carcinogenesis in humans in u/'yo. Estimated daily
intake of niacin in The Netherlands is at least 14 mg of niacin equivalents per
day (as nicotinic acid, the carboxilic acid niacin derivative), which is considered
adequate to prevent occurrence of niacin deficiency-related diseases like pellagra
(when intake is below 9-12 mg of niacin equivalents per day). However, since it
has been shown that m p/uo supplementation of healthy human persons with
nicotinic acid in doses of 100 mg/day resulted in increased lymphocytic NAD+
levels and decreased ex iroo oxygen-radical induced DNA strand breaks (10), it
was hypothesized that present dietary niacin intake may be suboptimal with
regard to adequate PADPR and repair of DNA damage induced by exposure to
carcinogens J'M P/PO.
The effects of in wuo nicotinic acid supplementation of male human
smokers on niacin status, (±)-flnfi-BPDE induced PADPR and (±)-«n//-BPDE-
N^-dG adduct removal and parameters of lymphocytic cytogenetic damage (SCE,
MN, VF) were therefore investigated, in a pilot study described in Chapter 4.
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Supplementation of human male smokers during 14 weeks with nicotinic acid
in doses of 50 to 100 mg/day resulted in evidently increased blood nicotinamide
levels and in moderately increased lymphocytic NAD+-levels. However, neither
an effect of supplementation on the degree of PADPR, determined in PBLs after
ex Z>I'DO treatment for 15 or 35 minutes with 40 uM (±)-flnr/-BPDE nor on the
rate of (±)-awfz-BPDE-N2-dG removal, within 24 h after treatment of isolated
PBLs with 0.5 uM (±)-flnfi-BPDE, was observed. Prior to nicotinic acid
supplementation, positive associations were found between smoking habits
(pack years) and parameters of cytogenetic damage, suggesting that in this
population smoking resulted in accumulation of lesions that caused
chromosomal damage and mutagenesis in PBLs, after stimulation to
proliferation ex u/uo. However, nicotinic acid supplementation had no effect on
lymphocytic mutagenesis and cytogenetic damage, in relation to the improved
niacin status. Therefore, no evidence was found that an improved niacin status
of male human smokers results in increased NAD+-dependent PADPR-mediated
DNA repair in peripheral blood lymphocytes and, consequently, in decreased
mutagenesis and cytogenetic damage in these cells.
An individuals capacity to perform (±)-fl>ifi-BPDE-induced lymphocytic DNA
excision repair decreases with increasing age which may underlie age-associated
accumulation of cytogenetic damage
As outlined in Chapter 1, human DNA repair capacity has been negatively
associated with aging (11-14). Moreover, in humans, genomic alterations
accumulate with increasing age (15,16). Therefore, it was hypothesized in Chapter
5 that the ability to perform adequate DNA repair declines with increasing age
and consequently results in accumulation of DNA damage, for example caused
by exposure to tobacco smoke.
To explore this hypothesis, (±)-fl«/i-BPDE-induced unscheduled DNA
synthesis was determined, in PBLs obtained from the population of male human
smokers described in Chapter 4. Moreover, sister chromatid exchange frequencies
and micronuclei frequencies, which had been determined in PBLs in this
population prior to nicotinic acid supplementation (Chapter 4), were used as
markers for JH wyo lymphocytic DNA damage.
A negative association was found between (±)-<iwh-BPDE-induced UDS and
age (Chapter 5, Figure 5.1). Average decrease in the degree of (±)-a>ifi'-BPDE-
induced DNA repair was found to be 1.1% per year between 20 and 60 years of
age. Comparable average annual decreases in lymphocytic DNA repair capacity
have been reported for UV-induced DNA damage, ranging from 0.43 to 0.75%
per year, between 20 and 60 years of age (12,14,17). Further, both lymphocytic SCE
frequencies and MN frequencies correlated negatively with the degree of ex
z'/i'o (±)-<Jn//-BPDE-induced UDS in PBLs. As described in Chapter 4 and
Chapter 5, SCE (significant) and MN were positively associated with age in this
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population. Therefore, it seems likely that the capacity of an individual's DNA
repair, as determined t\v u/uo in (+)-flH/i-BPDE-treated resting PBLs, resembles
the capacity of repair mechanisms in two which are responsible for removal of
damage that otherwise results in the induction of cytogenetic damage, in
lymphocytes stimulated to proliferation t\v i»ii?o. Moreover, these results
suggest that age-related decrease in the lymphocytic DNA excision repair capacity
may be responsible for accumulation of (smoking-induced) DNA damage. This
accumulation of DNA damage could have been responsible for the observed age-
associated increase in cytogenetic damage.
As discussed in previous Chapters, removal of (±)-an//-BPDE-N2-dG adducts
is believed to proceed through nucleotide excision repair mechanisms (2,18,19).
Recent models for nucleotide excision repair assume that at least 17 proteins are
involved in damage recognition, incision, excision of the damaged
oligonucleotide and refilling of the excision gap (20-23). As described in Chapter
4, no association was observed between the rate of (±)-rt?ih-BPDE-N2-dG adduct
removal, determined prior to the nicotinic acid supplementation period in
isolated PBLs after ex two treatment with (±)-anfi-BPDE, and age of this
population. UDS reflects the activity of all enzymes involved in the complete
excision repair process, while adduct removal solely reflects initial recognition of
DNA damage and removal of damaged oligonucleotides. Therefore, it was
speculated in Chapter 5 that aging may particularly affect those proteins,
involved in later steps, after initial damage recognition and removal, of
nucleotide excision repair.
PBLs do not represent target organs for human carcinogenesis. However,
decreased UV-induced DNA repair capacity of PBLs has been associated with
development of sunlight-induced skin cancer in the normal population (14).
Moreover, Hagmar et al. (24) reported a significant trend between increased
lymphocytic chromosome aberrations and overall risk for cancer. Thus, it was
concluded that the age-dependent decrease in DNA excision repair and increased
cytogenetic damage in PBLs, observed in this population of healthy smokers,
may resemble processes that are involved in age-related development of cancer
in target organs in human smokers.
Pre-treatment of isolated human peripheral blood lymphocytes with low levels
of (±)-a«r«-benzo[a]pyrene diolepoxide induces an adaptive response. No
evidence for the induction of poly(ADP-ribose) polymerase or DNA excision
repair mechanisms
As outlined in Chapter 1, ex u/uo pre-exposure of PBLs to low levels of ionizing
radiation, radiomimetic agents or alkylating agents may result in protection
against formation of cytogenetic damage, induced by later exposure to higher
levels of the particular carcinogen (see for references Chapter 1, Table 1.1), a
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phenomenon known as the adaptive response. Moreover, a few studies have
given indirect evidence that induction of PADPRT is necessary for this
preventive mechanism, when triggered by ionizing radiation or radiomimetic
agents (25-28).
Given these findings, it may be speculated that (chronic) pre-exposure of
humans to very low levels of environmental carcinogens, for example radon or
polycyclic aromatic hydrocarbons, may result in the induction of chromosomal
repair mechanisms in target organs. Ultimately, this would render target organs
less susceptible to the deleterious genotoxic effects of these carcinogens.
In Chapter 3, it was concluded that PADPRT might be involved in repair of
(±)-<JMh-BPDE-induced DNA damage. Taken together with the indirect evidence
that induction of PADPRT may be involved in the AR to IR in PBLs (25-28), it
was tempting to hypothesize whether a similar protective PADPRT-dependent
phenomenon could be induced by (±)-fl/i/i-BPDE in PBLs. In Chapter 6, studies
are described that address this hypothesis. Moreover, experiments were
performed to assess whether such a mechanism involves also the induction of
excision repair mechanisms.
PHA-stimulated isolated PBLs, obtained from 10 healthy non-smoking male
human individuals, were cultured for 24 hours, exposed to low levels c^  ±^V
n/ifi'-BPDE (2.5-25 nM), cultured for another 24 hours, and challenged by higher
concentrations (2.5 or 40 uM) of (±)-a/!fi-BPDE in order to induce detectable
processes related to chromosomal damage (MN), excision repair (UDS) and
PADPRT activity (poly(ADP-ribose) polymer formation and decrease in NAD+-
levels).
A preventive effect of pre-exposure on challenge-induced MN, as measure of
chromosomal damage, was observed in PBLs obtained from 4 individuals. Based
on this finding, it was concluded that the observed phenomenon may imply that
similar adaptive mechanisms may occur in human subpopulations m IOTO, in
relation to low environmental exposure to polycyclic aromatic hydrocarbons.
Besides inter-individual differences in the degree of adaptation, intra-individual
differences were observed as well, indicating that other than genetic factors may
also be of influence on the AR. Further, the AR was found to be dependent on
the concentration of (±)-anfi-BPDE applied during pre-exposure. This suggests
that the small amount of (cytogenetically undetectable) DNA damage may
determine the degree of induction of repair enzymes that prevent challenge-
induced micronuclei formation. However, no associations were found between
the adaptive response, found in these individuals, and the effects of pre-exposure
on challenge-induced poly(ADP-ribose) polymer formation and reduction in
NAD+-levels or unscheduled DNA synthesis. Thus, even though techniques
were applied that allow direcf detection of ex uiuo lymphocytic PADPRT
activity (as has been described in Chapter 3 an Chapter 4), the hypothesized
involvement of this enzyme in the adaptive response, as induced in PBLs by a
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reactive metabolite of benzo[a]pyrene, could not be established.
Moreover, for these 10 individuals, no association was observed between the
AR and the degree of DNA repair synthesis, measured as UDS. This suggests that
the prevention of (±)-flnh-BPDE-induced micronuclei formation by pre-
exposure, observed in some individuals, is likely to be caused by the induction of
mechanisms other than those involved in excision repair of certain lesions
which can be observed as UDS, e.g. nucleotide excision repair of covalent (±)-
rt»H-BPDE-DNA adducts. Induction of repair mechanisms that act on strand
breaks induced by unstable (±)-a?j<i-BPDE-DNA adducts may underlie the
observed AR.
Finally, 32p.postlabeling experiments with PBLs, obtained from 2 individuals,
were not supportive for the possibility that the preventive effect of pre-exposure,
with respect to chromosomal damage observed in some individuals, was related
to decreased initial binding of (±)-<?H*i-BPDE with DNA, as nuclear target
molecule.
(±)-a«r/'-benzo[a]pyrene diolepoxide-induced DNA damage and p53
accumulation in relation to modulation of poly(ADP-ribose) polymerase activity
Previous studies have indicated that accumulation of wild-type p53 tumour
suppressor protein is involved in cellular responses to DNA damage, induced by
several chemical or physical agents (29-38). As outlined before, p53 accumulation
may prevent the onset of carcinogenesis by triggering mechanisms which cause
selection against damaged cells in favour of adequately repaired cells (32,33,37,39,
40). While the interplay between p53 and other genes and gene products
involved in these mechanisms is being elucidated at present, detailed insight
into prior events that take place between initial induction of DNA damage and
p53 accumulation is lacking. Recently, it has been proposed that DNA strand
breakage is one of the triggers and presumably required for induction of p53
accumulation upon DNA damage (34,35,38). Since DNA single or double strand
breaks are also believed to be the trigger for rapid induction of PADPR in
carcinogen-exposed cells, it was tempting to investigate whether poly(ADP-
ribose) polymer formation plays a role in carcinogen-induced p53 accumulation
(Chapter 7).
As described in previous studies (3,4) and in Chapters 2-6 of this Thesis,
treatment of PBLs with (±)-anf/-BPDE results in induction of processes reflecting
DNA strand breakage and DNA repair. Therefore, experiments were performed
to investigate whether (±)-<?Hf/-BPDE-treatment of PHA-stimulated PBLs also
resulted in nuclear p53 accumulation (Chapter 7), in relation to DNA strand
break formation, determined as micronuclei frequencies. Both
immunocytochemical and immunoblot analysis indicated that treatment of
PBLs, obtained from several donors, with 2.5 uM (±)-anfi-BPDE evidently
resulted in p53 accumulation. In PBLs obtained from two donors, optimal
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accumulation was observed when cells were treated with 2.5 uM (±)-anf/-BPDE,
while accumulation was not detectable at concentrations lower than 2.5 uM and
higher than 10 uM. Accumulation of p53 was further found to be time-
dependent. Results obtained in Chapter 6 indicated that induction of micronuclei
frequencies in PBLs obtained from the same two donors tended to be maximal
when cells were treated with 2.5 uM (±)-anh'-BPDE (Chapter 6, Figure 6.1).
Furthermore, treatment of PBLs obtained from these donors with 2.5 uM in
combination with 1.0 mM 3-AB, a PADPRT inhibitor, both potentiated the (±)-
anh-BPDE-induced p53 accumulation and micronuclei frequencies. Although
the concentration-dependent effects of 3-AB on (±)-flnH-BPDE-induced p53
accumulation and micronuclei were not found to be strictly associated (Chapter
7, Figure 7.4 and Figure 7.5) -which may be explained by differential influence of
potential additional metabolic effects of 3-AB on these two parameters- these
findings are in agreement with the concept that DNA strand breaks are required
for carcinogen-induced p53 accumulation. Further, it was also concluded that p53
accumulation may represent-a protective mechanism in human peripheral
blood lymphocytes exposed to DNA strand break-inducing reactive metabolites
of benzo[a]pyrene. Furthermore, it was hypothesized that similar metabolites
may also trigger p53-dependent DNA damage-inducible pathways of p53
accumulation in target organs in humans exposed to PAH in uiuo. Given the
high doses of (±)-«nf/-BPDE required to induce detectable p53 accumulation,
such a protective mechanism in humans may only be relevant in cells from
target organs which are exposed to high levels of PAH, for instance the lung.
As indicated in Chapter 7, induction of PADPR likely precedes p53
accumulation. Treatment of PBLs with 2.5 uM (±)-anf/-BPDE and 0.1 mM 3-AB
appeared to potentiate the degree of (±)-<irth-BPDE-induced p53 accumulation.
Therefore, it was concluded that poly(ADP-ribose) polymers are presumably not
required in the sequence of events between (±)-anfi-BPDE-induced DNA strand
break formation and elevation of p53 levels.
Concluding remarks
In the previous Chapters, studies have been described which aimed to modulate
PADPR in humans in order to upregulate other DNA repair processes which
may prevent carcinogenesis. Results presented in this Thesis indicate that in
humans, PADPR is presumably involved in DNA repair processes induced by
reactive PAH metabolites, like (±)-nn</-BPDE. However, despite the fact that
nicotinic acid supplementation of human smokers was found to improve niacin
status, no beneficial effects of supplementation on PADPR were found in
relation to lymphocytic DNA repair induced by these benzo[a]pyrene metabolites,
and cytogenetic damage. The fact that pre-exposure of PBLs, obtained from some
individuals, to (±)-anfi'-BPDE rendered these cells less susceptible to the DNA
160
Genera/ discussion
damaging effects of high doses of (±)-anti-BPDE, could not be explained by
induction of PADPRT or other DNA excision repair enzymes. Further,
inhibition of PADPRT resulted in enhancement of p53 accumulation in PBLs,
induced by these reactive benzo[a]pyrene metabolites, indicating that poly(ADP-
ribose) polymers may presumably not be required in the cascade of events
between initial PAH-induced DNA strand break formation and p53
accumulation. Endogenous factors such as age, were found to be negatively
correlated with PAH-induced lymphocytic DNA repair and positively with
cytogenetic damage.
Therefore, it is concluded that in humans, DNA excision repair and PADPR
are presumably not influenced by nicotinic acid supplementation or chronic
exposure to PAH. Eventually, if these exogenous factors perhaps are found to
contribute to a reduction of cancer risk related to PAH-exposure, such a reduction
may not be related to upregulation of these DNA repair processes. The activity of
enzymes involved in repair of PAH-induced DNA damage seem to be negatively
influenced by other (endogenous) factors such as age, which may result in age-
related accumulation of genetic damage and thereby contribute to cancer risk.
Finally, improvement of poly(ADP-ribose) polymerase activity in humans may
not result in modulation of p53 accumulation in response to PAH-induced DNA
damage and thereby influence cancer risk.
Note added in proof
While this Thesis was in preparation, an important paper was published by
Wang et al. (41), which may shed a different light upon the issues discussed in
this Thesis. By developing mice with a homozygous mutated PADPRT gene,
they established an excellent model to study PADPRT and PADPR in
mammalians in two. PADPRT mRNA and enzyme activity were absent in
these homozygotes, indicating complete gene inactivation. However, these mice
were found to be healthy, fertile and to develop normally, suggesting that
PADPRT and PADPR are not required for normal chromatin function and
proliferation and differentiation in PIIXJ. Further, mutant embryonic fibroblasts
repaired DNA damage, induced ex WTO with MNNG or UV, as efficiently as
wild type cells, indicating that in w'uo both NER and BER likely do not directly
require PADPRT or PADPR. Cultured mutant fibroblasts were found to have a
reduced proliferation rate and cultured mutant thymocytes a delayed
proliferative response after y-irradiation. Further, ~ 30% of older mutant mice (>
5-6 months) developed epidermal hyperplasia. These observations suggest that
PADPRT/PADPR may have a function in responses to environmental stress.
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Summary
In daily life, humans are exposed to a variety of chemical and physical agents.
After uptake, these agents may, either directly or after metabolization, damage
DNA, as well as other intracellular macromolecules, in various ways. For
example, covalent adducts may arise from interaction of polycyclic aromatic
hydrocarbons like benzo[a]pyrene with DNA. Further, ultraviolet light may
induce so called cyclobutane pyrimidine dimers. Also, ionizing radiation may
result in the oxidation of DNA bases. As a consequence of DNA lesions,
irreversible genetic alterations may arise upon processes involved in normal
cellular physiology like DNA replication, DNA transcription and cell division.
The onset of carcinogenesis is believed to be directly related to these alterations.
In particular, structural alterations like DNA mutations in tumour-suppressor
genes and proto-oncogenes are believed to result in loss of normal cell growth
control and thus in the onset of cancer.
Fortunately, humans possess several DNA repair mechanisms which enables
them to restore the genomic integrity before these cellular processes take place.
One of the most clear examples illustrating the importance of DNA repair in
preventing carcinogenesis is the disease Xeroderma Pigmentosum. Individuals
affected by this disease have reduced DNA excision repair of certain kinds of UV-
light-induced DNA damage and are believed therefore to be cancer-prone.
In Chapter 1, several DNA repair mechanisms have been discussed and it has
been hypothesized that upregulation of DNA repair activities may prevent the
onset of human carcinogenesis. Aim of this thesis was therefore to explore
exogenous and endogenous factors which influence DNA repair in humans. In
particular, the role of the DNA repair-associated enzyme poly(ADP-ribose)
polymerase (PADPRT) was investigated. This nuclear enzyme is activated by
DNA strand break-inducing agents, and upon activation transfers ADP-ribose
units from intracellular NAD+ to poly(ADP-ribose) polymers. As a consequence,
intracellular NAD+ becomes depleted.
In the past years, several functions for poly(ADP-ribosylation) (PADPR) have
been proposed. For example, PADPR may serve to facilitate DNA repair and
reduce irreversible DNA alterations either by influencing the accessibility of
damaged DNA for other repair enzymes or by temporarily protecting DNA
breaks from undergoing genetic recombination, that arise during the repair
process. Taken this in mind, it was speculated that in humans exposed to
carcinogens, upregulation of the activity of PADPRT may modulate DNA repair
in a positive manner and consequently reduce DNA damage. Eventually, this
may reduce cancer risk. Studies described in this thesis were performed which
aimed to modulate the activity of PADPRT in humans, in relation to DNA
damage and DNA repair processes.
To study DNA damage, DNA repair and PADPR, untreated human peripheral
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blood lymphocytes (PBLs) and PBLs treated ex iwo with the DNA damaging
agent (±)-anfi-benzo[a]pyrene diolepoxide ((±)-anfi-BPDE) were applied as a
model. Treatment of mammalian cells with these reactive metabolites from the
environmental carcinogen benzo[a]pyrene has been shown to result in
formation of several DNA adducts and to induce DNA repair processes.
In Chapter 2 and Chapter 3 operationalization of measurements of (±)-««h-
BPDE-induced DNA repair and PADPR in PBLs are described. The 32p.
postlabeling technique was found to be useful to measure the persistence of the
main adduct involved in benzo[a]pyrene-induced carcinogenesis namely (±)-
«Mf/-BPDE-N2-dG, in PBLs treated ex D/'TO with (±)-anf;-BPDE. Applying this
method, it was found that in PBLs obtained from several donors most adducts
are removed within 4 to 7 h after treatment. Further, interindividual variability
was observed in both rate and extent of adduct removal. In Chapter 3,
observations are described which indicate that PADPR is induced during DNA
repair -assayed by means of measurement of DNA repair synthesis (UDS) and
adduct removal- of (±)-n«ti'-BPDE-induced DNA damage in PBLs. Given these
results, it was concluded that PADPR might be involved in repair of (±)-anfi-
BPDE-induced DNA damage.
Since nicotinic acid is one of the precursors of NAD+, it was hypothesized in
Chapter 4 that supplementation of humans with nicotinic acid may influence
PADPR and consequently modulates the persistence of DNA damage for
example induced by cigarette smoke. Therefore, the effects of i/i two nicotinic
acid supplementation of male human smokers on niacin status, (±)-«infi-BPDE-
induced PADPR, (±)-fl/ih-BPDE-induced DNA adduct removal, and lymphocytic
cytogenetic damage were investigated. While nicotinic acid supplementation of
smokers with at least 50 mg of nicotinic acid per day during a period of 14 weeks
was effective in improving niacin status, neither a positive effect of
supplementation on (±)-anf/-BPDE-induced DNA adduct removal nor on (±)-
anfi-BPDE-induced PADPR was found. Further, the improved niacin status
failed to reduce lymphocytic damage or mutagenesis. It was concluded that an
improvement of niacin status in humans did not result in increased NAD+-
dependent PADPR-mediated DNA repair in lymphocytes and consequently did
not influence mutagenesis or chromosomal damage.
In Chapter 5, results are presented which indicate that age is associated with an
individual's DNA repair capacity and with DNA damage. Prior to nicotinic acid
supplementation, (±)-anfi-BPDE-induced UDS, as a measure of DNA repair, was
determined in PBLs obtained from the same population as described in Chapter
4. Further, lymphocytic SCE frequencies and MN frequencies were determined as
markers for in DI'UO lymphocytic DNA damage. A negative correlation was
observed between the extent of (±)-anf/-BPDE-induced UDS and age. Further,
parameters of in iwo lymphocytic DNA damage were negatively correlated
with the extent of (±)-anfi-BPDE-induced DNA repair and positively associated
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with age of the donor. Based on these findings, it was concluded that, with
increasing age, a reduction of lymphocytic DNA excision repair capacity may be
responsible for accumulation of smoking-induced lymphocytic DNA damage.
Further, these phenomena observed may resemble processess that are involved
in age-related development of cancer in target organs in human smokers.
Chapter 6 describes experiments, designed to investigate whether pre-exposure
of PBLs to low doses of (±)-<infi-BPDE results in a reduction of chromosomal
damage, induced at a later time point by higher doses ('challenge') of (±)-fl«f/-
BPDE. Further, experiments were performed to assess whether such an
adaptation involves the modulation of DNA repair mechanisms, in particular
PADPR. A preventive effect of pre-exposure on challenge-induced MN
frequencies, as parameter of chromosomal damage, was observed in PBLs
obtained from 4 individuals. The adaptation was found to depend on the
concentration of (±)-an/z'-BPDE applied during pre-exposure. However, no
relations were found between this adaptation and effects of low pre-exposure on
the extent of PADPR and DNA repair synthesis, induced by high doses of (±)-
fl/7fi-BPDE. Thus, it was concluded that the observed pre-exposure-induced
reduction in (±)-anh-BPDE-induced chromosomal damage was not attributable
to the induction of PADPRT or excision repair mechanisms.
In chapter 7 the role of PADPR in carcinogen-induced accumulation of p53
tumour suppressor protein is described. Accumulation of p53 tumour suppressor
protein in response to DNA damage, presumably DNA strand breaks, may
induce mechanisms which serve to prevent the onset of carcinogenesis by
eliminating damaged cells or by preventing them from being replicated. Given
the fact that PADPR also proceeds rapidly after carcinogen-induced DNA strand
scission, it was hypothesized that PADPR may be a potential interjacent event
between carcinogen-induced DNA strand break formation and p53
accumulation. Experiments performed indicated that treatment of PBLs with (+)-
rt/ifi-BPDE resulted in a time-dependent p53 accumulation. Further, treatment
of PBLs with (±)-<jnfi-BPDE in combination with 3-aminobenzamide, a PADPRT
inhibitor, resulted in increased p53 accumulation, in comparison to cell treated
with (±)-an/i-BPDE alone. This combination also potentiated the frequency of
(±)-(?7!/i-BPDE-induced micronuclei, as marker for DNA breakage. Based on
these findings, it was concluded that (±)-anf/-BPDE-induced DNA strand break
formation is responsible for the observed p53 accumulation. Finally, it was
concluded that it is unlikely that PADPR is directly required in the process of p53
accumulation.
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Samenvatting
In het dagelijks leven is de mens aan een verscheidenheid van chemische
stoffen en fysische factoren blootgesteld. Na opname door het lichaam kunnen
deze, of direct of na metabole omzetting, het DNA en andere intracellulaire
macromoleculen op verschillende manieren beschadigen. Zo kunnen
bijvoorbeeld covalente adducten ontstaan door de interactie van polycyclische
aromatische koolwaterstoffen, zoals benzo[a]pyreen, met DNA. Daarnaast kan
ultraviolette straling zogenaamde cyclobutaan pyrimidine dimeren veroorzaken.
Een ander voorbeeld is de oxydering van DNA basen door ionizerende straling.
Deze DNA beschadigingen kunnen, door normale cellulaire processen zoals
DNA replicatie, DNA transcriptie en celdeling, worden omgezet in irreversibele
genetische veranderingen, bijvoorbeeld DNA mutaties. Verondersteld wordt dat
het proces van kankervorming (carcinogenese) direct gerelateerd is aan de
aanwezigheid van deze veranderingen. Aangenomen wordt dat als deze
structurele veranderingen optreden in tumor suppressor genen en proto-
oncogenen, de normale controle over celgroei verloren gaat en kankervorming
uiteindelijk optreedt.
Gelukkig bezit de mens verschillende DNA herstel mechanismen, welke hem
in staat stelt om DNA schade te herstellen voordat deze cellulaire processen
optreden. Een van de meest duidelijke voorbeelden welke het belang van DNA
herstel illustreert is de ziekte Xeroderma Pigmentosum. Individuen met deze
ziekte hebben verminderd DNA excisie herstel van bepaalde vormen van DNA
schade en zijn daardoor gevoeliger voor het krijgen van kanker.
In hoofdstuk 1 zijn verschillende DNA herstel mechanismen besproken en
werd verondersteld dat het stimuleren van DNA herstel mechanismen het
onstaan van kanker zou kunnen voorkomen. Doel van dit proefschrift was dan
ook om verschillende exogene en endogene factoren te bestuderen, welke van
invloed zijn op DNA herstel in de mens. In het bijzonder werd de rol van het
DNA herstel-geassocieerd enzym poly(ADP-ribose) polymerase (PADPRT)
bestudeerd. Dit enzym, aanwezig in de celkern, wordt geactiveerd door
verbindingen welke breuken in het DNA induceren. Door activatie brengt het
enzym ADP-ribose groepen over van intracellulair NAD+ naar poly(ADP-ribose)
polymeren. Een van de gevolgen hiervan is dat het intracellulair NAD+
gedepleteerd raakt. In de afgelopen jaren zijn een aantal functies voor PADPR
gedurende DNA herstel voorgesteld. PADPR zou bijvoorbeeld DNA herstel
kunnen bevorderen en de mate van irreversibele genetische schade kunnen
reduceren doordat het de bereikbaarheid van beschadigd DNA voor andere
herstel enzymen gunstig beinvloedt. Ook zou PADPR er voor kunnen zorgen
dat DNA breuken, welke ontstaan tijdens DNA herstel processen, afgeschermd
worden waardoor genetische recombinatie wordt tegengegaan. In hoofdstuk 1
werd daarom gehypothetiseerd dat, in mensen blootgesteld aan DNA
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beschadigende verbindingen, stimulering van de activiteit van PADPRT DNA
herstel in gunstige zin zou kunnen bei'nvloeden en hiermee de mate van
persistente DNA schade kan verminderen. Uiteindelijk zou dit de kans op het
optreden van kanker reduceren. In dit proefschrift zijn daarom een aantal
studies beschreven welke tot doel hadden om in de mens de activiteit van
PADPRT te moduleren, in relatie tot DNA herstel en DNA schade. Als model
om DNA schade, DNA herstel en PADPR te bestuderen zijn perifere
bloedlymfocyten (PBL), al dan niet blootgesteld aan (±)-flwt/-benzo[a]pyreen
diolepoxide ((±)-a«//-BPDE), gebruikt. Bekend is dat deze reactieve metabolieten
van de in het milieu aanwezige carcinogene verbinding benzo[a]pyreen
verschillende interacties met DNA kunnen aangaan en dat ze DNA
herstelprocessen activeren.
In hoofstuk 2 en hoofdstuk 3 is de operationalisering van methoden om (±)-
flHh'-BPDE-geinduceerd DNA herstel en PADPR te meten beschreven. De 32p.
postlabeling techniek bleek bruikbaar om, in geisoleerde PBL blootgesteld aan
(±)-nnh'-BPDE, persistentie van (±)-anf/-BPDE-N2-deoxyguanosine adducten te
meten. Dit is het belangrijkste DNA adduct verantwoordelijk voor
benzo[a]pyreen-gei'nduceerde carcinogenese. In PBL van verschillende donoren
werd met deze methode gevonden dat de meeste (±)-flM//-BPDE-geinduceerde
adducten binnen 4 tot 7 uur worden verwijderd. Verder bleek er
interindividuele variabiliteit in mate en snelheid van adductverwijdering te
bestaan. In hoofdstuk 3 zijn waarnemingen beschreven welke erop wijzen dat
PADPR plaatsvindt gedurende herstel van (±)-<7/!fi-BPDE-geinduceerde DNA
schade. DNA herstel werd gemeten door middel van de bepaling van adduct
verwijdering en door meting van DNA herstel synthese (UDS). Uit de resultaten
van hoofstuk 3 werd geconcludeerd dat PADPR betrokken zou kunnen zijn bij
het herstel van (±)-n«f/-BPDE-geinduceerde DNA schade in PBL.
In hoofdstuk 4 werd verondersteld dat suppletie van mensen met
nicotinezuur PADPR gunstig zou kunnen beinvloeden, aangezien NAD+ uit
nicotinezuur gevormd kan worden. Als gevolg hiervan zou de mate van
persistente DNA schade, bijvoorbeeld veroorzaakt door tabaksrook, in mensen
gereduceerd kunnen worden. Om dit te onderzoeken werden, binnen een
populatie van mannelijke rokers, de effecten van nicotinezuursuppletie op
nicotinezuur status, (±)-nnf/-BPDE-geinduceerde DNA adduct verwijdering, (±)-
OHfz'-BPDE-gernduceerde PADPR en genetische schade in lymfocyten bestudeerd.
Resultaten wezen uit dat terwijl nicotinezuursuppletie (minimaal 50 mg per dag,
gedurende 14 weken) effectief was om de nicotinezuurstatus te verhogen,
suppletie geen positief effect had op (±)-flnf/-BPDE-gei'nduceerde PADPR en (±)-
(ififi-BPDE-geinduceerde adductverwijdering. Ook werd, als gevolg van de
verbeterde nicotinezuurstatus, geen afname waargenomen in de mate van
chromosomale schade en DNA mutaties gemeten in lymfocyten. Geconcludeerd
werd dat een verbetering van nicotinezuurstatus in de mens niet leidt tot een
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verbeterd NAD+-afhankelijk, PADPR-gemedieerd DNA herstel in lymfocyten en
als gevolg hiervan de mate van lymfocytaire DNA schade niet beinvloedt.
In hoofstuk 5 zijn een aantal bevindingen beschreven welke erop wijzen dat
DNA herstel en DNA schade geassocieerd zijn met leeftijd. In de populatie
mannelijke rokers beschreven in hoodstuk 4 werd in PBL, voor nicotinezuur
suppletie, (±)-fl«fi-BPDE-gei'nduceerde UDS als maat voor DNA herstel bepaald.
Ook werden lymfocytaire zuster chromatiden uitwisselingen en micronuclei
bepaald, als maat voor de m UITO aanwezige lymfocytaire DNA schade. Tussen
(±)-fl?if/-BPDE-geinduceerde DNA herstel en leeftijd werd een negatieve
correlatie gevonden. Verder bleken parameters voor lymfocytaire DNA schade
negatief geassocieerd te zijn met de mate van (±)-a«h'-BPDE-gei'nduceerde UDS
en positief met de leeftijd van elke donor. Er werd daarom geconcludeerd dat,
met toenemende leeftijd, een afname in lymfocytair DNA excisie herstel kan
resulteren in accumulering van lymfocytaire DNA schade, zoals veroorzaakt
door roken. Verder werd gespeculeerd dat deze waarnemingen processen zouden
kunnen weergeven welke ten grondslag liggen aan de leeftijdsafhankelijke
toename in de vorming van kanker in doelwitorganen van rokers.
In hoofdstuk 6 zijn experimenten beschreven welke tot doel hadden om het
effect van blootstelling aan een zeer lage dosis (±)-a«f/-BPDE op de mate van
chromosomale schade in PBL, geinduceerd door een hogere dosis (±)-anf;-BPDE
op een later tijdstip, te onderzoeken. Verder werd onderzocht of zo'n adaptatie te
wijten zou kunnen zijn aan modulering van DNA herstel mechanismen, in het
bijzonder van PADPR. In PBL van 4 donoren bleek blootstelling vooraf aan een
lage doses (±)-<iHfi-BPDE een preventief effect te hebben op het aantal
micronuclei, als maat voor chromosomale schade, geinduceerd door
blootstelling aan een hoge dosis (±)-anfi-BPDE op een later tijdstip. Deze
adaptatie bleek verder afhankelijk te zijn van de concentratie (±)-<JHf/-BPDE
tijdens de voorblootstelling. De effecten van voorblootstelling op de mate van
PADPR en DNA herstelsynthese, geinduceerd door een hoge dosis (±)-<?nfi-
BPDE op een later tijdstip, bleken echter niet geassocieerd te zijn met de mate
van adaptatie. Geconcludeerd werd daarom dat de waargenomen adaptatie niet
toe te schrijven was aan de inductie van PADPRT en DNA excisie herstel
mechanismen.
In hoofdstuk 7 werd ingegaan op de mogelijke rol van PADPR in carcinogeen-
gei'nduceerde accumulering van p53 tumor suppressor eiwit. Accumulering van
p53, als respons op DNA schade, in het bijzonder DNA breuken, zou andere
intracellulaire mechanismen bei'nvloeden welke het ontstaan van kanker
kunnen voorkomen. De verwijdering van beschadigde cellen zou bijvoorbeeld
worden gestimuleerd. Daarnaast zou p53 accumulering DNA replicatie in
beschadigde cellen kunnen voorkomen, zodat het ontstaan van DNA mutaties
wordt tegengegaan. Aangezien PADPR een proces is dat eveneens snel
geactiveerd wordt door carcinogeen-geinduceerde DNA breuken, werd
verondersteld dat PADPR mogelijk een tussenliggende rol vervult bij inductie
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van DNA schade en accumulering van p53. Uit de experimenten beschreven in
hoofdstuk 7 bleek dat (±)-awH-BPDE behandeling van PBL resulteert in inductie
van p53 accumulering. Verder bleek dat in PBL blootgesteld aan (±)-<inh'-BPDE
in combinatie met 3-aminobenzamide, een remmer van PADPRT, p53
accumulering zelfs hoger lag dan in PBL alleen blootgesteld aan (±)-anfi-BPDE.
Deze combinatieblootstelling verhoogde eveneens het aantal micronuclei, als
maat voor DNA breukvorming, in vergelijking met het aantal micronuclei
gemeten in PBL blootgesteld aan alleen (±)-anfi-BPDE. Geconcludeerd werd
daarom dat (±)-anfi-BPDE-gei'nduceerde DNA breuken ten grondslag liggen aan
de waargenomen p53 accumulering. Tenslotte werd geconcludeerd dat het niet
waarschijnlijk is dat PADPR vereist is in het proces van p53 accumulering.
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piano (met wieltjes) moet weer verhuisd worden, ik bel je nog!
Drs. Irene Welle, voor je samenwerking tijdens practica, het kweekwerk en scoren van de
micronuclei (hoofdstuk 6). Je belangstelling heb ik zeer op prijsgesteld en blijkt wel uit het
feit dat je mij en Marielle in staat hebt gesteld om "The Chesapeake Bay" alvast "literair" te
bevaren.
Ing. Ben van Agen, voor je hulp bij het p53 werk. Mede hierdoor bleek hoofdstuk 7 meteen al
acceptabel als artikel. En, om Walter de Rochebrune maar weer eens te citeren: "Daaaaagh
professor".
Drs. Marieke van der Veer, merci beaucoup voor de NAD+ bepalingen (hoofdstuk 4) en
micronuclei (hoofdstuk 5) en al het andere werk dat je binnen het kader van je BGK
afstudeerstage heb verricht.
Ing. Angelique VanKan, voor de nicotinamide bepalingen (hoofdstuk 4). Bij nadere
beschouwing bleek je stagewerk zeer waardevol te zijn.
Drs. Ivo "Pernod" Zwingmann, op het eind sprong je even bij om het microscopie werk uit
hoofdstuk 6 af te krijgen. Ik hoop dat we een dezer dagen nog de kans hebben (of al
genomen hebben) om Absinth te stoken en hiermee het geheim van het afgesneden oor van
Van Gogh te doorgronden.
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Ing. Danielle Pachen, voor je inspanningen om de HPLC bepaling van 2-Py en 4-Py van de
grond te krijgen. En, het is goed lachen met jou in de pauze.
Mijn kamergenoten:
Drs. Roger Godschalk, voor je stimulerend enthousiasme voor de wetenschap, (you're next!).
Drs. Patrick Debats, voor het relativeren van bepaalde minder aangename zaken binnen de
universitaire wereld, je kennis van Fokker's, Ilyushin's en DC-10's en het filosoferen over het
hebben van een eigen friture.
Uiteraard wil ik de leden van de beoordelingscommissie: Prof. dr. J.P.M. Geraedts, Dr. W.A.
Buurman, Prof. dr. J.H.J. Hoeijmakers, Prof. dr. ir. P.H.M. Lohman en Prof. dr. F.C.S.
Ramaekers bedanken voor het beoordelen van mijn proefschrift.
Drs. Harma Albering, voor je collegialiteit en zo af en toe een overpeinzing.
Dr. Paul "Bourgogne" Borm, voor het zo nu en dan beantwoorden van wat vakinhoudelijke
vragen.
Dr. Jan Dallinga, voor het beantwoorden van mijn "computer" vragen. En, ik heb het alrijd
als zeer amusant ervaren dat men van goede huize moet komen om bij jou het laatste woord
te hebben!
Drs. Jurian Hoogewerff, wij hebben bij het indienen van projekten de bureaucratie van de EG
aan de levende lijve ondervonden, maar deze gelukkig, ieder op eigen wijze, toch met succes
overwonnen. Griifi Gott und Otzi, enne.. ik heb je E-mail adres.
Soedjajadi Keman, M.D., Terima Kasih Banyak, Sobat! Good luck with your studies!
Dr. Theo de Kok, toen ik jou zag pezen op het eind van je AIO periode dacht ik: 'Waar ben
ik aan begonnen?'. Maar, je hebt me hiermee wel laten zien dat een en ander wel ergens toe
kan leiden.
Dr. Jan van Maanen, van Ajax, Roxy Music en Jethro Tull heb ik geen verstand, maar dat
heeft, zoals tijdens de EEMS meeting van afgelopen zomer weer bleek, onze collegialiteit
gelukkig nooit in de weg gestaan.
Ing. Edwin Moonen "laup naor het Lab toe, Lei", voor je Limburgse muziek op en buiten het
lab, enne.... "Noorbeek Forever".
Ing. Els Rhijnsburger, voor je gezelligheid tijdens de pauzes, je recepten en voor de fijne
samenwerking tijdens practica.
Dr. Pauline Schilderman, omdat jij eerder hetzelfde hebt doormaakt was je in staat om op
positieve wijze een bijdrage te leveren aan mijn relativeringsvermogen. Bedankt voor je altijd
aanwezige belangstelling.
Dr. Frederik-Jan van Schooten, voor je vele discussies op het gebied van 32p.postlabeling en
je aanbevelingsbrieven.
Drs. Roel "Beam me up, Scotty!" Schins, voor je legendarische rubriek "Spreuk van de
(k)week", je unieke gevoel voor humor en je muziek.
Marie-Claire van der Voort, bedaank veur dien gezelligheid en veur ut liene vaan dien
tiepmesjien. H6666666ie.
Anke Wijnen, voor treinkaartjes, kopieerkaarrjes en andere secretariele zaakjes.
Gerrie, Chris en Michel, bedaank veur ut speulen en otoklaveere vaan ut glaaswerrek en
aander labmateriaol.
Verder wil ik de volgende personen bedanken:
Mijn paranimphen: Charles van Haaster (Dag Koos, met Koos!) en Robert Passier (je was
me net voor!),
en Sylvia Jans, Reno Debets, Marjolein van Driel en Edgar Smeets voor het delen van
AIO/OIO ervaringen.
Mijn familie en Marielle.
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